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Abstract 
Optically pure chiral molecules account for an increasing number of active 
pharmaceutical ingredients (API’s); yet despite giving high enantiomeric 
excesses, existing techniques for obtaining pure enantiomers are hindered by 
low yields, high complexities, large waste streams, and hence high operational 
costs. Diastereomic crystallisation is the most commonly used resolution 
method and is capable of giving high enantiomeric excesses yet many 
additional processing stages are required to recover the desired enantiomer. If 
a racemate exists as a conglomerate, i.e. a mechanical mixture of discreet 
homochiral crystals, preferential crystallisation may be employed. However, 
both techniques are limited to a theoretical maximum yield of 50%. Coupling 
resolution by preferential crystallisation with organometallic catalysed 
racemisation in a crystallisation induced asymmetric transformation (CIAT) 
process may overcome these problems potentially giving a theoretical 
quantitative yield of a chosen enantiomer from an initially racemic solution in a 
single, efficient crystallisation step.   
CIAT was attempted under isothermal and polythermal conditions using the 
conglomerate diol hydrobenzoin and the organometallic catalyst chloro(indenyl)-
bis-(triphenylphosphine)-ruthenium(II) for solution phase racemisation. Optically 
pure product crystals were obtained with chemical purities of up to 99.71% 
when isothermal temperature programmes were employed in short process 
runs yet only relatively low yields could be recovered. Under polythermal 
conditions, crystal yields were improved significantly whilst increases of up to 
61.57% were observed in the total quantity of the desired (S,S)-hydrobenzoin 
enantiomer present in both the solid and solution phases at the end of the 
process indicating that CIAT had occurred. However, in all of the polythermal 
runs trialled, nucleation of the undesired counter enantiomer and meso forms of 
hydrobenzoin could not be avoided. This was found to be a result of the 
catalysts being completely consumed in a side reaction leading to racemisation 
ceasing to progress after approximately 1-2 h. Hence, as the seeded 
enantiomer continued to be crystallised, the concentrations of the undesired 
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species were not reduced through transformation leading to them reaching their 
metastable solubility limits. 
CIAT of hydrobenzoin was also attempted using 
chloromonocarbonyltriphenylphosphine-(1,2,3,4,5-
pentaphenylcyclopentadienyl)-ruthenium(II) which was shown to remain active 
for up to 5 days. However, over the course of the CIAT experiments which 
exceeded 2 h, hydrobenzoin in solution was converted to benzaldehyde via C-C 
bond cleavage which resulted in the seed crystals being completely dissolved.  
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i. Nomenclature 
a Activity  
B Nucleation rate # crystals m
-3
 s
-1
 
b Cooling rate K s
-1
 
C Heat capacity  J K
-1
 
C Number of components  
c Molar concentration mol m
-3
 
c* Equilibrium concentration mol m
-3
 
D Dextrorotatory  
D Diffusion coefficient  m
2
 s
-1
 
ee Enantiomeric excess % 
F Face-centred lattice (unless stated otherwide)  
G Free energy J 
G Linear growth rate m s
-1
 
       Critical free energy for nuclei formation J 
H Enthalpy J 
    Molar enthalpy of fusion J mol
-1
 
J Mass change rate kg m
-3
 s
-1
 
k Boltzmann constant W m
-2
 K
-4
 
kn Nucleation rate constant s
-1
 
kv Geometric shape factor  
L Levorotatory  
L Characteristic crystal size m 
M Mass kg 
Mw Molecular weight kg mol
-1
 
m Nucleation order (unless stated otherwise)  
n Crystal number density distribution # crystals m
-3
 
P Number of phases  
R Rectus 
note in this report, using the CIP rules, subscript A 
denotes either enantiomer, R or S e.g.    
  
   
     
 
 and   
    
    
 
 
 
R Universal gas constant 8.314 J mol
-1 
K
-1
 
r Radius m 
rc Critical radius m 
S Relative supersaturation  
S Sinister  
    Entropy of mixing J mol
-1
 K
-1
 
T Temperature K or ˚C 
T
f
 Melting (fusion) Temperature K or ˚C 
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t1/2 Racemisation half-life s 
tind Induction time s 
V Volume (unless stated otherwise) m
-3
 
v Molar volume mol m
-3
 
x Mole fraction  
α Optical rotation (unless stated otherwise) ° 
  Interfacial tension (unless stated otherwise) J m
-2
 
μ Chemical potential J mol
-1
 
  Proportionality factor  
 
Subscripts   
A Enantiomer R or S  
R Racemate (unless stated otherwise)  
c Conglomerate  
   
Superscripts   
f 
Fusion  
l 
Liquid phase  
m 
Mixing  
Rac 
Racemisation  
s 
Solid phase  
 
Abbreviations    
API Active Pharmaceutical Ingredient  
CIAT Crystallisation-Induced Asymmetric 
Transformation 
 
CSD Crystal Size Distribution  
DKR Dynamic Kinetic Resolution  
DSC Differential Scanning Calorimetry   
GC Gas Chromatography  
HPLC High Performance Liquid Chromatography  
IR Infra-Red Spectroscopy   
MSZW Metastable Zone Width  
NMR Nuclear Magnetic Resonance  
ssNMR Solid State Nuclear Magnetic Resonance   
PXRD Powder X-Ray Diffraction  
SCRAM
TM
 Pentamethylcyclopentadienyl iridium dichloride dimer or [Cp*IrCl2]2 
SCXRD Single Crystal X-Ray Diffraction  
SHG Second Harmonic Generation  
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1 Introduction 
 
 
Chirality is a geometric phenomenon whereby an object cannot be superposed 
upon its mirror image. A left hand, for example, cannot be superposed upon its 
mirror image, a right hand. Molecules exhibit chirality when their three 
dimensional spatial configuration lacks any reflectional symmetry [1] due to the 
presence of a central atom bound asymmetrically to several different groups 
(Figure 1.1). Consequently, an interchange of any two groups about the 
stereogenic centre will produce two stereoisomers[2]. The resulting pair, known 
as enantiomers, share the same chemical and physical properties in an achiral 
environment; one possessing no chiral species. However, varying degrees of 
activity are seen between enantiomers of the same molecule when other chiral 
species are present, and additionally, each enantiomer is able to rotate plane-
polarised light in opposite directions giving rise to the expression optical 
isomers. 
 
Figure 1.1a) Non-superimposable mirror images, b) two enantiomers 
[3]
.  
When more than one asymmetric centre is present in a molecule diastereomers 
are possible. These are stereoisomers that are not mirror images of each other 
due to different orientations of groups about the corresponding asymmetric 
centres in each molecule. Ephedrine, for example, contains two stereogenic 
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carbon centres resulting in four different molecular configurations (Figure 1.2 - 
Note the two possible orientations about the stereo centres are assigned either 
R (rectus), or S (sinister), using the Cahn-Ingold-Prelog notation system which 
is recommended by IUPAC[4]. DL and +/- nomenclature are also used 
throughout this report where necessary). In this case the prefix ‘pseudo’ is used 
to denote the stereoisomers with opposite configurations around their chiral 
carbon atoms. Each of these has one molecule which is a mirror image of itself 
and two that are not therefore they are either enantiomers or diastereomers 
depending on which corresponding stereoisomer is considered. Diastereomers 
are unlike enantiomers in that they have different chemical and physical 
properties allowing them to be separated from each other by conventional 
techniques e.g. crystallisation. Consequently enantiomers are often converted 
to diastereomers using a suitable resolving agent allowing for their physical 
separation. 
 
Figure 1.2 Enantiomers and diastereomers of ephedrine 
 
The building blocks of life, amino acids, are all chiral (with the exception of 
glycine) as a result of the variation of their side groups and the tetravalency 
displayed by carbon, the most prevalent asymmetric central atom. Interestingly, 
all biological organisms are comprised predominantly of levorotatory or L-amino 
acid, and dextrorotatory, or D-carbohydrate, enantiomers. Biological organisms 
therefore interact selectively with chiral molecules showing varying degrees of 
activity as a result of the chiral recognition process[5]. Cushny [6] was the first to 
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identify this phenomenon when he noticed a difference in the pharmacological 
effects of pure hyoscyamine enantiomers administered to frogs. As enzyme and 
receptor binding is enantio-specific [7, 8], different enantiomers of the same 
molecule often have different effects on biological organisms. 
In recent years this discovery has had a profound impact on the 
pharmaceuticals and agricultural industries where traditionally, many 
enantiomeric compounds were produced as a racemate i.e. an equimolar 
mixture of two enantiomers [9]. Although the enantiomers in racemic active 
pharmaceutical ingredients (APIs) do at times show the same desired effect, 
such as ibuprofren whose enantiomers are both anti-inflammatory agents [10], 
more frequently, markedly different effects can be seen in their pharmacological 
activities. Often one enantiomer is simply less active yet there have been many 
cases where one of the administered enantiomers has induced an unexpected 
side-effect. Arguably the worst occurrence of this was with thalidomide which 
was marketed as a racemate during the 1960s. The (R)-enantiomer, an 
effective sedative, was administered to pregnant patients to remedy morning 
sickness; however, unknown at the time was that (S)-thalidomide was a 
teratogen[11] and consequently thousands of children were born with birth 
defects. 
 
1.1 Methods of Obtaining Enantiopure Compounds 
Since the tragic thalidomide case, great emphasis has been placed on obtaining 
only the active enantiomer for chiral APIs. Several techniques exist although 
each is attributed with its own limitations: 
 Asymmetric synthesis 
 Diastereomic crystallisation 
 Preferential crystallisation 
 Kinetic resolution/Dynamic kinetic resolution 
 Crystallisation induced asymmetric transformation (CIAT)/ crystallisation 
induced diastereomic transformation (CIDT) 
The success of these processes is based less so on the obtainable yields and 
instead, more importance is placed on achieving high enantiomeric purities. The 
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relative amounts of enantiomer present in a mixture can be expressed as the 
enantiomeric excess, ee, with respect to the major enantiomer (Equation 
1.1[12]). For [R] > [S]: 
                        
       
       
 
Equation 1.1 
 
 
Thus a pure enantiomer has an enantiomeric excess of 100% whereas that of a 
50:50 mixture or racemate is 0%.  
The existing techniques for obtaining pure enantiomers are able to give high 
ee’s yet they are hindered by low yields, high complexities, large waste 
streams, and hence high operational costs. Asymmetric hydrogenations and 
functional group interchange from optically active alcohol to amine are capable 
of giving high yields, however, development and operation of these processes is 
often complex requiring many different reagents and processing stages [13].  
Biocatalysts such as hydrolases and transaminases used in kinetic resolutions 
have been shown to be very enantioselective giving high ee’s [14-20]  . However, 
these are often chemoselective, limiting their application, and require reactions 
in water which is an unsuitable process solvent for most organic compounds. 
Due to its relative simplicity, diastereomic crystallisation is by far the most 
commonly used resolution method being responsible the manufacture of many 
common pharmaceutical APIs. However, without recycling the unwanted 
enantiomer using racemisation, the maximum theoretical yield obtainable is 
50%, and consequently, large volumes of waste are associated with this 
process. Preferential crystallisation also suffers from the same problems. 
Several processes exist in which the desired enantiomer is crystallised inducing 
the racemisation of the counter enantiomer in-situ giving a theoretical maximum 
yield of 100%. Crystallisation Induced Diastereomic Transformations (CIDT) are 
possible, yet these all rely on chiral centres that are easily racemised[21, 22].  
Crystallisation Induced Asymmetric Transformations (CIAT) of enantiomers 
have been shown to give high yields and enantiomeric excesses[23-31], but these 
all rely on complex racemisation mechanisms which are specific to the 
compounds used. To resolve these problems, a more general racemisation 
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method must be employed which can be applied to molecules baring the same 
functional groups without the need for chiral protons with low pKa’s. 
 
1.2 Objectives 
The aim of this research is to investigate the possibility of coupling seeded 
isothermal and polythermal programmed preferential crystallisation of 
conglomerates (SIPC and S3PC respectively) with in-situ solution phase 
racemisation using organometallic catalysts. Establishing dynamic equilibrium 
between enantiomers using a suitable organometallic catalyst, and 
subsequently seeding the metastable solution with enantiopure crystals of the 
desired stereoisomer should initiate its selective crystallisation which, in turn, 
should induce racemisation of the counter-enantiomer in solution (Figure 1.3). 
Unwanted spontaneous nucleation of the antipode should be avoided if the rate 
of racemisation exceeds that of crystallisation since a racemic or near-racemic 
solution will be maintained and therefore its magnitude of supersaturation will 
be equivalent to that of the desired enantiomer. This method could potentially 
lead to a quantitative yield of a chosen enantiomer from an equilibrated solution 
in a single, efficient process step, whilst the use of organometallic catalysts 
capable of racemising functionally related compounds could increase the 
applicability of this technique by eliminating the requirement of low pKa chiral 
protons seen in existing CIAT processes. 
 
Figure 1.3 Preferential Crystallisation and b) proposed Crystallisation-Induced Asymmetric 
Transformation (CIAT) process using organometallic racemisation catalysts, with maximum 
theoretical yields of 50% and 100% respectively. 
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1.3  Thesis overview 
 
Chapter 1: Introduction and research objectives 
Chapter 2: Discussion of the underlying fundamentals of crystallisation, 
racemate phase behaviour and conglomerates.  
Chapter 3: Review of chiral amine and alcohol organometallic catalysts, 
existing crystallisation-induced asymmetric transformation techniques and 
attrition-enhanced de-racemisation 
Chapter 4: Selection and characterisation of suitable conglomerates for use as 
model compounds in the CIAT process  
Chapter 5: Selection of organometallic catalysts for racemisation of the model 
conglomerates identified in chapter 4 
Chapter 6: Identification of the CIAT conditions through characterisation of the 
conglomerate solubility, preparation of enantiopure seed crystals 
Chapter 7: Presentation of results for CIAT using the conglomerates identified 
in chapter 4, the racemisation catalysts selected in chapter 5, and the CIAT 
conditions determined in chapter 6 
Chapter 8: Study conclusions 
Chapter 9: Recommended work based on the findings of the investigations 
 
 
 
 
 
 
 
 
 
 
27 
 
2 Crystallisation  
 
 
2.1 Solubility  
Solubility describes the maximum amount of a substance that can be dissolved 
in a solvent in order to achieve a saturated solution. This is an equilibrium 
process and a function of temperature therefore solubility can be more precisely 
referred to as equilibrium solubility.  Generally solubility increases with 
temperature allowing for more solute to be dissolved. The opposite occurs with 
a reduction in temperature in which the solution becomes supersaturated 
causing a certain amount of solute to precipitate in order to re-establish 
equilibrium 
A solute-solvent system can be considered as ideal if the molecular interactions 
between the solute and solvent are identical to those between the solute 
molecules and solvent molecules themselves[32] or thermodynamically 
speaking, the enthalpy of mixing is zero. Using this approximation the 
equilibrium solubility of a given compound can be predicted using the van’t Hoff 
equation: 
     
   
 
[
 
  
 
 
 
] Equation 2.1 
 
where x is the mole fraction of solution in solution,     is the molar enthalpy of 
fusion of the solute (J mol-1),   is the solute melting temperature (K), T is the 
solution temperature (K), and R is the universal gas constant (8.314 J mol-1 K-1). 
Equation 2.1 gives solubility as a function of the physical properties of the solute 
and the system temperature; however, it does not take into account the 
presence of any solvent molecules and any interactions that may result. To 
account for the deviation from ideality displayed by most solutions, the degree 
of non-ideality must be quantified. This can be approximated by considering the 
Gibbs free energy change of dissolution,      , at a constant temperature: 
                
Equation 2.2 
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where     is the enthalpy of mixing (J mol-1 K-1) and     is the entropy of 
mixing (J mol-1 K-1). For the formation of an ideal solution the Gibbs free energy 
may also be expressed as: 
             
Equation 2.3 
 
where x represents the mole faction of one of the components being mixed in 
solution, in this case the solute. As the solution is considered ideal, the enthalpy 
of mixing,     = 0, therefore from Equation 2.2: 
          
Equation 2.4 
 
If the overall free energy change is expressed in terms of activity, a, i.e. the 
degree of deviation from ideality, Equation 2.1 can be approximated for a non-
ideal system by way of an activity coefficient,  . Therefore Equation 2.3 
becomes: 
             
Equation 2.5 
 
For an ideal solution: 
              
Equation 2.6 
 
For a non-ideal solution: 
     
Equation 2.7 
 
where the activity coefficient,  , is less than one for non-ideal systems. Thus 
Equation 2.1becomes: 
        
   
 
[
 
  
 
 
 
] Equation 2.8 
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2.2 Supersaturation  
If the solubility of a compound in a given solvent is known over a range of 
temperatures, an equilibrium solubility curve can be constructed. Consequently, 
the solubility curve for a solute-solvent system can be used to describe the 
process of crystallisation from solution by cooling. Figure 2.1 shows a typically 
solubility curve in which the solubility of the solute in question, is reduced with 
cooling. At point A, the solution is homogeneous as the temperature of the 
system is greater than the equilibrium temperature for that particular 
concentration so the solute remains in solution. It is therefore said to be 
unsaturated as it is possible to dissolve more solute in the solution at this 
temperature. With regards to a crystallisation process, this would represent the 
feed or initial state where the concentration of the solute in solution is at its 
highest point before any mass transfer to the solid phase has occurred.  
A reduction in temperature takes the system to point B. At this stage the kinetic 
motion of the molecules within the homogeneous solution is reduced and the 
thermodynamic equilibrium solubility is achieved therefore the solution becomes 
saturated as no more solute can in theory be dissolved without precipitation 
occurring. As the temperature is reduced further the system enters a region 
known as the metastable zone. At this stage the solution has more dissolved 
solute than the equilibrium concentration and is therefore supersaturated. 
However, the solute remains in solution and does not crystallise as result of a 
kinetic barrier preventing the formation of stable nuclei from which crystals are 
grown. The width of this metastable zone i.e. the temperature range in which 
the system remains supersaturated and does not crystallise, is influenced 
considerably by factors such as the rate at which supersaturation is generated, 
the intensity of agitation, and the presence of foreign particles which can act as 
nuclei[32]. This means that the width of the metastable zone can vary 
considerably if the crystallisation conditions are not kept constant. In practice 
this can be difficult to achieve. However, if the system can be held within a 
metastable, supersaturated state, crystal ‘seeds’ can be introduced to act as 
sites for crystal growth as the solute molecules will leave the liquid phase to 
allow for equilibration. Supersaturation is the driving force for crystallisation and 
the degree of which can be given by the concentration driving force,   : 
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Equation 2.9 
where c is the solution concentration and c* is the equilibrium concentration. 
Supersaturation can also be expressed as the ratio of solution concentration to 
equilibrium concentration, S, or the relative supersaturation,  [32]. 
  
 
  
 Equation 2.10 
 
In the absence of seed, at point C, crystallisation, or more precisely nucleation, 
begins to take place instantaneously. This is the formation of very small nuclei 
of the solute which is a very complex process which has yet to be fully 
understood. Nucleation occurs after an induction time, tind (section 2.3.4), which 
is the time taken to form the first nuclei to form after saturation has been 
achieved. Once stable nuclei are formed, the crystals begin to grow and take 
shape. In its simplest form, crystal growth may be considered a two-step 
process involving mass transport, either by diffusion or convection from the bulk 
solution to the crystal face, followed by a surface reaction in which the growth 
units are integrated into the crystal lattice. Either step may control the overall 
growth process, although convective mass transport is unimportant for crystals 
smaller than ca. 10 μm because these crystals are scarcely affected by 
turbulent eddies and diffusional mass transport predominates[32].  
Alternatively, supersaturation may also be described in terms of chemical 
potentials. The difference in chemical potential between a solute in the solution, 
μ1, and in the crystalline state, μ2 i.e: 
         
Equation 2.11 
and: 
           
Equation 2.12 
An expression for supersaturation can thus be obtained: 
      (
 
  
)  
  
  
 Equation 2.13 
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     (
  
  
) Equation 2.14 
 
 
 
Figure 2.1 General solubility curve showing A) unsaturated zone, B) saturation point, C) 
metastable limit/supersaturation point, D) supersaturated region
[33]
 
 
 
2.3 Nucleation 
Two modes of nucleation are possible; primary, in the absence of crystals, and 
secondary, in the presence of crystals (Figure 2.2).  
 
 
Figure 2.2 Nucleation modes 
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2.3.1 Primary Nucleation 
2.3.1.1 Homogeneous Nucleation 
The formation of crystals from a homogeneous, supersaturated solution (i.e. 
completely free of any crystalline matter or foreign particles) requires the solute 
molecules to first form thermodynamically stable nuclei to act as centres on 
which subsequent crystallisation can occur. The exact mechanism behind nuclei 
formation is yet to be fully understood, however; it is thought that localised 
concentration fluctuations in the liquid phase give rise to ordered clusters of 
solute molecules[34], with subsequent bimolecular collisions and interactions 
resulting in the formation of crystalline, lattice structures[35].  
To form the new distinct solid phase, the nuclei must become 
thermodynamically stable by achieving a critical size. Particles not reaching the 
critical size will re-dissolve, whilst those larger than this are able to grow to form 
macroscopic crystals. For a spherical particle of radius r, the overall excess free 
energy change, ∆G, between the particle and the solute in solution is equal to 
the sum of the surface excess free energy, ∆GS, and the volume excess free 
energy, ∆GV, i.e. the excess free energy between a particle with a radius, r = ∞, 
and the solute in solution[32]  or 
           
Equation 2.15 
 
Since for a spherical particle the magnitude of ∆GS is proportional to r
2 and that 
of ∆GV is proportional to r
3, Equation 2.15 becomes: 
         
 
 
       Equation 2.16 
 
where ∆GV is the free energy change of the transformation per unit volume and 
  is the interfacial tension between the developing crystal surface and its 
corresponding supersaturated solution[32]. ∆GS and ∆GV are positive and 
negative quantities respectively, and Equation 2.16 shows that they each share 
a different relationship with r, therefore; ∆G has a maximum value 
corresponding to a nuclei of critical radius, rc,. This can be found when d∆G/dr = 
0 and ∆G is at its maximum value or: 
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                Equation 2.17 
 
Therefore: 
    
   
   
 Equation 2.18 
 
The critical free energy, ∆Gcrit, can be found by substituting for ∆GV from 
Equation 2.17 and Equation 2.18 giving: 
       
     
       
 
     
 
 
 Equation 2.19 
 
Equation 2.16 is reproduced graphically in Figure 2.3 to illustrate the concept of 
the critical nuclei radius with regards to the overall free energy change of the 
particle. For all vales of r less than rc, the nuclei dissolves as the free energy of 
the particle must decrease. Similarly, for all values of r greater than rc, the free 
energy is reduced and the nuclei continue grow.  
Smaller particles have greater surface energies as a result of their increased 
surface to volume ratios therefore solubility is reduced with particle size. The 
Gibbs-Thomson equation governs the growth of the nuclei based on their size, 
surface energies and the magnitude of supersaturation displayed by the 
solution: 
  
 
  
     
   
   
 Equation 2.20 
 
where S is the magnitude of supersaturation, c is the concentration of solute 
clusters of radius r, k is the Boltzmann constant and v is the molecular volume. 
Therefore: 
     
  
 
 
       
 
 Equation 2.21 
 
and Equation 2.19 becomes: 
       
       
           
 Equation 2.22 
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The rate of nucleation, J, i.e. the number of nuclei formed per unit time per unit 
volume can be expressed as: 
               
Equation 2.23 
 
Therefore from Equation 2.22 and Equation 2.23 the nucleation rate can be 
given as follows: 
      [ 
       
             
] Equation 2.24 
 
Nucleation has considerable influence on the mean crystal size and Crystal 
Size Distribution (CSD) resulting at the end of a crystallisation process. Fast 
rates of nucleation give rise fine crystals with a narrow CSD (and vice versa) as 
little time is allowed for crystal growth. It can be seen from Equation 2.24 that 
the magnitude of supersaturation is one of the primary influences on the rate of 
nucleation along with the temperature and interfacial tension. When the 
magnitude of supersaturation, S, reaches some critical value, nucleation 
proceeds at a very fast rate therefore the degree of sub-cooling is of paramount 
importance if it is necessary to control the final CSD. Form this equation it would 
be expected that the rate of nucleation would increase exponentially and 
indefinitely with supersaturation, however, a maximum value is achieved after 
which the nucleation rate decreases.  
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Figure 2.3 Free energy change for nuclei formation 
 
2.3.1.2 Heterogeneous Nucleation 
To keep a solution completely homogenous is practically impossible, especially 
during industrial crystallizations. Foreign substances or heteronuclei e.g. dust 
particles are naturally found in process solutions and act to reduce the energy 
required for nucleation by providing a surface onto which molecules can adhere 
and grow to form crystals. It is suggested that the most active heteronuclei in 
liquid solutions lie in the range 0.1-1 μm[32]. In addition to this, the physical 
attributes of process equipment such as crystalliser walls, stirrers and baffles 
can also act as nucleation surfaces. Consequently, heterogeneous nucleation 
will occur at a reduced magnitude of supersaturation than homogeneous 
supersaturation therefore the overall free energy change associated with critical 
nucleus formation under heterogeneous conditions, ∆G’crit will be less than the 
corresponding homogeneous nucleation free energy change, ∆Gcrit
[32]. This can 
be expressed as: 
      
          
Equation 2.25 
  
  
                
 
 
 Equation 2.26 
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where the proportionality factor   is less than unity. The reduction in free energy 
was shown by Volmer (1939)[36] to be dependent on the contact angle or wetting 
of the solid phase by the solution as a result of the relative affinities for each 
phase. Thus a contact angle of 180˚ corresponds to complete non-affinity 
between the foreign substance and the crystalline solid therefore the overall 
free energy change is equivalent to that exhibited during homogeneous 
nucleation (i.e.   = 1). It follows then that contact angles less than 180 ˚ 
represent a partial-affinity between the solid and solution therefore the free 
energy change for the heterogeneous process is lower than that for 
homogeneous nucleation. The system corresponds to a seeded solution i.e. no 
nucleation occurs, when   and  = 0 and thus ∆Gcrit = 0 
[32]. 
 
2.3.2 Secondary Nucleation 
Secondary nucleation results from the addition of seed crystals to a 
supersaturated solution. The presence of seed provides a surface onto which 
molecules from the solution can adhere to build up the crystalline structure. This 
lowers the overall free energy change (relative to homogenous nucleation) 
allowing crystallisation to occur at lower degrees of supersaturation. Several 
secondary nucleation mechanisms have been suggested (Figure 2.4) based 
either on the phase from which the nuclei are derived i.e. from the solid seed 
crystals or from the solute molecules in solution. 
 
Figure 2.4 Secondary nucleation mechanisms
[34]
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Initial breeding occurs when small “crystallites”, formed on the surface of seed 
crystals during crystal growth and greater than rc, act as nucleation sites
[37, 38]  
therefore supersaturation has no effect on nucleation. This problem can be 
eliminated by washing seed crystals with a suitable solvent to remove 
crystallites and smooth out the crystal surface.  
When the magnitude of supersaturation is very large, dendritic or needle-like 
structures can be formed, which act as nucleation sites upon fragmentation in 
the solution. Similarly, at even greater degrees of supersaturation, 
polycrystalline aggregates can form which produce nucleation sites upon 
fragmentation; however, these mechanisms are unlikely to occur during 
industrial crystallisation[34].   
It is possible to form fragments greater than rc when high stirrer speeds result in 
macroabrasion of crystal seeds. Similarly, microabrasion by collision or attrition 
can both lead to the formation of fragments which act as nucleation sites in 
which case the rate of nucleation is dependent on the crystal hardness, the 
concentration of the suspension and the retention time[34]. Additionally, the 
stirrer speed and hardness has been shown to have an influence on the rate of 
secondary nucleation by enhancing macro and microabrasion[39]. 
 
2.3.3 Metastable Zone Width 
As previously described, when more solute is dissolved in a solvent than the 
equilibrium composition at prescribed operating conditions (i.e. its solubility), the 
solution is supersaturated and is said to be in a metastable state. With regards 
to cooling crystallisation, the metastable sate is achieved when the system is 
sub-cooled below the equilibrium solubility for a given concentration and no 
crystallisation results (see Figure 2.1). It is expected that at this stage, 
spontaneous nucleation will occur; however, it is first necessary form molecular 
clusters of critical radius, rc, and thus the solution will remain supersaturated 
until this condition is met. The size of rc is dependent on the extent of sub-
cooling i.e. the magnitude of supersaturation achieved. Combining Equation 
2.18 and Equation 2.21 gives the critical radius taking into account the effect of 
supersaturation[32]: 
 
38 
 
   
   
       
 Equation 2.27 
 
As the magnitude of supersaturation is increased, the size of the critical radius 
necessary for crystallisation to ensue is reduced and, as a consequence, the 
time taken for nucleation to occur, tind, is also reduced. The rate of nucleation 
can therefore be controlled by the extent and rate of sub-cooling employed and 
hence the solution becomes less and less stable as supersaturation is 
increased[34].  Eventually the solution will become unstable resulting in 
crystallisation as it reaches its maximum non-equilibrium solute capacity. This is 
known as the metastable limit, or the spinodal, which is the absolute limit of the 
metastable zone at which phase separation must occur[34]. 
Many different factors influence the width of the metastable zone (MSZW) for 
example[32, 40, 41]: 
 The cooling rate (rate at which supersaturation is generated) 
 Saturation temperature 
 Intensity of agitation 
 The presence of crystalline material, impurities or other foreign particles 
such as dust 
 Solution thermal history i.e. the extent of heating above the saturation 
temperature prior to cooling 
 Solubility 
 Viscosity  
 Type of solvent 
It is therefore difficult to accurately define the MSZW and in practice, 
crystallisation processes relying on crystal seeding operate well within the 
metastable zone to minimise the potential for spontaneous nucleation. 
Using the empirical method proposed by Nyvlt[42, 43], measurement of the MSZW 
allows the nucleation kinetics to be determined.  The nucleation rate, J, can be 
defined as being a function of the maximum supersaturation possible, ∆cmax, 
giving the empirical relationship: 
         
  
Equation 2.28 
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Equation 2.29 
 
where kn is the nucleation rate constant and m is the order of nucleation. ∆cmax 
can be expressed as a function of the MSZW which is equivalent the maximum 
possible sub-cooling, ∆Tmax: 
      (
   
  
)      
 
Equation 2.30 
 
                   Equation 2.31 
where dc*/dT is the dependence of solubility on the solution temperature, T, and 
Tsat and Tcryst are the saturation and crystallisation temperatures respectively.  
The rate of nucleation at the metastable limit can be expressed as[34]: 
  (
   
  
)   Equation 2.32 
 
where b is the cooling rate. Combining Equation 2.28, Equation 2.30 and 
Equation 2.32, simplifying and taking logarithms results in an expression which 
relates the MSZW to the maximum supersaturation temperature: 
             
   
  
                Equation 2.33 
 
A plot of log b against log ∆Tmax will result in a straight line, the slope of which 
being equal to the order of nucleation, m, with the constant, kn, being obtained 
at the intercept[43]. 
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2.3.4 Induction Time 
The time delay between the onset of supersaturation and the formation of the 
first crystals of detectable size is known as the induction time, tind. This takes 
into consideration the time taken to achieve steady-state nucleation, tr, the time 
taken to form of stable nuclei, tn, and the time required for the nuclei to grow to 
a detectable size, tg, therefore tind can be expressed as
[32]: 
              
Equation 2.34 
 
2.4 Crystal Growth 
The formation of crystals involves the growth of stable nuclei by molecular 
surface addition.  Molecules in the bulk solution are transported either by 
diffusion or convection to the surface of the crystal and subsequently integrated 
into the crystal lattice in a surface reaction with either step controlling the rate of 
the overall process[44].  For a non-ionic crystal, the theoretical linear diffusion-
controlled growth rate, G, can be expressed as: 
  
  
     
 
 Equation 2.35 
 
where D is the diffusion coefficient, v is the molar volume and L is the crystal 
size. Convection-controlled crystal growth is less important as crystals with a 
size, L, less than 10 μm only slightly affected by turbulent eddies.  
 
Integration of molecules onto the crystal surface has a considerable influence 
on the overall rate of crystal growth. Two mechanisms dominate this process; 
polynuclear or birth and spread, and BCF or spiral growth. In the former, two-
dimensional nuclei form on the surface on the crystal which subsequently grow 
and spread forming a new monolayer (Figure 2.5). This process is analogous to 
three-dimensional nucleation in that it is necessary to form stable surface nuclei 
for growth of each new monolayer to ensue. The critical two-dimensional radius 
can therefore be similarly expressed in terms of supersaturation, S, and the 
step edge free energy, α, as[45]: 
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 Equation 2.36 
 
 
Polynuclear growth is favoured by high supersaturations as the nuclei are only 
required to reach a small size to become stable. As the magnitude of 
supersaturation is decreased, many more molecules are required to form rc the 
and BCF growth begins to dominate[45]. This mechanism occurs due the 
existence of screw dislocations which result in the formation of a step on the 
crystal surface (Figure 2.5a). Molecules are incorporated into the kinks 
associated with the formation of these step resulting in their growth in a spiral 
manner. It is therefore not necessary to form surface nuclei as sites for 
molecular addition are constantly provided as long as a screw dislocation is 
present hence growth by this mechanism can occur at low supersaturations. If 
the crystal surface becomes completely flat, growth can occur only by the 
polynuclear mechanism. 
 
Figure 2.5 Crystal growth mechanisms a) polynuclear 2D nucleation b) spiral/BCF 
 
The rate of crystal growth can be determined by considering either the linear 
growth rate of a chosen face or the indirect estimation of the overall linear 
growth rate, incorporating all crystal faces, by measuring the change in mass of 
an individual or group of crystals during crystallisation. Consequently three 
methods of expressing crystal growth rate exist[32]: mass deposition rate, B, 
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(kg/m2.s), mean linear growth velocity,  ̅ = dr/dt (m/s), and overall linear growth 
rate Gcryst = dL/dt (m/s). These are related as: 
 
      
  
 
 
  
  
 
         
 
 
   
 
  
  
 
    ̅ 
 
 
Equation 2.37 
 
 
where L is the characteristic crystal dimension, r is the radius of the equivalent 
sphere, g is the crystal growth order and   and   are volume and surface shape 
factors respectively which are related to the particle mass, m, and surface area, 
A, by[32]: 
 
 
       
 
Equation 2.38 
 
      
Equation 2.39 
 
2.5 Enantiomers 
2.5.1 Racemates 
Equimolar mixtures of two enantiomers whose physical sate is unspecified are 
referred to as racemates [9]. In the crystalline sate, enantiomers of a given 
molecule are able to assume three different structures; racemic compound, 
conglomerate, or solid solutions (Figure 2.6).   
Racemic compounds are the most prevalent accounting for approximately 90% 
of all crystalline racemates according to literature sources[1] yet no 
comprehensive investigation to date has confirmed this figure. These are co-
crystals that are comprised of a 1:1 mixture of each enantiomer, alternating 
within the crystal lattice in an ordered array. Conglomerates are mechanical 
mixtures of discrete, homochiral crystals which account for approximately 10% 
of all racemates yet their occurrence may be underestimated as chemists rarely 
characterise both racemic and pure enantiomer crystal structures. 
Conglomerates are of particular interest since an optically active compound can 
be obtained directly by resolution rather than requiring multiple, time-consuming 
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(and therefore expensive) processing steps as is required with diastereomic 
crystallisation. Moreover, they are separable by physical methods such as 
manual sorting, as performed in Pasteur’s experiment.  Solid solutions are 
much less common than the former and are rarely encountered therefore these 
will not be discussed any further. Analogous to polymorphism, the same 
racemate may exist as either a racemic compound or a conglomerate 
depending on their formation conditions i.e. solvent and temperature, with either 
being the most stable phase (for example 2-chromomandelic acid can exist as a 
stable racemic compound or a metastable conglomerate when the 
crystallisation conditions are varied [46]). 
 
Figure 2.6 Crystalline racemates 
 
2.5.2 Binary Phase Equilibria 
Phase diagrams describe the equilibrium relationships between distinct, 
mechanically separable portions of a system comprised of one or more 
components, as a function of temperature, pressure or concentration. These 
can therefore be used to distinguish between different types of racemate as 
they each exhibit characteristic melting behaviours as a result of their differing 
racemic crystal structures. If both enantiomers are available, it is possible to 
construct a binary phase diagram using DSC by measuring the melting points of 
a range of different enantiomeric compositions. Roozeboom[47] was the first to 
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characterise binary systems of crystalline racemates based on their melting 
points (Figure 2.7). In each case, the horizontal line represents the solidus 
below which only the solid phase exists. Above this, the solid and liquid phases 
can coexist until the liquidus line is reached, after which only the liquid phase is 
present.  
 
  
Figure 2.7 Characteristic binary phase diagrams for crystalline racemates: a) racemic 
compound b) conglomerate c) solid solution 
[48]
 (numbers indicate the number of phases 
present) 
 
The Gibb’s phase rule can be used to better understand the different regions of 
the phase diagrams with regards to their dependence on the system conditions. 
This describes the number of intensive variables in a system i.e. temperature 
pressure and component fraction, that can be altered without a change in the 
phases present, and is known as the degrees of freedom. For a given system 
consisting of a number of components, C, and phases, P, the degrees of 
freedom can be given by[32]  : 
        
Equation 2.40 
 
For condensed systems i.e. those with no gases present, pressure has little 
effect on phase equilibrium therefore Equation 2.40 can be reduced to:  
        
Equation 2.41 
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2.5.2.1 Conglomerates 
Conglomerates are the primary focus of this study due to their ability to be 
resolved directly from the melt or solution by seeding. Conglomerates are 
characterised by the existence of only a single eutectic point which occurs only 
when the enantiomers are present in a 50:50 mixture. At the eutectic point the 
system is invariant since C = 2 (each enantiomer is a single component), and P 
= 3, therefore F = 0 and any change in temperature (or concentration) will result 
in a change in the number of phases present.  Two phase regions are present 
either side of the eutectic point which consist of a pure enantiomer, R or S, and 
a liquid phase, saturated with respect to the excess enantiomer, whose 
composition is given by the corresponding point on the liquidus curve. Below 
the solidus line, both enantiomers are present as discreet crystals this is a bi-
phasic region, and above the liquidus line, both enantiomers are present in the 
liquid phase. The melting point of the pure enantiomers is always higher than 
that of the racemate. As the conglomerate consists of physically distinct crystals 
of each enantiomer, it would be expected that they share the same melting 
points. However, this is not the case and in fact, a difference in temperature 
between the enantiomers of > 25˚C is usually an indicator for the presence of a 
conglomerate [9] (section 2.6.2 melting behaviour). 
Consider the binary phase diagram for a conglomerate forming mixture of 
enantiomers, Q (Figure 2.8). In this case R, the more abundant enantiomer, has 
a mole fraction represented by point x; the mole fraction of S is therefore (1-x). 
In the solidus region, a mechanical mixture of R and S are present. Heating the 
mixture to the eutectic line initiates the melting of all of the S crystal and an 
identical mass of R crystals (i.e. 2(1-x)) as the number of degrees of freedom, F 
= 1. At this point, only R exists in crystalline form whilst the liquid phase has a 
eutectic, i.e. 50:50 composition represented by point E. On further heating, the 
R crystals continue to melt in the two-phase region and the liquid phase follows 
the liquidus curve ETfA until the temperature reaches T
f. All of the remaining R 
crystals melt at this point and the liquid phase has the composition m 
resembling the starting solid phase composition. 
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Figure 2.8 Binary phase diagram for a conglomerate forming racemate. x is the mole fraction of 
the excess enantiomer, R, in a mixture, Q. 
Enantiomers of conglomerate forming chiral systems are miscible in the liquid 
phase whilst being, by definition, immiscible in the solid phase. Assuming that in 
the liquid phase, the enantiomers behave ideally (i.e. there are no molecular 
interactions between the antipodes thus the enthalpy of mixing, ∆Hl
m = 0), and 
that the difference between the enantiopure liquid and solid phase specific heat 
capacities, Cl and Cs (cal mol-1 K-1), remains constant with respect to 
temperature (for a conglomerate Cl = CA
l = CR
l and Cs = CA
s = CR
s), the melting 
point, Tf, of a given mixture of enantiomers can be determined using the 
Schröder van-Laar equation[49, 50]: 
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Equation 2.42 
 
where x is the mole fraction of the excess enantiomer,    
 
(cal mol-1) and   
 
 
are the enthalpy of fusion and melting point of the pure enantiomers 
respectively, R is the universal gas constant (cal mol-1 K-1), and subscript A 
denotes either enantiomer. Equation 2.42 is seldom used as the effect of 
specific heat capacities on fusion temperature is negligible; instead the 
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simplified form is sufficient to calculate the binary phase diagram using the 
experimentally determined pure enantiomer heat of fusion and melting point: 
    
   
 
 
(
 
  
  
 
  
) Equation 2.43 
 
 
2.5.2.2 Racemic Compounds 
Racemic compounds are characterised by the presence of two eutectic points 
i.e. where the three phases; solid R, solid S, and a liquid phase mixture of R 
and S, all coexist at equilibrium.  50:50 mixtures of enantiomers can exhibit a 
melting point either lower or higher than the pure enantiomers with the latter 
being exclusive to racemic compounds. Below the solidus line (Figure 2.7) only 
a single phase exists as both enantiomers are mechanically indistinct. A two-
phase region exists at the far left and right hand sides of the diagram consisting 
of a pure enantiomer and a liquid phase, saturated with respect to the excess 
enantiomer, whose composition is given by the corresponding point on the 
liquidus curve, with a third two-phase region located at the centre of the 
diagram where the racemic crystals and the liquid phase coexist. Only the liquid 
phase consisting of the two miscible enantiomers is present above the liquidus 
curve. 
Assuming ideality, it is possible to construct a binary phase diagram for racemic 
compounds using the Prigogine-Defay equation which relates the melting point, 
Tf (subscript f denotes the end of fusion) of the major enantiomer, x, to the 
enthalpy of fusion,    
 
, and melting point,   
 
, of the racemate [9]: 
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) Equation 2.44 
 
 
2.5.3 Ternary Phase Equilibria 
Ternary phase diagrams describe the equilibrium relationship between three 
different components under prescribed conditions of temperature, pressure, or 
concentration. The aim of this study is to preferentially crystallise one 
enantiomer from solution, and as a mixture of two enantiomers and a solvent 
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are a three-phase thermodynamic system, it is essential to understand the 
stable and metastable equilibrium relationships between them. 
 
Taking into account the presence of solvent, the planar binary phase diagrams 
described in the previous sections become three dimensional. For simplicity, 
however, the ternary phase diagram is generally presented as a 2D isothermal 
slice, with a collection of these isotherms allowing for the construction of the 3D 
representation. Both will be considered in the following discussion.     
The isotherm for a ternary conglomerate-solvent system consisting of 
enantiomers R and S, and solvent, V, is presented in Figure 2.9a[51]. Each 
vertex represents the pure components with the mole fraction of R, S and V 
following the lines SR, RV and SV respectively. DE and DE’ are the equilibrium 
solubility curves for R and S respectively, and the eutectic point is given by 
point E. The extensions of the solubility curves (dotted lines) are the metastable 
solubility curves for each enantiomer. The region A represents an 
undersaturated solution of R and S  in the solvent, V. B and B’ are the bi-phasic 
regions consisting of pure R crystals + a solution saturated in R, and S crystals 
+ a solution saturated in S, respectively. Discreet crystals of R and S + a 
solution saturated in R and S exist in the region C. As enantiomers share the 
same physical properties in a non-chiral environment, the phase diagram is 
symmetrical 
Consider a binary mixture of enantiomers with an excess of R whose 
composition is given by v. If a small amount of solvent is added, the system 
moves point w. Recrystallisation of the system, e.g. by cooling, gives crystals 
exhibiting a new composition, U, and a racemic solution whose composition is 
represented by point E. When more solvent is added, the system moves to x, 
where recrystallisation gives pure crystals of and a racemic solution R therefore 
S is entirely in solution, which itself is racemic. Continuing to add solvent, the 
system moves to y where the pure R crystals are in equilibrium with a solution 
saturated in R whose composition is given by m. At z, recrystallisation results in 
a homogeneous yet saturated solution with a composition mirroring that at the 
start (v). Beyond z the solution remains undersaturated. 
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Collecting a series of ternary isotherms allows the 3D polythermic phase 
relationship for the R-S-V system to be depicted (Figure 2.9b). As the 
temperature is increased, the undersaturated 1 phase region grows larger 
corresponding to the increasing solubility of the enantiomers. The solubility 
curve for racemic mixture can therefore be deduced by following the eutectic 
curve Eε, with the solubility for varying enantiomeric compositions given by the 
shaded surfaces (Figure 2.9c). TfR is the melting point of the racemate, E, and it 
can be seen that the plane TfA-R-S-T
f
R represents the binary phase relationship 
for the two enantiomers. 
 
 
b) 
 
c)  
 
Figure 2.9 Isothermal section of a ternary phase diagram for a conglomerate forming system R-
S-V, showing the different regions A: undersaturated solution, B and B': R solid + solution 
saturated in R and S solid + solution saturated in S respectively, C: R solid + S solid + solution 
saturates in S, b) Polythermal 3D representation of the R-S-V system constructed using three 
isotherms, c) symmetrical surface od solubility for the R-S-V surface
[51]
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Figure 2.10a-c illustrates the isoplethal plane R-Y-T for a ternary system 
forming crystalline conglomerates[51]. Throughout this section of the phase 
diagram, the solute-solvent ratio is constant which is of significant importance to 
the crystallisation process, as, in the figure displayed, only R crystals are 
produced if the system does not deviated from this plane. These diagrams are 
used to describe preferential crystallisation and will be considered more detail in 
section 2.6.5 
 
   
Figure 2.10 R-Y-T isoplethal plane in a ternary phase diagram, for the conglomerate crystal 
system, in which the ratio S:V is constant, b) isolated isopleth illustrating the various regions 1: 
R solid + S solid + V solvent, 2: S solid + solution saturated in R and S, 3: R solid + solution 
saturated in R, 4: undersaturated solution, 5: S solid + solution saturated in S, 6: S solid + V 
solvent + solution saturated in R and S, c) trajectory of solution phase composition on cooling 
for the T-R-Y isopleth in which the system remains equilibrated throughout the process
[51]
 
 
2.5.4 Phase Diagram Construction 
If the racemate and at least one of the pure enantiomers are available, it is 
possible to construct a binary phase diagram by simply measuring the melting 
points of enantiomer mixtures with a range of compositions. Differential 
Scanning Calorimetry (DSC) is an effective and accurate technique that can be 
employed[52-54].  The samples must firstly be prepared by mixing a known 
amount of racemate and pure enantiomer and either crystallising form the melt 
or by solvent evaporation. It is essential that the crystalline sample is as 
homogeneous as possible which can be achieved by crushing or grinding[9]. For 
accuracy, it is useful to determine the ee for each sample, for example by chiral 
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chromatography, eliminating any experimental error associated with sample 
weighing. 
Due to the symmetrical nature of enantiomeric binary (and ternary) phase 
relationships, only a single enantiomer and the racemate are required to 
construct half of the phase diagram with the other half being safely assumed as 
identical. Additionally, it may only be necessary to identify several melting 
temperatures for the different compositions as coincidence with the calculated 
equilibrium lines, signifying ideality, would allow for the remainder of the 
diagram to be determined numerically. 
Construction of ternary phase diagrams require the identification of the solubility 
curves at a constant temperature for the pure enantiomer and racemate, and a 
range of mixtures, in a chosen solvent system. Generally five or six mixtures of 
enantiomers, the pure and racemic forms are required, covering the range 0-
100% ee in equal increments[9]. Sufficient time should be allowed to ensure that 
equilibrium is achieved between the solid and liquid phases. Thus identifying 
the saturated solution phase enantiomeric composition e.g. by chiral GC/HPLC 
gives a single point of the solubility curve. Figure 2.11 illustrates this process. 
Allowing a mixture of enantiomers, R and S, and solvent, V, of composition, b, 
to reach equilibrium results in a saturated solution whose composition is given 
by c. The composition of the crystal phase, A, can be estimated by drawing the 
tie line ca. Repeating the process for different compositions allows the solubility 
curve PEP’ to be constructed, and drawing tie lines from the eutectic point, E, 
segregates the bi and tri-phasic regions. 
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Figure 2.11 Construction of a conglomerate ternary phase diagram 
 
 
2.6 Conglomerates 
2.6.1 Formation 
Chiral molecules are by definition unsymmetrical. It follows then that homochiral 
crystals must occupy only chiral crystallographic space groups i.e. those with no 
inverse elements of symmetry i.e. a centre of inversion (one-fold rotary 
inversion) or a mirror plane (two-fold rotary inversion)[55]. Of the 32 point groups, 
11 are void of inverse symmetry elements therefore only 65 space groups are 
possible for enantiomers crystallising as conglomerates with the most frequently 
encountered being P212121 (~58%) and P21 (~30%) 
[9]. Conversely, racemic 
compounds can occur in all crystal configurations; however, these are generally 
limited to the 164 space groups exhibiting inverse symmetry elements[9]. This 
may be a contributing factor towards the infrequent occurrence of enantiomers 
crystallising as conglomerates. 
Conglomerates are highly desirable as they possess the unique characteristic of 
being resolvable by crystallisation rather than comparably more complex 
processes. Consequently, much research has been concerned with 
investigating the factors influencing their formation[56-64]. The most 
comprehensive study to date, performed by Kinbara et al[65], involved X-ray 
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crystallographic studies on a range of chiral primary amine salts with achiral 
carboxylic acids. Previous studies[66, 67] had suggested a link between the 
occurrence of a conglomerate and the characteristic columnar hydrogen bond 
networks observed in the crystals of chiral 1˚ amine-carboxylic acid salts 
therefore an assortment of different crystals were examined to provide some 
statistical evidence for this observation; seven conglomerates, seventeen 
racemic compounds and four pure enantiomers. Each of the enantiopure salts 
and those crystallising as a conglomerate displayed characteristic hydrogen 
bond networks between the molecules, and as a consequence, the space 
groups P21 and P212121 were always encountered. In each case, hydrogen 
bonding was observed between adjacent enantiomers, and also between 
translation units resulting in a columnar assembly about a two-fold screw axis 
along the shortest cell axis, b or c[65] (Figure 2.12a). Formation of the 
macroscopic crystal structure occurs due to van der Waals interactions between 
the 21-columns resulting in either parallel (P21) or antiparallel (P212121) packing 
of homochiral columns (Figure 2.12b). Racemic compounds of these salts were 
found to crystallise in both chiral and achiral space groups (P21and P )̅ with 
equal probability. In the former, homochiral supramolecular 21-columns were 
packed alternatively, either parallel or anti parallel, by van der Waals 
interactions to form the macroscopic crystal structure. An achiral inversion 
column (P )̅ was also formed due to the existence of an inversion centre 
between the ammonium cations and carboxylate anions within the unit cell. 
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Figure 2.12 Conglomerate crystal structure of a primary chiral amine-achiral carboxylic salt 
forming a 21-column a) viewed down the axis of the 21 column (b axis) with the unit cell outlined 
(solid line) and the hydrogen bonds shown (dotted lines), b) schematic illustration of 21-column 
packing 
In another study into the formation of homochiral salt crystals, Kinbara et al[68] 
considered the role of the derivatising agent in influencing the resultant crystal 
structure. The investigation focused on chiral amines and chiral carboxylic 
acids, normally used in conjunction during diastereomeric crystallisation, rather 
than chiral amine-achiral acid systems previously investigated with direct 
crystallisation in mind.  Previous studies[69] into diastereomic crystallisation 
showed that high resolution efficiencies could be achieved when the chiral 
resolving agent exhibited a similar molecular length to the racemate, and the 
crystal produced occupied the P21 space groups. From these findings, it was 
postulated that the prevalence of conglomerates resolvable by preferential 
crystallisation could therefore be increased by using high performance 
diastereomic resolving agents as derivatising agents. Their results suggested 
that the probability of obtaining a conglomerate can be increased from ~10% to 
over 50% when the chiral derivatising agent used is also an effective resolving 
agent in diastereomic crystallisations. Generally speaking, the probability of 
obtaining a conglomerate can be increased by forming a salt using any 
derivatising agent that has a similar molecular length and/or shape as the 
racemate and forms helical 21-columns resulting from supramolecular hydrogen 
networks[65]. 
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2.6.2 Melting Behaviour 
When a crystalline substance is at its melting point the solid and liquid phases 
are in equilibrium i.e.  
 
              
Equation 2.45 
 
where the superscript f denotes fusion.  Therefore when enantiopure crystals 
melt, they are in equilibrium with a single liquid phase whereas racemates are in 
equilibrium with a binary liquid mixture. 
 
The Shröder Van Laar relationship (Equation 2.42) assumes that a mixture of 
liquid phase enantiomers behaves ideally i.e. its enthalpy of mixing is zero, 
whilst its entropy of mixing can be given by[9]: 
 
   
                    
Equation 2.46 
 
For a racemate, xR = xS (where R and S denote each enantiomer) = 0.5 therefore 
   
  = R ln 2 = 5.78 J/mol K.  
 
Racemic compounds have zero mixing entropy in the solid state, or more 
specifically zero configuration entropy. The configuration entropy for 
conglomerates,    
 , given by[70], 
 
   
  (
    
  
)       Equation 2.47 
 
where Nc/m is the number of crystals per mole of material and N0 is Avogadro’s 
number,  is greater than zero; however, it is negligibly small and can only be 
measured in systems that are disordered at the molecular level[70]. The entropy 
of mixing associated with the melting of a binary mixture of enantiomers is 
therefore    Rln2 greater than that of the pure enantiomer which, as a 
consequence, has a higher melting point due to the lower free energy of the 
liquid phase. A conglomerate has the same enthalpy and, in effect, the same 
entropy as the pure enantiomers. The difference in melting point between 
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racemic conglomerates and their corresponding crystalline enantiomers is thus 
determined only by the liquid with which it is in equilibrium. 
Figure 2.13 illustrates this graphically. The free energy of the “racemic” liquid 
RTln2 is less than the enantiopure “chiral” liquid. For chiral crystals i.e. 
enantiopure crystals, the melting point is located at the intersection of the liquid 
free energy curve for the enantiopure liquid. Similarly, the conglomerate and 
racemic compound melting points can be obtained at the corresponding 
intersects of the binary liquid phase free energy curve. Figure 2.13 also shows 
that the racemic compound an conglomerate are in equilibrium with the same 
liquid i.e. there relative stabilities are only governed by their differences in 
enthalpy. In the diagram shown, the racemic compound has the higher melting 
point; however, the conglomerate is the more stable of the two. This therefore 
shows that the racemic compound is not always the most stable crystalline form 
for chiral molecules[70] contradictory to Wallach’s rule[71]: racemic compounds 
are denser than homochiral crystals and are, hence, more stable due to the 
tighter packing within the unit cell.  
 
 
Figure 2.13 Free energy diagram for the solid and liquid phases illustrating the difference in 
melting temperatures between chiral crystals i.e. enantiopure, conglomerates, and racemic 
crystals i.e. racemic compounds, as a consequence of the entropy of mixing associated with 
melting binary racemates
[70]
. 
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The enthalpy and entropy changes associated with the melting of 
conglomerates can be described using thermodynamic cycles shown in 
Scheme 2.1[9]. Consider a pair of solid phase enantiomers, Rs + Ss, at the 
melting point of the pure enantiomer, TfA. Melting yields the liquid phase Rl + Sl 
which upon mixing gives the racemic liquid, RSl. A reduction in the liquid phase 
heat capacity, Cl, occurs as the racemic liquid is cooled to the melting point of 
the racemate, TfR (note: for conglomerates there is no difference between the 
pure enantiomer and racemic solid phase heat capacities, and those for the 
corresponding liquid i.e. CsA = C
s
R = Cs, and C
l
A = C
l
R = Cs). Solidification of the 
racemic liquid to form RSs is accompanied by a change in the fusion 
enthalpy/entropy for the racemate, ∆HfR / ∆s
f
R, and the enthalpy/entropy of 
mixing of the solid phase, ∆HfR / ∆s
f
s. 
 
Scheme 2.1 Thermodynamic cycles for the a) enthalpy and b) entropy changes associated with 
the melting of a conglomerate (subscripts s and l denote solid and liquid phases respectively). 
 
The Shröder Van Laar expression (Equation 2.43) for ideal conglomerates 
postulates that the enantiomers are perfectly miscible in the solid phase and are 
ideal in the liquid phase i.e. ∆Hms = ∆H
m
l = 0. Therefore using Scheme 2.1 the 
following expressions can be obtained: 
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     Equation 2.48 
 
   
     
            
    
   Equation 2.49 
 
As Cs>Cl and has a magnitude of 84–168 J mol-1 [9] and TfA-T
f
R for 
conglomerates is typically 20-30°C, ∆HfA > ∆H
f
R with the difference for ideal 
systems lying between 1.7-5.0 kJ mol-1.  
Considering entropy changes, a mechanical mixture of two separate phases, Rs 
and Ss, constitute the conglomerate, RSs, therefore no entropy change is 
associated with the mixing of Rs and Ss i.e. ∆s
m
s = 0. However, for the liquid 
phase enantiomers, Rl and Sl, interactions between them result in the entropy of 
mixing, ∆sml, being equal to Rln2 = 5.78 J mol
-1 if they behave ideally (see 
Equation 2.46). Using Scheme 2.1, in a similar manner as shown above for 
enthalpy, the following expressions can be obtained which permits calculate of 
∆sml for a given system using the experimentally determined melting points and 
enthalpies of fusion of the racemate and pure enantiomer: 
 
   
       
  
 
  
     
     
      
  
 
  
     
    Equation 2.50 
 
    
   
   
 
  
  
   
 
  
  
   
     
 
  
    
   
  
 
  
  Equation 2.51 
 
 
2.6.3 Solubility 
Since enantiomers share the same physical and chemical properties, their 
solubilities are identical. Assuming ideal behaviour, each enantiomer exhibits its 
solubility independently when present as a mixture of crystalline enantiomers in 
equilibrium with a saturated solution. As a consequence, a 50:50 mixture will 
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have a solubility twice that of the pure enantiomers. This is known as the 
“Meyerhoffer double solubility rule”[72].  
Using crystals of the conglomerate forming imine 2-methyl-benzaldehyde and 
phenylglycinamide in equilibrium with a saturated racemic solution, Izumi 
(2009)[73] showed that this is also true for enantiomers racemising in solution. 
The compound undergoes rapid base-catalysed racemisation in methanol when 
small amounts of 1,8-diazabucycloundec-7ene (DBU) are added. Little variation 
was seen between the solution concentrations of non-racemising and 
racemising systems. It must follow then that for slower rates of racemisation, 
whereby the solution can be observed to be non-racemic, the solid-liquid 
equilibrium position changes throughout the duration of the process as the 
solution phase ee evolves. At the end of crystallisation, dissolution of an equal 
amount of homochiral crystals should be observed for an equilibrated slurry with 
and initial crystalline enantiomeric excess undergoing slow racemisation. This is 
a result of the entropy of mixing increasing as the solution becomes racemic i.e. 
the solid phase is in equilibrium with a solution that has a different enantiomeric 
composition hence some solid dissolves to re-establish solid-liquid equilibrium . 
This may need to be addressed during this study if the racemisation rate is 
found to be too slow to maintain a racemic solution yet fast enough to prevent 
nucleation of the counter enantiomer. The product crystals can simply be 
filtered from the process solution at the end of crystallisation and before solution 
phase racemisation is achieved. 
 
2.6.4 Detection 
The first successful detection of a conglomerate was by Pasteur in 1848[74]. The 
sodium ammonium tartrate tetrahydrate crystals which he was using displayed 
hemihedral <111> faces which allowed each homochiral crystal to be 
distinguished under a microscope. This technique is applicable to chiral 
compounds crystallising the same space group P212121 as these display 
hemihedrism; however, visibility of the faces is dependent on the crystal habit. 
Additionally, this method of manual sorting is very inefficient and becomes 
unfeasible beyond laboratory scales. 
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When both the racemate and pure enantiomers are present, characterisation of 
the racemate type can be achieved using modern spectroscopic techniques that 
are capable of distinguishing differences in solid state structure; powder X-ray 
diffraction (PXRD), single crystal X-ray diffraction (SCXRD), infrared (IR), 
Raman spectroscopy and solid-state nuclear magnetic resonance (ssNMR). 
Since the molecular arrangements seen in opposing homochiral crystals are 
identical yet opposing, and conglomerates are mechanical mixtures of these, 
the resultant spectra for the racemate and corresponding pure enantiomers will 
be superimposable. SCXRD is particularly useful as this allows for 
characterisation of the crystal structure. 
When sufficient quantities of both the racemate and one of the enantiomers are 
available, the characteristic binary phase diagram can be constructed. This can 
be achieved by mixing varying amounts of the racemate and pure enantiomer to 
give a desired enantiomeric excess, and measuring the resultant melting point 
using a thermal analytic technique such as DSC (for systems in which thermal 
decomposition is not observed below the melting point of the pure 
enantiomers). Using only one of the enantiomers and the racemate, several 
samples of different ee are all that is required to construct the diagram. If the 
melting point of any of the mixtures is lower than that of the racemate, a 
racemic compound must be present as the eutectic points are always at 
compositions other that 50:50. Samples with an ee close to 0% must therefore 
be prepared to account for systems forming a racemic compound whose 
eutectic points are close the racemic composition. If the racemate is a 
conglomerate, the melting points of the mixtures will always decrease from the 
pure enantiomers to the racemate. Additionally, the experimental data can be 
compared with the values obtained using the Shröder Van Laar and Prigogine-
Defay expressions whereby coincidence with the calculated curve indicates the 
presence of a conglomerate or racemic compound respectively. 
Another simple yet effective characterisation technique requiring both a single 
enantiomer and the racemate is the solubility test. Addition of the pure 
enantiomer to a saturated racemic solution will result in no dissolution or 
partial/complete dissolution if the racemate is a conglomerate or racemic 
compound respectively. This is analogous to construction of the binary phase 
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diagram in which the racemic compound has a lower stability as its 
enantiomeric composition deviates from racemic up until the eutectic points, 
upon which the stability subsequently increases.  
The number of characterisation techniques becomes limited when only the 
racemate is available. Analysis of a single crystal using chiral chromatography 
(GC and HPLC) can give an indication to which form of racemate is present. For 
a racemic compound, both enantiomers are present in the unit cell therefore two 
peaks will appear on the resultant plot when a single crystal of the racemate is 
analysed. Conversely, only a single component will be identified if the racemate 
is a conglomerate as each crystal is homochiral. Polarimetry can be used in a 
similar manner whereby a single crystal of a racemate dissolved in a solvent will 
rotate plane polarised light if it is a conglomerate and hence enantiomerically 
pure. 
It has recently been shown by Coquerel et al[75] that it is possible to efficiently 
identify conglomerates using Second Harmonic Generation (SHG) which 
requires only a small amount of the crystalline racemate. When light of 
wavelength, λ, is beamed on a sample of the racemate, a new beam of 
wavelength λ/2 is generated for crystals occupying non-centrosymmetric space 
groups, whose intensity is given by the second order susceptibility tensor, X(2). 
Conversely, the elements of the second order susceptibility tensor, X(2), are 
zero for crystals occupying centrosymmetric space groups[51]. Conglomerates 
can therefore be quickly detected as, by definition, they can only occupy non-
centrosymmetric space groups whereas the vast majority of racemic 
compounds crystallise in those that are centrosymmetric. Despite this, there are 
several limitations associated with its use[51]. Some racemic compounds are 
able to crystallise in chiral space groups giving a positive yet false SHG 
response. Additionally, it is possible that the incident or emitted electromagnetic 
radiation is absorbed by the crystal, or that X(2) is too small to observed 
meaning that the conglomerate remains undetected. These drawbacks, despite 
being relatively infrequent, have limited the use of SHG as the sole method of 
characterising conglomerates; however, its use in preliminary analysis, as a 
complementary tool to traditional methods, is becoming more prevalent. 
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2.6.5 Preferential Crystallisation of Conglomerates 
If a racemic system can exist as a conglomerate, it may be possible to resolve 
the mixture using preferential crystallisation. Also referred to as resolution by 
entrainment, this technique involves the selective crystallisation of only a single 
enantiomer by seeding a supersaturated solution that is slightly enriched with 
the enantiomer being crystallised (although this is not a necessity). Preferential 
crystallisation is an attractive technique for resolving enantiomers since it gives 
high ees (> 99%), is relatively inexpensive and requires no auxiliaries or 
reagents; only solvents are required. Despite this, as with all chiral resolution 
methods, preferential crystallisation is limited to a maximum theoretical yield of 
50%. 
The process of preferential crystallisation was first identified by Gernez in 
1866[76]. He noticed that no crystallisation occurred when a supersaturated 
solution of levorotatory sodium ammonium tartrate was seeded with crystals of 
its antipode. The procedure was repeated using a saturated racemic solution. 
Crystallisation of only the seeded enantiomer occurred, and as a consequence, 
the composition of the resultant mother liquor had an excess of the levorotatory 
enantiomer which was subsequently crystallised upon seeding.  
Despite being confirmed as an effective resolution procedure[77], the use of 
preferential crystallisation for enantiomer resolution on an industrial scale has 
been limited primarily as only ~ 10% of compounds have been shown to 
crystallise as conglomerates[9]. However, several compounds exist which are 
resolved on an industrial scale by the entrainment process for example α-
methyldopa[78]. Development of the technique has led to three different methods 
of resolving enantiomers by entrainment[51]: 
 Seeded Isothermal Preferential Crystallisation (SIPC) 
 Seeded Programmed Polythermic Preferential Crystallisation (S3PC) 
 Auto-Seeded Programmed Polythermic Preferential Crystallisation 
(AS3PC) 
 Evaporative Preferential Crystallisation 
The general procedure for Seeded Isothermal Preferential Crystallisation (SIPC) 
is best described using a ternary phase diagram for a racemate that forms a 
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conglomerate crystal system (Figure 2.14)[79]. Note for each of the preferential 
crystallisation techniques described, ideality is assumed therefore the following 
conditions apply: 
 No solid solution exists between the enantiomers  
 No stable or metastable solvate exists 
 No unstable or metastable racemic compound exists 
 The effect of the heat of crystallisation on temperature is neglected 
Firstly consider a system where no homochiral seed crystals are used and 
crystallisation of both enantiomers is allowed to occur. Initially, the system is 
undersaturated at the temperature T1 and has a composition represented by 
point a showing there is a slight excess of the (-)-enantiomer. Although this 
does increase the rate of the resolution process, it is not a necessary condition 
therefore it is possible to start with a racemic composition. However, an initial 
enantiomeric excess can be achieved by simply dissolving a known amount of 
the pure enantiomer in an undersaturated racemic mixture to produce an 
optically active solution. If the system reaches the reduced temperature, T2, in 
the absence of seed crystals, the system will be supersaturated and the phase 
composition will move from a to c to achieve equilibrium. At this point, 
simultaneous crystallisation of both enantiomers would occur  and the eutectic 
composition consists of an equimolar mixture of both enantiomers in solution, 
and a solid composition represented by point d i.e. there is an excess of the (-)-
enantiomer crystals.  
Alternatively, if homochiral seeds are added to the supersaturated system, in 
this case the (-)-enantiomer, the change in system composition follows a 
different route. As there is an initial excess of one enantiomer in solution, this 
experiences a greater degree of supersaturation at T2 than that of the minor 
enantiomer. Consequently, when the seed crystals are added, the (-)-
enantiomer molecules in solution are deposited on the surface of the crystals 
due to chiral recognition and the greater mass transfer driving force. Hence the 
system composition follows the trajectory abc. Nucleation of the undesired (+)-
enantiomer crystals occurs at the point where the curved path abc leaves the 
line aa’ (which represents the change in system composition when only the (-)-
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enantiomer is crystallised with no nucleation of its antipode). Nucleation of the 
minor enantiomer must of course be avoided therefore the most favourable 
resolution conditions will remain close to the line aa’ for the maximum possible 
time which corresponds to the greatest difference in crystallisation rates of the 
two enantiomers[9]. 
 
Figure 2.14 Ternary phase diagram for a conglomerate system illustrating the process of 
preferential crystallisation
[79] 
It is clear that the method described for the preferential crystallisation of a single 
enantiomer is poorly productive as the theoretical maximum yield obtainable of 
the desired enantiomer is limited to the duration of time it takes for the counter 
enantiomer in solution to reach its supersaturation limit. Elsner et al[80]  
suggested a ‘quasi-continuous’ operational mode whereby each enantiomer is 
preferentially crystallised sequentially in a cyclic process eliminating these 
problems (Figure 2.15)[79]. As before, the system composition is represented by 
point a; an optically active solution. Seeding with the (-)-enantiomer whilst the 
system is supersaturated results in the growth of the seed crystals due to mass 
transfer from the solution phase to the solid surface in an attempt to reach 
equilibrium, and the system composition moves along the line ab. At b there is 
now an excess of the (+)-enantiomer in solution. The newly formed (-)-
enantiomer crystals are removed from the system (e.g. by filtration) and a mass 
of racemate equivalent to that of the crystals produced are added. The system 
now exhibits a composition represented by point c mirroring the starting 
conditions in which there is an excess of the (+)-enantiomer. The procedure is 
then repeated using seeds of the (+)-enantiomer therefore the complete cycle 
abcd is capable of producing a single batch of each enantiomer.  
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Figure 2.15 Trajectories for a sequential, cyclic preferential crystallisation process
[79] 
Figure 2.16 illustrates the experimental set-up used for the cyclic preferential 
crystallisation of threonine enantiomers in water by Elsner et al[80]. The aim of 
their investigation was to determine the feasibility of such a process and to 
identify the parameters influencing its operation. The system consists of two 1.2 
litre vessels arranged in sequence with a 250 ml filtration unit between them to 
separate the solid product from the process solution. The optical rotation and 
density of the solution within the first vessel is measured externally by 
circulating a small amount the mother liquor.  The temperature of the entire 
system, including the filtration unit, density metre, polarimeter, and all the lines 
between them, are thermostated and maintained at the process temperature to 
ensure no unwanted crystallisation occurs outside of each vessel. 
During their experiments, a batch of each threonine enantiomer was crystallised 
from a solution with a concentration corresponding to saturation at 40˚C and an 
initial enantiomeric excess of 0% i.e. a racemic solution (i.e. two subsequent 
‘half-cycles’ were employed for each enantiomer - abcd in Figure 2.15). Initially, 
the undersaturated racemic solution in vessel 1 was maintained at a 
temperature greater than its crystallisation temperature to ensure that any 
remaining particulate matter had been dissolved. After cooling 10 ˚C below the 
saturation temperature, 2.5 g of homochiral seed with a sieve fraction of 212-
300 μm were added resulting in the desired enantiomer crystallising by growth 
or secondary nucleation mechanisms. The slurry produced was then passed 
through the filter unit to remove the crop of enantiopure crystals, after which a 
mass of racemate equivalent to the mass of crystals removed was added to the 
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solution. This was then passed to vessel 2 with the procedure described being 
repeated for the opposing enantiomer.  
 
Figure 2.16 Experimental set-up for cyclic preferential crystallisation used by Elsner et al
[80]
 
To avoid nucleation of the unwanted enantiomer in each vessel, the optical 
rotation of the solution was monitored with crystallisation being interrupted when 
the solution ee reached 2% for the counter-enantiomer which corresponds to an 
optical rotation of approximately   0.056˚ (Figure 2.17 [79, 80]). This value was 
determined in similar preliminary experiments in which the counter enantiomer 
was instead allowed to crystallise whilst the solution ee was measured by 
polarimetry. The reversal of the optical rotation is indicative of the counter 
enantiomer nucleating therefore the process can be stopped at any value of 
optical rotation before the limit is achieved Obviously if crystallisation is 
interrupted closer this limit, the process will be more productive due to the 
greater crystallisation time for the desired enantiomer. However, it must be 
remembered that resolution will continue until the crystals are filtered from the 
mother liquor therefore an allowance must be made to compensate for the time 
taken for the slurry to be filtered - hence a lower ee that the actual limit is 
selected. 
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Figure 2.17 Optical rotation trajectories for two subsequent separation cycles crystallising L-
Threonine and D-Threonine sequentially
[79, 80] 
Seeded Programmed Polythermic Preferential Crystallisation (S3PC) is a 
modification of SIPC whereby crystallisation occurs over a range of 
temperatures. Figure 2.18a shows the isopleth R-Y-T for such a process. when 
the solution becomes supersaturated at Thomo, seed crystals are introduced and 
controlled cooling is applied to favour crystal growth over secondary nucleation 
and the liquid phase composition follows the  stable solubility curve HL[51] unit a 
racemic solution is achieved. Meanwhile the (R)-enantiomer leaves solution via 
secondary nucleation or crystal growth mechanisms as the system proceeds 
along LF with the liquid phase composition now containing an excess of the (S)-
enantiomer. Therefore in this method equilibrium is maintained between the 
temperatures TA to TL, whereas the (S)-enantiomer is non-equilibrated and the 
(R)-enantiomer in metastable equilibrium from TL to TF. The Pure crystals are 
filtered and an amount of racemate equal to the mass of that removed is added. 
The process is then repeated for the opposite enantiomer. 
The SIPC and S3PC processes described are limited by the fact that they 
require seed crystals for each enantiomer (for cyclic operation) produced ex 
situ. An improvement of these processes involves the in situ partial 
crystallisation of the enantiomer in excess which is subsequently used as seed; 
Auto-Seeded Programmed Polythermic Preferential Crystallisation (AS3PC) 
(Figure 2.18b). Initially the composition is given by point EB within the biphasic 
region of the phase diagram. At this temperature (TB) a slurry exists consisting 
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of the pure (R)-enantiomer in thermodynamic equilibrium with its saturated 
solution. As with S3PC, an appropriate cooling profile from TB to TL, stirring 
mode and rate are selected so the system remains close to equilibrium 
favouring crystal growth rather than uncontrolled nucleation[81], and the liquid 
composition moves along the metastable solubility curve BL.  This technique 
utilises the enantiopure crystals suspended in the slurry hence the title “Auto-
Seeded”. The Pure crystals are filtered and an amount of racemate equal to the 
mass of that removed is added. The system is then heated back to TB resulting 
in selective dissolution of the (R)-enantiomer crystals as the composition enters 
the biphasic region comprised of (S)-enantiomer crystals in equilibrium with the 
saturated racemic solution. The rate of crystallisation i.e. the rate of secondary 
nucleation and growth is influenced not only by the degree of supersaturation 
but also on the quantity of seed present at the start of the process, with a 
greater amount favouring fast crystallisation[82]  as a result of the increased 
surface area provided.  
 
 
a) 
 
b) 
 
Figure 2.18 R-Y-T Isopleth from a ternary phase diagram showing the principle of a) Seeded 
Programmed Polythermic Preferential Crystallisation (S3PC) and b) Auto-Seeded Programmed 
Polythermic Preferential Crystallisation (AS3PC)
[51]
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3 Racemisation 
 
 
3.1 Background 
 
Racemisation involves the interconversion of enantiomers to irreversibly form a 
racemate from a pure enantiomer or an optically active mixture. Since the 
enthalpy change of the enantiomers undergoing racemisation,        , the 
process is thermodynamically favourable only because of the increased entropy 
associated with the mixing of the enantiomers in the liquid phase, which is equal 
to RTln2 (Equation 2.46) [83].  
 
 
Equation 3.1 
The rate of racemisation is proportional to the concentration of the excess 
enantiomer. Assuming k1 = k2 = k, the rate equation for a reversible first-order 
reaction for conversion of the pure enantiomer R to S is given as [84]: 
 
  [
     
     
]      
Equation 3.2 
 
where S/R is the stereoisomeric ratio which approaches unity as the excess R-
enantiomer is racemised. 
Alternatively, the racemisation kinetics can be described by the decay in 
enantiomeric excess from 100% to 50% i.e. the racemisation half-life,  t1/2: 
 
       
 
  
 
Equation 3.3 
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Several racemisation methods exist which can be categorised as follows [85]: 
 Thermal racemisation 
 Base-catalysed racemisation 
 Acid-catalysed racemisation 
 Racemisation via Schiff bases  
 Enzyme-catalysed racemisation 
 Racemisation via redox  and radical reactions 
The application of these techniques remains limited due to the necessity of 
elevated temperatures, strongly acidic or basic environments, and their inherent 
specificity. A more effective approach is the use of “general purpose” 
organometallic racemisation catalysts which can be applied to chiral centres 
bearing the same functional groups in mild conditions.  
 
 
3.2 Amine Organometallic Racemisation Catalysts 
One of the first investigations into organometallic racemisation catalysts for 
chiral amines was performed by Murahashi et al [86]. (S)-(-)-α-phenylethylamine 
was quickly racemised using a palladium black catalyst under argon at 100 ˚C 
and 50˚C (Figure 3.1). However, only a 3% yield was possible as the reaction 
also produced a mixture of (S,S)-, (S,R)- and (R,R)- α, α’-
dimethyldibenzylamine (77%, ee = 1.7%), and N-(methylbenzylidene)- α-
methylbenzylamine (20%, ee = 6.6%).  
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Figure 3.1 Optical rotation profiles for the palladium catalysed racemisation of (S)-(-)-α-
phenylethylamine at 50˚C (●) and 100 ˚C (○) and the conversion at 50˚C (▲) and 100 ˚C (∆) 
[86]
. 
 
Palladium-based racemisation catalysts have since been used in the DKR of α-
methylbenzylamine in toluene at 70˚C under hydrogen. Parvulescu et al [87] 
noticed that the amine could be better preserved during racemisation when an 
alkali earth metal support was used instead of charcoal. Using 5 wt% of 
Pd/BaSO4, the selectivity was significantly improved up to 91% in 5 hours with 
the remainder being composed of ethylbenzene (ETB), however, the ee was 
25%. 2% ee was achieved with a 56% conversion when the reaction was 
allowed to proceed for 24 hours although the selectivity was reduced to 81%. 
The mechanism for the racemisation reaction involves dehydrogenating the 
amine to an imine with a subsequent hydrogenation to form the antipode 
(Scheme 3.1). When charcoal is used the imine is condensed with the amine to 
form a dimeric product with a high selectivity. However, it seems that the alkali 
earth metal supports act to minimise the formation of the condensation 
products. 
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Scheme 3.1 Mechanism for the racemisation of 1-phenylethylamine showing the formation of 
the dimeric impurities 
[87]
 
 
Park et al [19] used a Pd-nanocatalyst entrapped in aluminium oxide 
(Pd/AlO(OH)) to effectively racemise chiral amines in a DKR process giving 
enantiomeric excesses and yields of up to 99%. (S)-1-phenylethylamine (ee > 
99%) was racemised to 2% ee within 24 hours using 1 mol% of the Pd-
nanocatalyst in toluene at 70˚C. However, 18% of the resultant reaction mixture 
consisted of impurities resulting from hydrolysis and condensation side 
reactions. Additionally, some amines required 12 mol % of catalyst for effective 
racemisation. The success of their DKR, with regards to yield and ee, was due 
to the rate of the enzymatic resolution being faster than that of racemisation 
thus the formation of the side products was minimised. Problems may therefore 
arise if this catalyst were to be used in a system whose resolution rate was 
slower than the racemisation rate. 
Bäckvall et al [88] have developed an efficient ruthenium-based hydrogen-
transfer catalyst for the racemisation of primary and secondary amines. This 
can be used in mild conditions and allows for high functional group tolerance, 
improving on the Pd catalysts performance. Previous studies by the group [15] 
have shown that low valent Ru-complexes are able to catalyse the transfer 
hydrogenation of amines to imines.  (S)-1-phenylethlamine was racemised 
using 5 mo% of the Ru-complex 1 for 48 hours at 100˚C (Scheme 3.2). 
Complete racemisation was successful; however, a large proportion of the 
reaction mixture consisted of impurities 4a and 5a. To improve the process, 
several approaches were employed; dilution of the reaction mixture, addition of 
ammonia and addition of a hydrogen donor to increase the concentration of 1a.  
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Scheme 3.2 Ru-catalyst (1), used by Backvall et al 
[88]
 in the racemisation of primary and 
secondary chiral amines. Right hand side - proposed mechanism for the the formation of the 
imine 4a and amine 5a impurities during racemisation. 6 – hydrogen donor 2,4-dimethyl-3-
pentanol 
 
A significant improvement was seen in the selectivity of the process from 5% to 
91 % when the concentration was reduced; however, the ee increased from 0% 
to 6%.  When ammonia was added to the system, the production of side 
products was effectively inhibited and an ee of 2% was obtained. Despite this, 
the use of ammonia resorts back to the harsh conditions seen with traditional 
base-catalysed racemisations, and as a consequence, the functional group 
tolerance of the Ru catalyst is reduced. To eliminate this problem 2,4-dimethyl-
3-pentanol (6) was used as a hydrogen donor giving identical results; 
production of the impurities was inhibited with an ee of 2% being achieved .  
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Table 3.1 Racemization of (S)-1-phenylethylamine using an Ru-complex under a range of 
different conditions and with additives ammonia and 2,4-dimethyl-3-pentanol 
[88]
 
 
 
 
The catalyst was successful at racemising a number of different primary and 
secondary chiral amines. The later were found to racemise at a much faster rate 
requiring less than an hour to achieve 100% ee. The rate of racemisation was 
seen to be enhanced by the presence of electron-donating substituents with the 
opposite also being observed.  Despite being shown to be effective at 
racemising a wide range of different chiral amines under mild conditions, use of 
the Ru-catalyst requires high loadings (5 %) and high temperatures (100˚C+) in 
order for racemisation to proceed at a sufficient rate. 
The most robust racemisation catalyst to date has been developed by Blacker 
et al [17] which has been used in the DKR of chiral amines under mild conditions 
and with low catalyst loadings. Pentamethylcyclopentadienyl iridium(III) iodide 
dimer ([Cp*IrI2]2) (Scheme 3.3a) acts as a pre-catalyst that reacts with primary, 
secondary or tertiary amines to form the SCRAMTM catalyst which is 
subsequently used for racemisation. Preliminary investigations showed that (R)- 
and (S)-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline could be slowly 
racemised using a precursor to the CATHy catalysts 
pentamethylcyclopentadienyl-rhodium and iridium (III) chloride dimers 
([Cp*IrCl2]2) by forming an imine which can be reduced to either enantiomer. 
When [Cp*IrI2]2 was used, the rate of racemisation was increased 120 fold as 
the effective charge on the metal was modified by the addition of a different 
halide ligand, which in turn acts to alter the activity of the catalyst. 
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The racemisation of a number of different primary, secondary and tertiary 
amines was performed using SCRAMTM (catalyst loadings 0.1-1.0 mol%) in a 
range of solvents under mild conditions. Primary amines were shown to form 
large amounts of dimeric impurities (~70%) due to a combination of rapid 
dehydrogenation, and high reactivity of the resultant imine with the substrate. 
By contrast, secondary amines were shown to be efficient racemised within 22 
min to 24 hrs, with a tertiary amine being racemised in less than 21 hrs. 
The success of SCRAMTM in racemising secondary amines led to it being used 
in the DKR of the API Sertraline [16]. Each chiral centre of the waste 
diastereomer was epimerised (conformational change of a single chiral centre) 
sequentially using SCRAMTM for the amino-chiral centre and potassium tert-
butoxide for the methine. SCRAMTM showed high activity with low loadings (0.1 
mol%) in a range of different solvents, although toluene was found to be the 
most effective. Scheme 3.3b illustrates the possible mechanism for sertraline 
epimerisation and imine formation using SCRAMTM. 
 
Scheme 3.3 a) SCRAM
TM
 racemisation catalyst (Pentamethylcyclopentadienyl iridium dichloride 
dimer or [Cp*IrCl2]2), b) Possible mechanism for sertraline epimerisation and sertraline imine 
formation 
[16]
. 
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3.3 Alcohol Organometallic Racemisation Catalysts  
Unlike amines, racemisation of chiral alcohols is comparatively well established 
with many examples of organometallic complexes being demonstrated as 
effective in DKR and asymmetric transfer hydrogenations. Ruthenium sports the 
greatest number of complex variations [19, 88-115] whilst palladium [14] , rhodium 
[116], and aluminium [117] based catalysts have also all been used successfully 
often being highly active and requiring relatively mild conditions. 
 
 
Figure 3.2 Examples of ruthenium-based organometallic complexes used for racemisation in 
DKR. 
 
Perhaps the most well-known complex, Shvo’s catalyst [(η4-Ph4C4CO)(CO)2Ru]2 
(1) [91] has been has been demonstrated to be a highly effective in hydrogen 
transfer reactions being capable of giving complete conversions of many 
different substrates within 10 min. Bäckvall et al [95] were the first to utilise 
Shvo’s catalyst for racemisation in a DKR process for the resolution of a 
racemic alcohol (Figure 3.3). (R)-α-methylbenzyl alcohol was shown to be 
successfully racemised after 45 h using 2 mol% of complex (1) and 1 equivalent 
of acetophenone in tBuOH at 70°C. Combining in-situ solution phase 
racemisation using 1 with the transesterification enzyme Candida antarctica 
Lipase B, it was possible to selectively react the racemic mixture with a number 
of different acyl donors leading to the undesired enantiomer being converted in 
solution and  > 99.5% ee being obtained.  However, since the process required 
one equivalent of acetophenone, which remained present in the reaction 
mixture with most of the acyl donors trialled, relatively poor yields of the single 
enantiomer were obtained. 
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Figure 3.3 DKR of (R)-α-methylbenzyl alcohol using Shvo’s catalyst (1), Candida antarctica 
Lipase B, an acyl donor, and 1 equivalent of acetophenone 
[95]
  
 
Following on from this, the same research group found that a specifically 
designed acyl donor, 4-chlorophenyl acetate, resulted in efficient DKR of a wide 
range of chiral alcohols using Shvo’s catalyst (1), the enzyme Candida 
antarctica Lipase B for selective acylation, and 1 equivalent of benzophenone 
[118]. Using the racemate 1-phenylethanol, it was possible to obtain > 99% ee of 
the desired acylated enantiomer using 2 mol% 1 in a number of different 
solvents in as little as 20 h at 70°C. For the 13 chiral alcohols investigated, DKR 
in toluene resulted in consistently high enantiomeric purities (> 99% ee in the 
majority of cases) and considerable yields (up to 88%) demonstrating the 
effectiveness of catalyst 1 for in-situ solution phase racemisation. Furthermore, 
the DKR system developed by Bäckvall et al [95] was effectively applied [119] to 
the resolution of bifunctional alcohols such as hydroxyl acid esters [96, 120], diols, 
hydroxy aldehydes [120], β-halo alcohols [121], β-hydroxy nitriles [122],  β-azido 
alcohols[123] and hydroxyalkanephosphonates [124]. 
Catalyst 2, (η5-indenyl)RuCl(PPh3)2, was shown to be highly active for the chiral 
alcohol racemisation [89]. Complete conversion (S)-1-phenylethanol to its 
corresponding racemate was achieved in < 20 at room temperature using 1 
mol% 2 in dichloromethane (Figure 3.4). Unlike Shvo’s complex, racemisation 
did not require 1 equivalent of ketone; however, the presence of KOH or tBuOK 
in solution was necessary for activation of the catalysts. In the same study, the 
versatility of catalyst 2 was further demonstrated where, under the reactions 
conditions, it was successfully applied in the racemisation of a number of 
different chiral alcohols with complete conversion always being observed.  
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Figure 3.4 Proposed pathway for racemisation of (S)-1-phenylethan-1-ol with catalyst 2 
[89]
. 
 
In another study, Park et al [107] showed that catalyst 2 could be activated using 
a combination of molecular oxygen and triethylamine hence negating the 
requirement of low solubility KOH as shown in the previous study. Enzymatic 
resolution of 1-phenylenthanol was performed using Pseudomonas cepacia 
lipase to selectively acylate the desired enantiomer using 2 (2 mol%), oxygen (2 
mol%), which was injected after degassing the system and refilling with argon, 
and 3 equivalents of triethylamine. The reactions were performed at 
temperatures =< 40°C for 5 h in a number of different solvents resulting in up to 
99% ee of the desired acylated product being obtained. Furthermore, the 
process was also applied successfully to a number of different benzylic alcohols 
similarly giving enantiomeric purities of 99% with yields of up to 98%. 
Complex 3 and an analogue were also demonstrated as being highly active 
alcohol racemisation catalysts [103]. Complete conversation of (S)-1-
phenylethanol could be achieved within 10 min at room temperature using only 
0.5 mol% 3 which was activated using tBuOK. In a subsequent study [125] DKR 
of a range of different chiral alcohols was successfully performed using catalyst 
3 and isopropenyl acetate as an acyl donor (Figure 3.5) frequently giving > 99% 
ee, and when optimised within 3 h of reaction time. Additionally, unlike previous 
examples, DKR of 3 could also be applied to aliphatic alcohols broadening the 
application of these ruthenium-based complexes.  
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Figure 3.5 DKR of 1-pheylethanol in toluene using catalyst 3 and Candida antarctica Lipase B 
 
Catalyst 4 is one of the few ruthenium based-complexes which remains active 
under aerobic conditions. Synthesising this complex by replacing a CO ligand in 
catalyst 3 with PPh3, Park et al 
[126] were able to racemise many different 
benzylic alcohols and diols using 4 mol% 4 activated by Ag2O at room 
temperature in toluene with reaction times ranging between 1 and 5 h for 
complete conversion to the racemate. Similar to previous investigations, 4 was 
paired with Candida antarctica Lipase B and the acyl donor isopropenyl acetate 
in a DKR process which was applied to a number of both benzylic and aliphatic 
chiral alcohols giving > 99% ee of the acylated single enantiomer in all cases in 
as little as 6 h operational time. 
 
Figure 3.6 Synthesis of catalyst 4 from 3 and its use as an air stable racemisation catalyst in the 
DKR of 1-phenylethanol
[126]
. 
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3.4 Crystallisation of Conglomerates with In-situ Racemisation 
3.4.1 Crystallisation-Induced Asymmetric Transformation 
Despite its attractiveness as a method of resolving racemates, preferential 
crystallisation of conglomerates is inherently limited to a maximum theoretical 
yield of 50% of the desired enantiomer. Coupling preferential crystallisation with 
in-situ solution phase racemisation in a crystallisation-induced asymmetric 
transformation (CIAT, also referred to as second order asymmetric 
transformation or SOAT) overcomes this issue increasing the potential 
maximum obtainable theoretical yield to 100%. Since addition of the catalyst to 
the solution results in the enantiomers existing in dynamic equilibrium, the 
ternary phase diagram for given racemate-solvent, used for development of a 
preferential crystallisation, is modified so that the areas within which the pure 
enantiomers exist are inaccessible. Figure 3.7 [82] illustrates the CIAT process in 
terms of the ternary phase equilibria for a racemate-solvent system. When a 
system of racemising enantiomers is seeded, solute is enantio-selectively 
removed from solution which (for fast racemisation) subsequently leads to 
conversion of the excess antipode to re-equilibrate the solution phase. 
Consequently, as the seed crystals grow, the total composition of the desired 
enantiomer in the system increases resulting in horizontal evolution of the 
synthetic mixture as depicted by the red arrow. Simultaneously, the solution 
phase composition follows a vertical trajectory (depicted by the blue arrow) 
since the dissolved racemate is maintained by the action of the catalyst.  Figure 
3.7d shows the progression of both the solution and solid phase compositions 
during polythermal CIAT. As the system is cooled to generate a crystallisation 
driving force, the system composition gradually moves towards enantiopure 
edge of the phase diagram whilst the solution continues towards the vertices 
being representative of the reduction in solute concentration as it is removed 
due to seeding.  
 
81 
 
 
Figure 3.7 Description of crystallisation-induced asymmetric transformation in terms of the 
ternary phase equilibria for a racemate-solvent system 
[82]
. 
 
Due to the strict requirements of the CIAT process, which necessitates a 
racemic conglomerate system that can undergo solution phase racemisation 
using a catalyst, the application of CIAT has been relatively limited [23, 29, 85, 127-
131]. Chibata et al [127] successfully applied the CIAT process to the resolution 
and subsequent transformation of N-acetyl-leucine. A solution of the racemate 
in acetic acid was equilibrated using catalytic amounts of acetic anhydride and 
seeded with enantiopure crystals. Cooling at a controlled rate of 10°C h-1 from 
100°C to 40°C to generate supersaturation led to an almost chirally pure 
product being obtained with a 140% yield being obtained of the desired 
enantiomer. 
Carlson et al [29] isolated enantiopure crystals of the conglomerate narwedine 
from an initially racemic solution using CIAT. Racemic narwedine was dissolved 
in a binary solvent of 9:1 ethanol-triethylamine at 80°C in the presence of 1 
mol% galanthamine which acted as the racemisation catalyst. This was then 
cooled to 40°C, resulting in precipitation, where it was held for 16 h. Unlike the 
previous example, no seed crystals were utilised during the process; however, 
analysis of the solid after filtration showed that it consisted entirely of a single 
enantiomer. This was postulated to be due to the mechanism of conversion 
using galanthamine which was thought to stereo-selectively interact with and 
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racemise one of the narwedine enantiomers in solution generating seed in-situ 
upon cooling. Subsequent growth of these crystals due to the solution being 
supersaturated further enhanced the catalytic process leading to ~150% yield of 
a single enantiomer in one operational stage. To highlight the efficiency of the 
process, 10 g of racemic starting material gave 9.02 g of enantiopure product in 
two crystallisation cycles. 
CIAT was applied to the resolution and simultaneous antipode conversion of the 
cholecystokinin antagonist Asperlicin[132]. In preliminary experiments, separation 
of the racemate was achieved through crystallisation of its camphorsulphonic 
acid (CSA) salt from ethyl acetate leading to high yields and enantiomeric 
purities of the desired enantiomeric salt being obtained (80-84% yield and 
99.5% ee respectively) albeit the counter enantiomer constituted as waste.  
During the investigation is was noticed that the undesired antipode could 
undergo thermal racemisation at 90°C in the presence of CSA, yet at this 
temperature crystallisation was not a suitable option. By increasing the acidity of 
the chiral proton through the addition of catalytic quantities of an aromatic 
aldehyde forming an intermediate imine, it was shown that the Asperlicin could 
be racemised at ambient temperatures opening up the possibility of using CIAT 
to recycle the waste enantiomer in-situ. Consequently, the optically pure 
enantiomer was obtained in as much as 91% yield, i.e. 182% considering the 
starting composition of the desired enantiomer.  
The above brief review of several CIAT processes highlights its potential as a 
method of obtaining pure enantiomers from an initial racemate. However; in 
each of the cases discussed, and in those referenced, the common theme is 
that the applicability of each process has been limited to a single substrate 
since the mechanisms for racemisation are all system specific. Typically 
conversion of the undesired enantiomer occurs due to the presence of a low 
pKa chiral proton which can dissociate with relative ease allowing the chiral 
centre to be racemised by rehydrogenation of the resulting planar intermediate. 
Therefore the ability of a chosen species to undergo racemisation is determined 
by its functionality rather than the effectiveness of the selected catalytic method. 
In section 3.3 several organometallic complexes were discussed with each 
being capable of racemising a wide range of functionally related compounds in 
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DKR. If the capability of these catalysts could be utilised in preferential 
crystallisations, the applicability of CIAT could potentially be extended to a 
much broad range of racemates. 
  
3.4.2 Viedma Ripening 
Even when the conditions for resolution by crystallisation and racemisation 
coincide, CIAT is still limited due to the possibility of the counter enantiomer 
crystallising during the process. Viedma[31, 133, 134] has demonstrated an unusual 
method to lead to the emergence of single phase homochirality without counter 
enantiomer nucleation for inorganic chiral NaClO3 crystals initially present as an 
equimolar mixture of two enantiomorphic crystalline phases in equilibrium with 
an achiral aqueous phase (NaClO3 exists as achiral ions in solution which can 
crystallise as two enantiomeric crystals in the cubic chiral space group P21/3.  
3 mm diameter glass balls were added to an initially, racemic (with regards to 
the solid phases), equilibrated slurry. Upon agitation, attrition between the balls 
resulted in the random emergence of only single crystalline enantiomeric phase. 
When the starting slurry had an initial crystalline enantiomeric excess of 5%, the 
crystals produced at the end of the process were always of a single chiral 
phase. Viedma was able to achieve compete homochirality within 10 hours with 
a symmetric starting  composition, and 8 hours with an initial crystalline 
enantiomeric excess in a system that would otherwise maintain its starting 
composition indefinitely. It was also shown that an increase in the number of 
balls and stirring rate reduced the time taken to achieve a single chiral phase 
(Figure 3.8).  
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Figure 3.8 NaClO3 achiral solutions with an initial equimolar mixture of enantiomeric crystals 
and glass balls showing a) the time taken to achieve complete symmetry breaking depedning 
on the number of balls (600 rpm) b) the time taken to achieve achieve complete symmetry 
breaking depedning on the stirring rate (4 g of balls)
[31]
 
 
It is believed that abrasion and grinding provided by the glass balls results in the 
crystals breaking apart into smaller fragments including microcrystalline 
particles. As the solubility of the particles increases with a reduction in size 
(Gibbs-Thomson effect), these tend to dissolve back into solution subsequently 
“feeding” the larger crystals (Ostwald’s ripening).  Chirality is only a property of 
NaClO3 in the crystalline state as the unit cell is comprised of four molecules 
packing in a chiral space group. Molecular addition via mass transfer from the 
solution is therefore achiral so a dissolving particle can feed any crystal 
independent of its previous chirality. Growth of the larger crystal is favour by 
Ostwald’s ripening so by chance, either chiral phase may result randomly due to 
the enhancement by attrition (when the slurry is initially racemic). For molecules 
that are chiral in both the liquid and solid phases, racemisation must be 
sufficiently fast to emulate this. 
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Figure 3.9 NaClO3 achiral solutions with an initial 5% excess of enantiomeric crystals and glass 
balls showing the progression of symmetry breaking a) over 8 hours (8 g balls, 600 rpm) b) over 
24 hours (4 g balls 600 rpm)
[31]
 
 
Similar results were seen by Sainz-Diaz et al[28] using 1,1-binaphthyl 
enantiomers which spontaneously racemise in solution at room temperature 
over the course of several hours, or in the melt at 180˚C in a matter of 
seconds[135, 136]. A mixture of 1,1-binaphthyl was held at 180˚C to for 20 min to 
ensure complete racemisation. Crystallising from solution at 150˚C produces a 
racemic compound; however, crystallising at the same temperature whilst 
stirring eventually led to enhancement of chiral discrimination in the solid phase 
producing crystals with a large enantiomeric excess. Figure 3.10 shows the 
powder X-ray diffraction patterns for the two samples obtained with and without 
stirring, and for the enantiomeric and racemic forms of 1,1-binaphthyl. It is clear 
that stirring results in transformation from the racemic to enantiopure crystal 
forms. Analogous to grinding with balls, stirring induces the micro-fragmentation 
of crystals producing nuclei or clusters which dissolve due to their increased 
solubility feeding the growth of larger crystals.  
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Figure 3.10 Powder X-ray diffraction patters of 1,1-binaphthyl a) crystallised from the melt whilst 
stirring b) crystallised from the melt without stirring c) pure enantiomer (P42121) c) racemic 
compound (C2/c)
[28]
. 
 
Noorduin et al[24] were the first to apply Viedma’s findings[31]  to true molecular 
enantiomeric amino acid derivatives. The conglomerate forming imine of 2-
methyl-benzaldehyde and phenylglycinamide underwent fast base-catalysed 
racemisation in methanol with the organic base 1,8-diazabucycloundec-7ene 
(DBU) . Equilibrated slurries, with an initial 2-10% solid phase enantiomeric 
excess of either crystalline enantiomer, were stirred at 1250 rpm under ambient 
condition with will 2.5 mm glass beads. Addition of DBU initiated racemisation 
(racemisation half-life = 2 min) leading to complete chiral discrimination (99.9% 
ee), at best, within approximately 6 days when the initial enantiomer excess 
was 10%. When glass beads were absent, the crystalline enantiomeric excess 
remained unchanged indefinitely. Perhaps even more interesting is that the 
handedness of the resulting crystalline phases from an initially racemic solution 
could be controlled by using a chiral additive to direct the evolution of a single 
solid phase. Using as little as 0.1 mol % of pure (R)-phenylglycine and (S)-
phenylglycine resulted in the formation of only (S)-2-methyl-benzaldehyde and 
(R)-2-methyl-benzaldehyde respectively, with the time taken to achieve 
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complete chiral decimation being reduced with an increase in DBU 
concentration. This study proved that the concept of chiral “amnesia” observed 
in Viedma’s achiral NaClO3 solutions applies to racemisable organic 
compounds that crystallise as conglomerates i.e. it is possible for a crystalline S 
enantiomer to dissolve (by attrition leading to increased surface area and hence 
solubility), racemise, and be deposited on the larger enantiopure R crystals.  
 
Figure 3.11 Attrition-enhanced evolution of solid-phase ee for 2-methyl-benzaldehyde-
phenylglycinimine in MeCN a) starting with an initial crystalline enantiomeric excess as shown 
b) starting from a crystalline racemic mixture with chiral additive (R) and (S)-phenylglycine
[24]
. 
 
The method of Noorduin et al [24]  was repeated by Viedma et al [134] using 
aspartic acid, one of only two amino acids that crystallise as a conglomerate 
under ambient conditions, in acetic acid with the catalyst racemisation 
salicylaldehyde. Near identical results were produced, with compete chiral 
discrimination of the solid phase occurring at 160˚C within 6 days with attrition 
enhancement and an initial enantiomeric excess (< 10%), and unlike Noorduin, 
this was also achieved without glass beads in around 8 days perhaps 
suggesting that agitation alone was sufficient to cause abrasion. Similarly 
Tsogoeve et al[30]  confirmed that using glass balls was not necessary to induce 
chiral symmetry breaking in a reversible Mannich reaction; instead agitation is 
all that is required to produce secondary nuclei. Attrition enhanced 
deracemisation has since been applied to the production of enantiomeric 
compounds of industrial importance including the pharmaceuticals Naproxen[25] 
and Clopidogrel[137].  
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4 Conglomerate Selection 
 
 
4.1 Introduction 
The proposed CIAT process involves coupling preferential crystallisation with in-
situ solution phase racemisation of the undesired counter enantiomer. A 
prerequisite of the former is that the chiral system exists as a stable 
conglomerate i.e. a mechanical mixture of discreet homochiral crystals, as 
opposed to a racemic compound whose racemic crystals contain a 1:1 mixture 
of both enantiomers within the unit cell, as conglomerates are able to be 
resolved by seeding since their enantiopure solid phases are more stable than 
the corresponding enantiomeric-co-crystals. Conversely, seeding a racemic 
solution of a racemic-compound-forming system with enantiopure crystals 
would lead to dissolution of the seeds as the eutectic point occurs at ees ≠ 0%, 
hence solubility of the mixture increases with ee up to the eutectic. This leaves 
approximately 10% of chiral systems that may be suitable for CIAT; however, 
since the influences behind conglomerate formation are not fully understood, 
and the fact that the heterogeneous phase equilibria of chiral compounds are 
often overlooked, it is possible that in time this number will increase. 
In addition to forming a conglomerate, it was also necessary that the selected 
chiral system was able to undergo efficient solution phase racemisation using 
available racemisation catalysts. Existing CIAT processes rely on chiral centres 
that can be easily racemised under the correct conditions, typically due to the 
presence of low pKa chiral protons, which limits its application. Using 
organometallic complexes, which have been successful racemisation catalysts 
in the DKR of chiral alcohols and amines, should overcome this problem 
potentially increasing the number of conglomerates that could be processed by 
CIAT.  
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4.2 Objectives 
 
Scheme 4.1 Conglomerate candidates investigated to identify model chiral systems for use in 
the CIAT process: 1-indanol (1), hydrobenzoin (2), N-methylephedrine (3). 
 
In this chapter, three chiral systems were investigated for use as model CIAT 
compounds due to being reported as conglomerates in the literature and 
possessing chiral centres with the potential to undergo racemisation by 
organometallics; 1-indanol (1), hydrobenzoin (2) and N-methylephedrine (3) 
(Scheme 4.1). To explore their heterogeneous phase equilibria and confirm 
conglomerate formation from the solvents earmarked for CIAT (the choice of 
solvent being limited primarily by the catalysts – see section 4.3.1), binary 
phase diagrams were constructed for each of the potential candidates. The 
crystal structures of both their racemate and enantiopure forms were also 
investigated. 
The melting point of the pure enantiomers and racemates,   
 
 and   
 
 
respectively, were determined using DSC to give an indication of enantiomeric 
composition as melting a non-racemic mixture of enantiomers gives rise to two 
endotherms which correspond to the binary phase diagram solidus i.e. melting 
of the racemic portion of the mixture, and the liquidus, which results from 
melting the remaining pure enantiomer. Consequently, a truly racemic or an 
enantiopure sample should give rise to only a single endotherm over a narrow 
temperature range; however, it must be noted that, using DSC, for enantiomeric 
compositions close to 0% and 100% ee (100% ee and close to the eutectic 
composition for a racemic compounds), the endotherms of the solidus and 
liquidus tend to overlap as the temperature difference between them decreases, 
hence, this technique should be used in conjunction with more accurate 
methods, such as polarimetry or chiral HPLC. 
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In addition to giving an insight into enantiomeric composition, identifying   
 
and 
  
 
was used to give an indication of the type of crystalline racemate that is 
present. For chiral systems crystallising as a conglomerate, the difference 
between   
 
and   
 
is typically greater than 20°C, whereas the pure enantiomers 
of a corresponding racemic compound can melt at temperatures above, below 
or equal to that of   
 
. This can be extended by considering the enthalpy of 
fusion of the pure enantiomer and the racemate,    
 
 and    
 
 respectively, 
since the difference between the two typically lies between 1.7 and 5.0 kJ mol-1 
for a conglomerate [138] (section 2.6.2). 
Binary phase diagrams were constructed by measuring the solidus and liquidus 
temperatures (melting points) of a range of mixtures of enantiomers prepared 
by solvent evaporation from toluene (see section 4.3.1 for a discussion on 
solvent selection). This allows for characterisation of the chiral solid phase 
equilibria since the eutectic point will always occur at 0% ee for conglomerates, 
whereas a racemic compound possess two eutectics at ees ≠ 0%. Deviation 
from liquid phase ideality was qualitatively assessed by examining the 
coincidence of the measured liquidus temperatures with those predicted using 
the Schröder-Van Laar expression (Equation 2.43) and the measured   
 
and 
   
 
values. This was extended by comparing the calculated entropy of 
mixing,    
 , based on the measured calorimetric data (Equation 2.51) with that 
of in ideal conglomerate which can be shown to be equal to Rln2 or 5.77 J mol-1 
K-1. 
Binary phase diagram construction may not always lead to a definitive 
conclusion on the chiral heterogeneous phase equilibria of a given system as 
the eutectic points of a racemic compound can occur at any non-
racemic/enantiopure composition and in the case that this is close to racemic, it 
may appear that a conglomerate is present. To eliminate this problem, powder 
XRD and infra-red spectroscopy were used to identify the diffraction patterns of 
both the racemate and pure enantiomer. Since a conglomerate is a 1:1 
mechanical mixture of the enantiopure phases, its racemic and enantiopure 
spectra should away be identical; however, racemic compounds are 1:1 
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mixtures of both enantiomers in the crystal lattice therefore their corresponding 
enantiopure spectra will differ from that of the racemate.  
 
4.3 Conglomerate Selection  
4.3.1 Selection Criteria 
The choice of a suitable model chiral system for development of the CIAT 
process was dependent on satisfying a number of criteria:  
 Stable conglomerate (~10% of all chiral systems) when crystallised 
under the prescribed operating conditions  
 No possibility of solid solution or metastable racemic compound 
formation 
 Crystalline at room temperature  
 Ideally contain only a single stereogenic centre 
 Able to undergo efficient racemisation using available organometallic 
complexes  
 Exhibit a solubility in common solvents suitable for crystallisation and 
use with racemisation catalysts 
 Available in both racemic and enantiopure forms 
 Non-hygroscopic  
 Chemically and thermally stable  
 Available to purchase or synthesize at a relatively cheap price 
 Safe to handle with the available personal protective equipment 
Perhaps the most important prerequisite for development of the proposed 
process is that the chosen chiral system crystallises as a conglomerate with 
chiral discrimination in the solid phase allowing for resolution by seeding with 
the pure enantiomer. Since the CIAT process relies on seeding a racemising 
solution of enantiomers, it is essential the stability of homochiral crystals 
exceeds that of the corresponding racemic form (or solid solution) so that a 
single enantiomer can be selectively crystallised.  
 
92 
 
Examples of racemic compound resolution by entrainment have been 
demonstrated [139, 140], however, this process relies on seeding at eutectic 
compositions which, for this type of racemate, is at an ee ≠ 0. Consequently, 
coupling preferential crystallisation of racemic compounds with in-situ 
racemisation would not be possible since (in an ideal case) the solution phase 
ee would remain racemic throughout CIAT due to the action of the catalyst.  
One-pot Crystallisation Induced Diastereomeric Transformations (CIDT) of 
racemic compounds are known [21, 22], however, these often rely on the 
presence of chiral centres than can be easily racemised. Additionally, the 
conditions used to form diastereomers, e.g. by reaction with a chiral acid, may 
not be suitable for the organometallic catalysts earmarked for use in the CIAT 
process. Performing diastereomeric crystallisation and racemisation in series a 
quasi-continuous process could eliminate these problems (this is currently 
under investigation within our research group), however, this project aims to 
perform crystallisation and racemisation simultaneously in a single-step batch 
process therefore the investigation was limited to conglomerate forming chiral 
systems. 
In addition to being resolvable by entrainment, it was also essential that the 
chosen model compound could be efficiently racemised using available 
organometallic complexes. Typically these catalysts are capable of racemising 
chiral amines and alcohols by dehydration leading to the formation of 
intermediate imine/ketone species which are subsequently rehydrogenated to 
form the racemate. However, racemisation of primary amines and alcohols can 
lead to the irreversible formation of dimers, whereas few examples of tertiary 
structure racemisation exist in the literature. Hence, the search was limited to 
chiral secondary amines and alcohols which ideally had only a single 
stereogenic centre at the functional carbon. Racemisation of compounds with 
multiple centres leads to both antipode and diastereomer formation, and in the 
case that the latter exhibits a solubility lower than the corresponding 
enantiomers, their exclusive crystallisation may be inhibited since the 
diastereomer would be first to achieve saturation in solution. Additionally, the 
presence of the diastereomer in solution could influence the crystallisation 
characteristics of the enantiomers as it can be considered to be an impurity; 
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therefore, crystallisation kinetics or even formation of the conglomerate could be 
affected by its presence. 
It is evident due to the criteria discussed so far that solvent selection is of 
paramount importance to the success of the CIAT process. The solvent must 
allow for crystallisation of the model system in conglomerate form, with the 
solute being readily soluble and easily deposited upon cooling. Additionally, 
racemisation in solution must also be possible whilst the solvent remains inert to 
the catalytic process. This requires that the catalyst is completely soluble under 
the conditions used to perform CIAT and remains undersaturated for the 
duration of the process. Generally, non-polar aprotic solvents are most suitable 
for use with organometallic racemisation catalysts as they appear to give the 
greatest racemisation cycle efficiencies. Toluene is the most widely used 
solvent due to its ability to dissolve many organic compounds, whilst also being 
suitable for use with racemisation catalysts. Hence, this was chosen to be the 
CIAT process solvent and is used throughout the subsequent chapters. 
To perform CIAT it was necessary to obtain the chosen model system in both 
racemic and enantiopure forms for the solution being entrained and the seed 
crystals respectively, in addition to the preliminary analysis that was required. 
Since the racemate can be obtained by mixing equimolar quantities of each 
enantiomer, either the racemate and a single enantiomer, or both enantiopure 
forms were needed. Furthermore, the organometallic racemisation catalysts 
tend to require dry, oxygen free environments; therefore it was also necessary 
that the chosen chiral substrate was not hygroscopic in order to prevent 
inhibition of the catalysts activity during the process. 
 
 
4.3.2 CIAT Candidates 
Initial searches of the literature were focused on identifying a chiral amine that 
would be suitable for the CIAT process since these have been shown to be 
racemisable with iridium-based catalysts that are widely used within our 
research group [16, 17]. However, after a thorough review of the literature it was 
clear that there were few, if any, chiral amines that satisfied the criteria given in 
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section 4.3.1; primarily the requirement of conglomerate formation. The focus of 
the search for a model system was then turned to chiral secondary alcohols for 
which racemisation by organometallics is well established, despite the 
availability of conglomerates still being limited. 
1-indanol (1, Scheme 4.1) was proposed as a possible candidate as it has been 
listed in the text by Jacques et al [9] as a conglomerate that can be resolved by 
preferential crystallisation. The molecule contains a single secondary alcohol 
stereogenic centre which can potentially be racemised by a number of different 
catalysts, particular ruthenium-based complexes [119], whilst its racemic and 
enantiopure forms can be readily synthesised or purchased from commercial 
sources. 
Despite having two chiral centres, hydrobenzoin (2) was the second choice of 
model system. This has been shown to crystallise as a conglomerate allowing 
for its resolution by direct crystallisation [9, 141-143]. Similar to 1, hydrobenzoin 
contains two secondary alcohol chiral centres which should undergo efficient 
racemisation with several available catalysts and is readily available in both 
racemic and enantiopure forms. 
Although there was initial doubt about its ability to undergo racemisation due to 
its tertiary chiral amine, for which few racemisation examples exist in the 
literature, and its dual chiral functionality, having both a chiral amine and alcohol 
group, N-methylephedrine (3) was selected for investigation as it has been 
shown to form a stable conglomerate [138] and is readily available in both 
racemic and enantiopure forms.  
 
4.4 Methodology and Analytical Techniques 
4.4.1 Enantiomer Preparation  
As a result of cost and commercial lead times, it was necessary to synthesise 
the pure enantiomers of 1 and 2 to confirm conglomerate formation and for 
subsequent use as model chiral systems for the CIAT process ((R,S)-3 and 
(S,R)-3 were obtained from Sigma Aldrich, purity taken as stated by the 
supplier, > 99%). Details of the synthetic literature procedures and materials 
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used can be found in the respective Enantiomer Synthesis sections for 1 and 2 
(11.2.1 and 11.2.2 respectively). For each of the chiral systems investigated, 
the racemate was obtained by mixing equimolar quantities of the two 
enantiomers, heating them to form a racemic melt, and allowing this to 
recrystallise by natural cooing to room temperature. The resulting solid was 
ground to a fine powder using a pestle and mortar to ensure chiral homogeneity 
for subsequent analysis. Details of the analytical techniques used to 
characterise the materials, and for the analyses performed in the subsequent 
sections, can be found in 11.1. 
 
 
4.4.2 Binary Phase Diagram 
Binary phase diagrams for 1, 2 and 3 were constructed by measuring the 
melting points of mixtures of antipodes with a range of enantiomeric excesses 
(0 – 100% ee) using the DSC instrument described in section 11.1.4. The 
samples were prepared by mixing known quantities of each enantiomer and 
dissolving them in toluene. The solvent was then left to evaporate yielding  
crystals of the racemate which were subsequently ground to a fine powder 
using a pestle and mortar to ensure chiral homogeneity. As discussed in section 
4.3.1, toluene was earmarked as a possible process solvent as it has been 
used successfully with a number of different organometallic catalysts; hence it 
was used for preparation of the samples to identify if any changes crystal 
structure occurred as a result of its use. The enantiomeric mixtures were loaded 
into 40 μl aluminium pans and subjected to a heating programme which, for 1, 2 
and 3, consisted of holding the pan temperature for 25 min at 25°C, 40°C and 
80°C, and heating at a rate of 2°C min-1 to 90°C, 110°C and 170°C respectively. 
Using the resultant DSC curves, the solidus and liquidus melting temperatures 
were obtained and plotted against ee giving one half of the binary phase 
diagram which was sufficient for the analysis. 
 
4.4.3 Crystal Structure  
The powder X-ray diffraction pattern and infra-red spectra of the pure 
enantiomer and racemate was identified for 1, 2 and 3 to determine if they 
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share the same crystal structure (and hence the same spectra) which would 
indicate conglomerate formation. For structures which could not be elucidated 
using the powder XRD and published databases of crystal structures, single 
crystal XRD was necessary. Details of the instruments used for both powder 
and single crystal X-ray diffraction can be found in section 11.1.6. 
 
4.5 1-indanol Characterisation 
4.5.1 Binary phase diagram  
As a preliminary investigation into whether 1 belongs to the class of crystalline 
conglomerates, the melting points and enthalpies of fusion of (R)-/(S)-1 and rac-
1 were determined using calorimetry. As previously discussed, a difference in 
racemate and pure enantiomer melting point (∆   = ∆  
 
-∆  
 
) greater than 
20°C is usually indicative of the presence of a conglomerate. Similarly, 
assuming ideal behaviour, a conglomerate will usually exhibit a difference in 
enthalpy of fusion between the pure enantiomer and racemate (∆  = ∆  
 
-∆  
 
) 
in the range 1.7-5.0 kJ mol-1. However, since racemic compound forming 
systems can also exhibit   
 
>=20°C above that of the corresponding racemate, 
and varying differences in enthalpy of fusion, calorimetric assessment of the 
type of racemate present should only be used as a preliminary method of 
analysis. 
Figure 4.1 shows the DSC thermogram for the synthesised material rac-1, (R)-1 
and (S)-1 prepared from toluene. For each curve a single endotherm occurs 
with the peak corresponding to the melting temperature, whilst integration of the 
endotherms yields the enthalpies of fusion. These values for 1 are listed in 
Table 4.1. Considering the average melting point of the pure enantiomers (R)-1 
and (S)-1, 73.7°C, the difference in melting point, ∆  , between the average 
and rac-1 is 18.8°C. Although close to the > 20°C difference typically observed 
between the pure enantiomers and the corresponding racemate for most 
conglomerate systems, this finding suggests, but is not conclusive, that 1 does 
not belong to the class of crystalline conglomerates. However, the difference 
between the average pure enantiomer and racemic enthalpies of fusion, ∆  
 
-
∆  
 
, of 1 is 1.8 kJ mol-1, which is only just within the typical range normally 
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seen for conglomerates. These conflicting findings confirm that further analysis 
is required. 
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Figure 4.1 DSC thermogram of (R)- and (S)-1 (synthesised according to the procedure by Li et 
al 
[144]
), and racemic rac-1 (obtained by melt-recrystallisation of an equimolar mixture of both 
enantiomers). 
 
Table 4.1 Melting points, T
f
, and fusion enthalpies, ∆H
f
 ,determined using DSC for (R)-, (S)- and 
racemic rac-1. 
 
1-indanol (1) 
Melting point, T
f
 (°C) 
Enthalpy of fusion, ∆H
f
 
(kJ mol
-1
) 
TR
f
 TA
f
 ∆HR
f
 ∆HA
f
 
(R)- - 73.6 - 20.1 
(S)- - 73.7 - 18.7 
rac- 54.9 - 17.6 - 
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The use of calorimetry to investigate racemate behaviour can be extended by 
constructing the binary phase diagram for a given chiral system. Conglomerates 
can be identified by their single eutectic point which occurs at 0% ee, whilst 
racemic compounds exhibit two eutectics at compositions ≠ 0% ee. 
 
Figure 4.2 shows the DSC thermogram for 1 with a range of enantiomeric 
excesses from 0-100% ee. It can be seen that for compositions other than 0 
and 100% ee, two endotherms occur of varying sharpness with the peaks 
corresponding to the solids and liquidus temperatures; the areas of each being 
determined by the relative amounts of racemate and excess enantiomer present 
in the sample. At 0% ee a single endotherm occurs as the composition is 
racemic and each enantiomer melts simultaneously. As the ee is increased to 
4%, a second smaller endotherm appears at a lower temperature, whilst the 
larger endotherm now occurs at a slightly lower temperature and has a smaller 
area than the 0% ee curve. This alone is a strong indicator of racemic 
compound formation since, as previously mentioned, the eutectic occurs at 0% 
ee for a conglomerate therefore for compositions greater than 0% ee the 
second endotherm should appear at a higher temperature (liquidus) whilst the 
racemic endotherm remains in the same position (solidus), albeit with a reduced 
area. Assuming at this stage that this does happen to be a racemic compound, 
the smaller endotherm occurs as a result of melting of the pure enantiomer in 
excess (4%) whereas melting of the 1:1 racemic solid gives rise to the larger 
endotherm, hence the relative areas. 
As the composition is increased from 4 to 20% ee, the area of the endotherm at 
the lower temperature increases yet remains in the same position. However, the 
area of the racemic endotherm reduces in size whilst also occurring at 
progressively lower temperatures. Eventually the two peaks overlap becoming 
indistinguishable at 24 and 30% ee and only single endotherm is present which 
represents the liquidus point. As ee is increased beyond 30%, a second smaller 
endotherm reappears, this time at a higher temperature, with the area and peak 
position gradually increasing with ee until 100%, at which point the low 
temperature solidus endotherm disappears and only a single peak remains 
which corresponds to the pure enantiomer melting point. The behaviour 
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observed is highly characteristic of racemic compounds as the liquidus 
temperature initially decreases as the ee is increased beyond racemic until only 
a single endotherm occurs at 24 and 30% ee. This suggests that the eutectic 
point occurs between 24 and 30% ee which can never be the case for 
conglomerates (the exact ee could not be identified due to the overlapping of 
the endotherms).  
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Figure 4.2 DSC curves for mixtures of 1 enantiomers showing the solidus and liquidus 
temperatures (note: heat flow DSC was used for some samples, e.g. 20% ee, whose 
thermograms were inverted for comparison hence the negative slopes).  
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Table 4.2 Melting points of mixtures of 1 enantiomers determined using DSC, and expected 
melting points calculated using the simplified Shröder van-Laar and Prigogine-Defay 
expressions (Equation 2.43 and Equation 2.44) 
Enantiomeric 
Excess, ee 
(%) (S)-1 
Measured melting point (°C) Calculated liquidus (°C) 
Expected 
solidus
a
 Liquidus Solidus 
Schröder-
Van Laar  
Prigogine-
Defay  
0 54.7 
-- 
-- 
54.9 
52.2 
4 54.3 50.6 54.8 
8 53.8 50.7 54.7 
16 52.1 50.4 54.2 
20 51.8 51.4 53.8 
24 51.7 
-- 
53.3 
30 51.3 
-- 
52.4 
40 54.3 
51.2 
55.4 
-- 
49 55.7 
51.6 
58.4 
50 56.9 
51.7 
58.8 
61 59.8 
50.9 
62.2 
73 63.6 
50.9 
65.9 
80 66.1 51.5 68.1 
100 73.6 
-- 
73.7 
a
Based on observed intersection of the calculated liquidus curves  
 
The peak temperatures for the endotherms of each curve in Figure 4.2 were 
identified and are listed in Table 4.2. Additionally, the corresponding racemic 
compound ideal liquidus temperatures are also given which were calculated for 
enantiomeric compositions between 0 and 30% ee using the Prigogine-Defay 
expression (Equation 2.44) and experimentally determined, ∆  
 
 and ∆  
 
; and 
the Schröder-Van Laar expression (Equation 2.43) with ∆  
 
 and ∆  
 
beyond 
the eutectic i.e 40 to 100% ee, as is the convention for racemic compound 
forming systems (note: only a liquidus temperature occurs at 0% ee as the 
enantiomers are present in equal quantities; for the samples with 24 and 30% 
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ee only a single endotherm could be identified as these correspond to the 
eutectic region therefore they were taken as liquidus temperatures). The last 
column in Table 4.2, the expected solidus, was determined by identifying the 
intersection between the two calculated liquidus curves. 
Using the data presented in Table 4.2, half of the binary phase diagram for 1 
was constructed using (S)-1 as the excess enantiomer (Figure 4.3). With this 
graphical representation of the endotherm temperatures it is evident that 1 
belongs to the racemic compound class of racemates as it possess the 
characteristic curved liquidus at compositions < 30%, and the lowest liquids 
temperature i.e. the eutectic occurs at an enantiomeric composition greater than 
0% ee. Furthermore, the experimental and calculated data are in close 
agreement. Although the exact ee could not be elucidated due to overlapping 
endotherms, the eutectic occurs at an ee between 24 and 30% based on the 
experimental data, and approximately 31% ee based on the intersection of the 
two calculated liquidus curves.  
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Figure 4.3 Half binary phase diagram for 1-indanol (1) with (S)-1 in excess (■ measured liquids, 
● measured solidus, ▬ calculated liquids, ▬ expected solidus). 
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4.5.2 Crystal Structure 
Despite the data presented so far strongly suggesting that 1 forms a racemic 
compound, its racemate and enantiopure crystal structures were investigated. 
Figure 4.4 shows the powder XRD patterns for (R)-1 and rac-1. As expected, 
examination of the peak positions shows that the two diffraction patterns are 
different which is true of racemic compounds as they are 1:1 crystals comprised 
of each enantiomer within the lattice and therefore have a different crystal 
structure than the corresponding pure enantiomer. Conversely, since a 
conglomerate is a mechanical mixture of discreet homochiral crystals, its 
racemate shares the same crystal structure as its pure enantiomer and 
therefore its diffraction patterns would be identical. 
1 was further confirmed to exists as a racemic compound by identifying the 
infra-red spectra of (R)- and rac-1. As with powder XRD, the solid state 
structure influences the infra-red spectrum, however, this is due to the 
crystallographic positions of the characteristic absorption groups; hence the 
racemate of a racemic compound does not share the same spectrum as its pure 
enantiomer. 
 
10 20 30 40 50 60
0
25000
50000
75000
100000
In
te
n
s
it
y
 (
c
o
u
n
ts
)
2
 (R)-1
 rac-1
 
Figure 4.4 (R)- and rac-1 powder X-ray diffraction spectra. 
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Figure 4.5 (R)- and rac-1 FT-IR spectra. 
 
Using the powder XRD data presented in Figure 4.4, attempts were made to 
deduce the crystal structure of the racemic compound rac-1 by searching 
crystallographic databases with its diffraction pattern, yet no crystal structure 
was available for rac-1. This is typical for enantiomeric systems as chemists 
rarely investigate the type of racemate that a chiral system forms as two 
different synthetic routes are needed to produce enantiopure compounds and 
their racemic counterparts (where resolution is not used).  
As a result of the lack of information available on the crystal structure of rac-1, 
single crystal XRD analysis was performed to elucidate is solid state 
arrangement. Figure 4.6 shows the crystal packing and unit cell structure for 
rac-1. The racemate crystallises in the body-centred tetragonal space group 
I41/a, indicating it has a 4-fold screw axis along the a direction, with 16 
molecules of 1 in the unit cell (cell lengths a = b ≠ c where a = 20.19 Å, b = 
20.19 Å, c = 7.60 Å, and cell angles α = β =  = 90˚). Since space group I41/a is 
centrosymmetric both enantiomers are present in the crystal structure and it is 
therefore a racemic compound. Examination of the figure shows that there are 
two full and two half homochiral columns within the unit cell which possesses 16 
molecules in total. The molecules are held together by two hydrogen bonds 
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between the hydroxyl hydrogen and corresponding oxygen on an identical 
molecule with van der Waals forces being responsible for the interactions 
between the homochiral columns. 
a) 
 
b) 
 
 
c) 
 
 
d) 
 
Figure 4.6 Crystal structure of rac-1 showing a) molecular packing along the c axis and the 
contents of the unit cell along the b) a axis c) b axis and d) c axis. Blue and thin red lines 
indicate hydrogen bonging to other molecules and molecules not shown respectively. Hydrogen 
bonded distances and angles for O-H…O: O-H = 0.84 Å, H…O = 1.87 Å, O-…O = 2.71 Å, 
OHO = 176.2°. 
 
Figure 4.7 and Figure 4.8 show the crystal packing and unit cell structures for 
(R)- and (S)-1. The enantiomers crystallises in the chiral monoclinic space 
group P21 indicating a twofold screw axis with a half translation along the c axis, 
having two molecules in the unit cell (cell lengths a ≠ b ≠ c where for (R)-1: a = 
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7.06 Å, b = 4.84 Å, c = 11.01 Å, and cell angles α =  = 90˚, β = 95.75°, and (S)-
1: a = 7.05 Å, b = 4.82 Å, c = 10.97 Å and α =  = 90˚, β = 95.76°). Examination 
of the figures shows that the enantiomers exhibit the characteristic hydrogen 
bonding networks observed in the majority of chiral crystals. The crystal 
structure is comprised of homochiral 21 columns in which each molecule is held 
together by two hydrogen bonds between the hydroxyl hydrogen and 
corresponding oxygen on an identical molecule with van der Waals forces being 
responsible for the interactions between the homochiral columns. 
a) 
 
b) 
 
 
c) 
 
 
d) 
 
Figure 4.7 Crystal structure of (R)-1 showing a) molecular packing along the b axis and the 
contents of the unit cell along the b) a axis c) b axis and d) c axis. Blue and thin red lines 
indicate hydrogen bonging to other molecules and molecules not shown respectively. Hydrogen 
bonded distances and angles for O-H…O: O-H = 0.84 Å, H…O = 1.94 Å, O-…O = 2.77 Å, 
OHO = 170.4°. 
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a) 
 
b) 
 
 
c) 
 
d) 
 
 
Figure 4.8 Crystal structure of (S)-1 showing a) molecular packing along the b axis and the 
contents of the unit cell along the b) a axis c) b axis and d) c axis. Blue and thin red lines 
indicate hydrogen bonging to other molecules and molecules not shown respectively. Hydrogen 
bonded distances and angles for O-H…O: O-H = 0.84 Å, H…O = 1.93 Å, O-…O = 2.76 (9) Å, 
OHO = 176.2°. 
 
4.5.3 Metastable conglomerate formation 
The findings from the powder and single crystal XRD analysis confirmed that 1 
exists as a stable racemic compound crystallising in the centrosymmetric I41/a 
space group. Further investigation revealed that 1 can also exist as a 
metastable conglomerate when crystallised under the correct conditions [52, 145]. 
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Attempts were made to obtain 1 in its conglomerate form using a method from a 
1960 study by Hückel et al [145]. 15 g of the racemic compound was melted and 
held at 120°C for 30 min in a round bottom flask. This was then cooled to 40°C 
using a water bath and combined with 180 ml of petroleum either 30-60°C to 
form a solution. After cooling to room temperature, the solution was seeded with 
a single crystal of (R)-1 and refrigerated for several hours to induce 
crystallisation of the metastable conglomerate. The resulting solid was filtered, 
washed with cold solvent and dried under vacuum to give the product crystals. 
Figure 4.9, the DSC curve for the product obtained using the methodology given 
above, shows that no transformation from racemic compound to conglomerate 
occurred as its melting point,   
 
, has remained unchanged at 54.9°C, although 
some broadening of the peak has occurred for reasons which are unclear but 
could be linked to partial decomposition of the substrate at the high temperature 
isotherm. Using the Shröder van-Laar expression (Equation 2.43) and the 
experimentally determined values of   
 
 and    
 
 (Table 4.1), the melting point 
of the conglomerate form of 1 was predicted to be 39.8°C which is in close 
agreement to the 37°C that has been reported but far below that of the sample 
analysed. The procedure was repeated several times holding the racemate for a 
longer duration in its molten state, and in refrigeration; however, each attempt at 
obtaining the conglomerate was unsuccessful. 
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Figure 4.9 DSC spectra for rac-1 after attempting to obtain the metastable conglomerate using 
the method by  Hückel et al 
[145]
. 
An alternative method [52] suggested simply holding the racemate in its molten 
state for several minutes at 80°C before cooling to room temperature, though 
this was performed by the authors at a ~ 5 mg scale using DSC. The method 
was attempted in a round bottom flask using 5 g of racemic material, holding it 
in the molten state for up to 1 h before cooling; yet, again the conglomerate 
could not be isolated. Observation of the round bottom flask at the end of the 
process revealed a web of thin fibrous crystals had occupied its entire volume 
suggesting that, upon melting the racemate, its vapours had condensed on the 
inner walls of the flask in racemic compound form and acted as sites for crystal 
growth thus preventing the formation of the less energetically favoured 
metastable conglomerate nuclei.  
The procedure given above was repeated using DSC with a scaled down 8 mg 
sample. The racemate was held in its molten state for 30 min at 90°C before 
being cooled at a rate 1°C min-1 to 0°C. After maintaining this temperature for 2 
hr, the sample was heated to 80°C at a rate of 2°C min-1. Despite several 
attempts (including holding the sample at -5°C for up to 10 hr) the racemate 
remained in the molten state and would not crystallise therefore its melting point 
could not be obtained. However, when mixtures of 1 enantiomers with non-
racemic compositions were analysed, crystallisation was observed after holding 
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the sample at the bottom temperature of the heating program, hence their 
melting points could be determined. 
The DSC curves in Figure 4.10 show the melting points of a range of non-
racemic enantiomeric compositions of 1 after being subjected to the heating 
programme described above. For each curve, two endotherms occur which 
correspond to the solidus melting temperature, which remains consistent for 
each composition, and the liquidus melting temperature, which can be seen to 
increase with enantiomeric excess; the areas of each peak being determined by 
the relative amounts of racemate and excess enantiomer present.  
 
Comparison of the melting temperatures obtained from the DSC data 
(presented in Table 4.3) with those used to construct the racemic compound 
binary phase diagram of 1 (Table 4.2) shows that there has been a 
considerable reduction in solidus temperature from approximately 51°C to 37°C 
which happens to be in close agreement with the predicted conglomerate 
racemate melting point of 39.8°C. This trend is also seen in the liquidus 
temperatures of the 16 and 24% ee samples which are lower than those given 
in Table 4.2 with the same composition. The difference in melting points is 
indicative of a change in crystal structure as it implies that the magnitude of the 
intermolecular forces have been reduced due to molecular orientation changes 
within the crystal lattice.  
In addition to the decrease seen in both solidus and liquid temperatures, the 
single endotherm for 24 and 30% ee, which corresponds to the eutectic region 
of the binary phase diagram for 1 (Figure 4.3), is no longer present in Figure 
4.10; instead the difference between the solidus and liquidus temperatures 
increases with ee, thus the eutectic that existed at this composition is no longer 
present. These features of the calorimetry data presented are characteristic of 
conglomerate behaviour and show that the application of the above described 
DSC temperature programme has resulted in a crystal structure change from a 
1:1 racemic compound to a mechanical conglomerate mixture, therefore 1 can 
be said to be stable and metastable with respect to the former and latter. 
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Figure 4.10 DSC curves showing the melting points of mixtures of 1 enantiomers after 
attempting to form its metastable conglomerate.  
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Table 4.3 Melting points of mixtures of 1 enantiomers for its metastable conglomerate 
determined using DSC, and expected melting points calculated using the simplified Shröder 
van-Laar expression (Equation 2.43) and the experimentally determined pure enantiomer 
melting point, TA
f
, and enthalpy of fusion, ∆HA
f
 . 
Enantiomeric 
Excess, ee (%) (S)-1 
Measured melting point (°C) Expected 
Solidus (°C)
a
 
Calculated 
Liquidus (°C) Solidus Liquidus 
0 -- -- 
39.8 
39.8 
16 37.6 43.4 46.6 
24 37.6 47.7 49.7 
30 37.6 49.1 51.9 
49 37.6 55.0 58.8 
61 37.7 60.6 62.2 
75 35.8 63.4 66.5 
100 -- -- 73.6 
a
Based on the calculated liquidus curve 
 
The metastable conglomerate solidus and liquidus temperatures obtained from 
the DSC data were combined with the racemic compound temperatures from 
section 4.4.2 and plotted to give half of the complete binary phase diagram for 1 
with an excess of (S)-1 (Figure 4.11). Furthermore, the corresponding ideal 
conglomerate liquids temperatures calculated using the Schröder-Van Laar 
expression (Equation 2.43) with the experimentally determined melting point 
and enthalpy of fusion of the pure enantiomer are also plotted.  
Examination of the binary phase diagram shows that the DSC data from Table 
4.3 is characteristic of a conglomerate as there is no evidence of a eutectic 
point at an ee > 0%, and the solidus temperatures are consistent whilst the 
liquidus temperatures increase with ee. For ees greater than ~30% (the racemic 
compound eutectic) there is a close agreement between the liquidus 
temperatures of both the racemic compound and metastable conglomerate 
which is expected for systems for this type of system (stable racemic 
compound, metastable conglomerate) since there is of course no change in the 
 
112 
 
enthalpy of fusion of the pure enantiomer which is in excess. Below ~30% ee 
however, the metastable conglomerate liquid temperatures are always lower 
than the corresponding racemic compound samples with the same ee as the 
two types of racemic crystals have different structures, and hence different 
enthalpies of fusion.  
As described in the methodology used to obtain the metastable conglomerate of 
1, the melting point of the racemate could not be obtained as it would not 
crystallise, even after prolonged cooling. Despite this, the data obtained for ees 
> 0% follow a clear trend which culminates close to the predicted racemate 
melting point of 39.8°C at 0% ee i.e. the eutectic occurs at this point hence it 
can be safely concluded that this is indeed the metastable conglomerate form of 
1. Ideally powder XRD would have been used to prove this, however, as 
mentioned previously, the metastable conglomerate of 1 could not be obtained 
on a scale larger that ~8 mg which is far below the sample requirements of the 
available powder XRD instrument. Despite this, the data presented can be 
taken as very strong evidence for 1 forming a metastable conglomerate. 
0 20 40 60 80 100
30
40
50
60
70
80
T
e
m
p
e
ra
tu
re
 (
°C
)
Enantiomeric excess (%) (S)-1
 
Figure 4.11 Binary phase diagram for 1-indanol (1) showing the solidus and liquidus 
temperatures for both its racemic compound, and metastable conglomerate forms (Racemic 
compound: ■ measured liquids, ● measured solidus, ▬ calculated liquids, ▬ expected solidus; 
metastable conglomerate: □ measured liquids, ○ measured solidus, --- calculated liquids, --- 
expected solidus).  
 
113 
 
 
4.5.4 Conclusion: 1-indanol (1) Characterisation 
1-indanol (1) was investigated for use as a model chiral system for the CIAT 
process as it has been listed in the literature as a resolvable conglomerate [9] 
and has the potential to undergo racemisation at is 2° alcohol chiral centre 
using available organometallic complexes. The pure enantiomers were 
synthesised following the procedure given in section 11.2.1, and the racemate 
obtained by combining, and recrystallising equimolar quantities of the two pure 
stereoisomers. Calorimetry was then used to investigate the melting behaviour 
of the racemate and pure enantiomer, and to construct the binary phase 
diagram which gave a clear indication of racemic compound formation as the 
eutectic occurred at a non-racemic enantiomeric composition (~30% ee). 
 
Differences in the powder XRD and infra-red spectra of the racemate and pure 
enantiomer confirmed the findings of the calorimetric data, indicating differences 
in crystal structures which would not occur for conglomerate forming systems as 
they are mechanical mixtures enantiopure crystals. Conversely, as racemic 
compounds are essentially 1:1 co-crystals of each enantiomer, their internal 
structure, and hence solid state spectra, will always differ from that of the pure 
enantiomer. Single crystal XRD showed that the racemate of 1 crystallises in 
the body-centred tetragonal space group I41/a which is centrosymmetric and 
hence cannot consist of enantiopure crystals as their constituents are inherently 
asymmetric. The pure enantiomers on the other hand were shown to crystallise 
in the chiral monoclinic space group P21 which happens to be the most 
frequently occurring non-centrosymmetric space group. 
 
Further investigation into the heterogeneous equilibria showed that a 
metastable conglomerate form of 1 could be obtained under the correct 
temperature program. Calorimetric analysis showed a significant reduction in 
solidus temperature from ~51°C to ~37°C with the latter being close to the 
conglomerate racemate melting temperature predicted using the Schröder van-
Laar equation (39.8°C). Additionally, disappearance of the non-racemic eutectic 
was observed, with the liquidus temperature trend indicating the presence of a 
eutectic at 0% ee. The calorimetric data was combined with the racemic 
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compound binary phase diagram giving a complete description of the 
heterogeneous phase equilibria for 1 and showing that it exists as a stable 
racemic compound, and a metastable conglomerate. 
 
Although examples of metastable conglomerate preferential crystallization have 
been demonstrated [139, 140], the data presented shows that 1 is an unsuitable 
candidate for use as a model CIAT system. In addition to being a stable racemic 
compound, which cannot be resolved by preferential crystallisation under 
normal circumstances, the conditions used to obtain the metastable 
conglomerate, consisting of heating well above the racemate melting point, and 
subsequent cooling and holding for a prolonged period at a low temperature far 
below the racemate melting point, are unsuitable for racemisation by 
organometallics. Not only would the racemisation rate be compromised at low 
temperatures, but it may be possible for the catalyst itself to become 
supersaturated and crystallise. Furthermore, the metastable conglomerate 
could only be obtained from the melt with all attempts of solution crystallisation 
being fruitless. 
 
In conjunction with the ability of the racemate of 1 to form a conglomerate, it 
may be possible that the presence of the catalyst and enantiopure seed crystals 
could result in exclusive crystallisation of a single enantiomer due to lowering of 
the crystallisation energy barrier. This was to be investigated; however, 1 was 
shown to be extremely soluble in all organic solvents due to a combination of 
low molecular weight, potential for hydrogen bonding, and its aromaticity. 
Combinations of different solvents also proved to be inadequate for 
crystallisation, and when water was used in conjunction with organic solvents, 
oiling out of 1 was observed. Due to these factors, which would unnecessarily 
complicate the CIAT process, 1 was eliminated from the investigation and other 
chiral systems were considered. 
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4.6 Hydrobenzoin Characterisation 
4.6.1 Binary Phase Diagram  
Figure 4.12 shows the DSC thermogram for rac-2, (R,R)-2 and (S,S)-2, with the 
corresponding melting points and enthalpies of fusion given in Table 4.4. 
Considering the average pure enantiomer melting point, 147.7°C, and that of 
the racemate, 120.7°C, the difference of 27.0°C between them is a strong 
indicator of conglomerate formation. Furthermore, the difference of 3.3 kJ mol-1 
seen between the average pure enantiomer enthalpy of fusion, 32.3 kJ mol-1, 
and that of the racemate, 29.0 kJ mol-1, is typical of conglomerate forming 
systems which are usually in the range 1.7-5.0 kJ mol-1.
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Figure 4.12 DSC thermograms of (R,R)- and (S,S)-2 (synthesised according to the procedure by 
Ikariya et al 
[146]
), and rac-2 (obtained by melt-recrystallisation of an equimolar mixture of both 
enantiomers). 
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Table 4.4 Melting points, T
f
, and fusion enthalpies, ∆H
f
, determined using DSC for (R,R)-, (S,S)- 
and rac-2. 
Hydrobenzoin (2) 
Melting point, T
f
 (°C) 
Enthalpy of fusion,  
∆H
f
 (kJ mol
-1
) 
TR
f
 TA
f
 ∆HR
f
 ∆HA
f
 
(R,R)- - 148.3 - 32.2 
(S,S)- - 147.0 - 32.3 
rac- 120.7 - 29.0 - 
 
The DSC thermograms were obtained for a range of enantiomeric compositions 
of 2 prepared in toluene (Figure 4.13). It can be seen that for compositions 
other than 0 and 100% ee, two endotherms occur of varying sharpness with the 
peaks corresponding to the solidsus and liquidus temperatures; the areas of 
each being determined by the relative amounts of racemate and pure 
enantiomer present in the given sample. At 0% ee a single endotherm occurs 
since both enantiomers are present in equimolar quantities and melt 
simultaneously; only a single endotherm occurs at 100% ee as the sample is of 
course enantiopure.  
As the ee is increased from 0 to 25% a second smaller and broader endotherm 
appears at a higher temperature (liquidus), whilst the racemic endotherm 
(solidus) remains at the same temperature despite now having a smaller area 
than the 0% ee peak (note: the solidus and liquidus peaks could not be 
discerned for ee < 25% due to endotherm overlapping). This behaviour alone is 
a strong indicator of conglomerate formation as its eutectic always occurs at 0% 
hence the liquidus for higher ees will only be seen at higher temperatures, 
whereas racemic compounds will always show an initial reduction in liquidus 
temperature as the ee is increased beyond racemic. The appearance of the 
higher temperature endotherm is due to the presence of the excess enantiomer; 
as a result of the entropy of mixing associated with forming a binary liquid from 
a mechanical mixture of discreet homochiral solid phases (the liquid phase 
mixing lowering the overall free energy change of the melting process relative to 
that of an enantiopure solid melting to form an enantiopure liquid), the racemic 
portion of the sample will always be first to melt leaving the excess pure 
enantiomer which melts at a higher temperature. 
 
117 
 
As the ee is increased, the liquidus endotherm can be seen to become sharper, 
occurring at increasingly higher temperatures and with a greater area, whereas 
the solidus peak temperature remains consistent yet its area can be seen to 
reduce in size as its relative amount in the sample is decreased. Eventually, 
when the ee reaches 100%, the solidus endotherm disappears as there is no 
antipode present and hence the pure enantiomer that was originally in excess 
remains. As the liquidus temperature increases with ee to 100%, and is at its 
lowest when the ee = 0 %, the data in Figure 4.13 strongly indicates that 2 
exists as a conglomerate. 
100 110 120 130 140 150 160
-10
-5
0
5
10
15
100% ee
95% ee
90% ee
80% ee
68% ee
65% ee
49% ee
43% ee
40% ee
30% ee
25% ee
O
ff
s
e
t 
H
e
a
t 
F
lo
w
 (
m
W
)
Temperature (°C)
0% ee
 
Figure 4.13 DSC curves for mixtures of 2 enantiomers showing the solidus and liquids 
temperatures. 
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Table 4.5 Melting points of mixtures of 2 enantiomers determined using DSC, and expected 
melting points calculated using the simplified Shröder van-Laar expression (Equation 2.43) 
Enantiomeric 
Excess, ee 
(%) (S,S)-2 
Mole Fraction 
(S,S)-2 
Measured 
Liquidus (°C) 
Measured 
Solidus 
(°C) 
Expected 
Solidus 
(°C) 
Calculated 
Liquidus 
(°C) 
0 0.50 120.7 -- 
120.72 
120.7 
25 0.63 127.5 120.3 127.8 
30 0.65 128.3 120.5 129.4 
40 0.70 131.7 121.1 132.6 
43 0.72 133.2 119.8 133.5 
49 0.75 135.3 120.3 135.2 
65 0.83 139.7 120.4 139.7 
68 0.84 140.1 119.9 140.5 
80 0.90 143.0 119.6 143.5 
90 0.95 144.9 119.2 146.0 
95 0.98 146.7 119.2 147.1 
100 1.00 148.3 -- 148.3 
 
Table 4.5 lists the solidus and liquidus temperatures obtained from the 
calorimetry data presented in Figure 4.13. The corresponding ideal liquidus 
temperatures, determined using the Schröder van-Laar expression (Equation 
2.43), are also given with the expected solidus temperature taken as the 
racemate melting point. Using this data half of the binary phase diagram was 
constructed for 2 with an excess of (S,S)-2 (Figure 4.14). It is clear from 
examination of the phase diagram that 2 exists as conglomerate since the 
lowest liquidus temperature, i.e. the eutectic, occurs at 0% ee which is always 
the case for conglomerates.  
 
Comparison of the experimentally determined liquidus and ideal liquidus 
temperatures shows that they are in very close agreement which implies that 
the enantiomers behave close to ideally in the liquid phase i.e. their enthalpy of 
mixing approaches zero. The entropy of mixing of the enantiomers in the liquid 
phase, calculated to be 5.2 J mol-1 K-1 (Equation 2.51), further suggests ideality 
as this is very close to the expected liquid phase entropy of mixing for ideal 
conglomerates, Rln2  = 5.8 J mol-1 K-1 (see section 2.6.2). The difference seen 
between the calculated and expected values occurs since, in practice, the 
magnitude of homochiral and heterochiral interactions in the liquid phase must 
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be different therefore an enthalpy change must accompany the mixing of 
antipodes. Despite this, several authors [147, 148] have shown that the scale of the 
heterochiral mixing enthalpy change represents approximately 1% of the 
enthalpy of fusion and can therefore be considered to be negligible; hence it is 
reasonable to assume that the enantiomers behave ideally in the liquid phase 
which is confirmed by the coincidence of the experimental and calculated 
liquidus temperatures in Figure 4.14. 
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Figure 4.14 Half binary phase diagram for hydrobenzoin (2) with (S,S)-2 in excess (■ measured 
liquids, ● measured solidus, ▬ calculated liquids, ▬ expected solidus) 
 
 
4.6.2 Crystal Structure 
The powder XRD pattern and infra-red spectra of rac-2 and (R,R)-2 prepared 
from toluene are presented in Figure 4.15 and Figure 4.16. The diffraction 
pattern for meso-2, the diastereomer with respect to (R,R)- and (S,S)-2, is also 
given for comparison. Considering rac-2 and (R,R)-2, it can be seen that the 
number and positions of the  peaks in each diffraction pattern are identical 
which is characteristic of a conglomerate since the racemate is a mechanical 
mixture of the two crystalline enantiomers. On the other hand, the diffraction 
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pattern for meso-2 differs from that of the racemate and enantiomer since it has 
a different crystal structure.  
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Figure 4.15 Powder X-ray diffraction patterns of the stereoisomers and racemate of 2. 
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Figure 4.16 FT-IR spectra of (R,R)- and (S,S)-2. 
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Figure 4.17 shows the crystal packing and unit cell structures for (R,R)-2 which 
were generated using crystallographic database data [149]. The enantiomer 
crystallises in the non-centrosymmetric chiral primitive monoclinic space group 
P21 indicating a twofold screw axis with a half translation along the c axis, 
having two molecules of (R,R)-2 in the unit cell (cell lengths a ≠ b ≠ c where a = 
5.84 Å, b = 7.90 Å, c = 12.41 Å, and cell angles α =   = 90˚, β = 93.04°). The 
crystal structure is comprised of homochiral 21 columns in which each molecule 
is held together by two hydrogen bonds between the hydroxyl hydrogen and 
corresponding oxygen on an identical molecule with van der Waals forces being 
responsible for the interactions between the homochiral columns. 
Considering the crystal structure of meso-2 (Figure 4.18), the diastereomer 
crystallises in the centrosymmetric primitive monoclinic space group P21/c 
indicating a two-fold screw axis perpendicular to a glide plane along the c axis, 
with four molecules in the unit cell (cell lengths a ≠ b ≠ c where a = 12.54 Å, b = 
5.08 Å, c = 9.31 Å, and cell angles α =   = 90˚, β = 106.67°) [149].  
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a) 
 
 
b) 
 
 
c) 
 
 
d) 
 
Figure 4.17 Crystal structure of (R,R)-2 (space group P21) showing a) molecular packing along 
the b axis and the contents of the unit cell along the b) a axis c) b axis and d) c axis. Red lines 
indicate hydrogen bonds. 
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a) 
 
 
b) 
 
c) 
 
d) 
 
 
Figure 4.18 Crystal structure of meso-2 (space group P21/c) showing a) molecular packing 
along the b axis and the contents of the unit cell along the b) a axis c) b axis and d) c axis. Red 
lines indicate hydrogen bonds. 
 
 
4.6.3 Conclusion: Hydrobenzoin (2) Characterisation 
Hydrobenzoin (2) was investigated for use as a model chiral system for the 
CIAT process as it has been listed in the literature as a conglomerate, is 
resolvable by preferential crystallisation, and has the potential to undergo 
racemisation at is two 2° alcohol chiral centres using available organometallic 
complexes. The pure enantiomers were synthesised following the procedure 
give in section 11.2.2, and the racemate was obtained by combining, and 
crystallising, equimolar quantities of the two enantiomers from the melt. 
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Calorimetry was used to investigate the melting behaviour of the racemate and 
pure enantiomers obtained by solvent evaporation from toluene, and to 
construct the binary phase diagram which gave a clear indication of 
conglomerate formation as the difference as the eutectic occurred at 0% ee, 
Coincidence of the experimental liquidus data with the predicted ideal liquidus, 
and the close agreement between the calculated entropy of mixing with that of 
an ideal system, suggested that the enantiomers behave close to ideally in the 
liquid phase which is generally observed for conglomerates. 
The findings of the calorimetry data were confirmed by powder XRD and infra-
red spectroscopy with the racemate and pure enantiomer having identical 
spectra since the former is a mechanical mixture of discreet enantiopure solid 
phases. The crystal structure of the pure enantiomer obtained from the literature 
[149], proved the existence of a conglomerate showing that (R,R)-2, and hence 
rac-2, crystallises in the non-centrosymmetric primitive monocline space group 
P21 which is the second most frequently observed chiral crystal structure for 
conglomerates accounting for approximately 30% [9].  
Despite having two chiral centres, which upon racemisation would yield a 
diastereomeric meso form in addition to the two enantiomers, the 
characterisation results described above show that 2 could be a suitable 
candidate for use as a model chiral system in the CIAT process thus its use was 
further investigated in the subsequent chapters. To compensate for the 
formation of additional species, it was necessary to determine the solubility of 
the mixture that resulted upon racemisation, as opposed to the solubility of the 
racemate which would need to be identified for a system with a single chiral 
centre, as it is this that would need to be seeded with the pure enantiomer. 
Additionally, as the meso form was also present in the racemisation mixture, its 
solubility had to be identified and compared with that of the pure enantiomer to 
ensure that the later had the lower solubility and hence would be first to reach 
supersaturation. 
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4.7 N-Methylephedrine Characterisation 
4.7.1 Binary Phase Diagram  
Figure 4.19 shows the DSC spectra for rac-3, (R,S)-3 and (S,R)-3, with the 
corresponding melting points and enthalpies of fusion given in Table 
4.6.Considering the average pure enantiomer melting point, 87.7°C, and that of 
the racemate, 63.4°C, the difference of 24.3°C between them is a strong 
indicator of conglomerate formation. Furthermore, the difference of 3.4 kJ mol-1 
between the average pure enantiomer enthalpy of fusion, 28.7 kJ mol-1, and 
that of the racemate, 25.3 kJ mol-1, is typical of conglomerate forming systems 
which are usually in the range 1.7-5.0 kJ mol-1.
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Figure 4.19 DSC thermogram of commercial (R,S)- and (S,R)-3 (Sigma Aldrich), and rac-3 
(obtained by melt-recrystallisation of an equimolar mixture of both enantiomers). 
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Table 4.6 Melting points, T
f
, and fusion enthalpies, ∆H
f
, determined using DSC for (R,S)-, (S,R)- 
and rac-3. 
 
N-methylephedrine (3) 
Melting point, T
f
 (°C) 
Enthalpy of fusion,  
∆H
f
 (kJ mol
-1
) 
TR
f
 TA
f
 ∆HR
f
 ∆HA
f
 
(R,S)- - 87.9 - 28.9 
(S,R)- - 87.5 - 28.5 
(±)- 63.4 - 25.3 - 
 
The DSC spectra were obtained for a range of enantiomeric compositions of 3 
prepared from toluene (Figure 4.20). The trends observed in the calorimetry 
data, which are characteristic of a conglomerate forming system since the 
lowest liquidus temperature i.e. the eutectic occurs at 0% ee, are identical to 
those described for 2 (see section 4.6.1 for discussion of calorimetric data 
trends for conglomerates). 
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Figure 4.20 DSC curves for mixtures of 3 enantiomers showing solidus and liquidus 
temperatures. 
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Table 4.7 Melting points of mixtures of 3 enantiomers determined using DSC, and expected 
melting points calculated using the simplified Shröder van-Laar expression (Equation 2.43) 
Enantiomeric Excess, 
ee (%) (R,S)-3 
Measured melting point (°C) 
Expected 
Solidus (°C) 
Calculated 
Liquidus (°C) 
Solidus Liquidus 
0 -- 63.4 
63.4 
63.4 
12 63.2 68.1 67.3 
15 63.7 69.3 68.3 
25 63.2 70.2 71.2 
33 62.8 72.4 73.2 
57 63.4 77.0 78.9 
80 63.1 83.7 84.0 
90 63.1 86.6 86.0 
100 -- 87.9 87.9 
 
Table 4.7 lists the solidus and liquidus temperatures obtained from the 
calorimetry data presented in Figure 4.20. The corresponding ideal liquidus 
temperatures, determined using the Schröder van-Laar expression (Equation 
2.43), are also given with the expected solidus temperature taken as the 
racemate melting point. Using this data half of the binary phase diagram was 
constructed for 3 with an excess of (R,S)-3 (Figure 4.21). It is clear from 
examination of the phase diagram that 3 exists as conglomerate since the 
eutectic, occurs at 0% ee which is always the case for conglomerates.  
 
Comparison of the experimentally determined liquidus and ideal liquidus 
temperatures shows that they are in very close agreement which implies that 
the enantiomers behave close to ideally in the liquid phase i.e. their enthalpy of 
mixing approaches zero. The entropy of mixing of the enantiomers in the liquid 
phase, calculated to be 5.44 J mol-1 K-1 (Equation 2.51), further suggests 
ideality as this is very close to the expected liquid phase entropy of mixing for 
ideal conglomerates, Rln2  = 5.78 J mol-1 K-1 (see section 2.6.2).  
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Figure 4.21 Half binary phase diagram for N-methylephedrine (3) with (R,S)-3 in excess (■ 
measured liquids, ● measured solidus, ▬ calculated liquids, ▬ expected solidus). 
 
 
4.7.2 Crystal Structure 
 
The powder XRD pattern and infra-red spectra of rac-3 and (R,S)-3 prepared 
from toluene are presented in Figure 4.22 and Figure 4.23. Examination of the 
data shows that the number and positions of the peaks in each spectrum are 
identical which is characteristic of a conglomerate since the racemate is a 
mixture of the two discreet crystalline enantiomeric phases.  
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Figure 4.22 Powder X-ray diffraction spectra of (R,S)- and rac-3.  
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Figure 4.23 FT-IR spectra for (R,S)- and rac-3. 
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Figure 4.24 shows the crystal packing and unit cell structures for (R,S)-3 which 
were generated using crystallographic database data [150]. The enantiomer 
crystallises in the non-centrosymmetric primitive orthorhombic space group 
P212121 indicating a two-fold screw rotation axis with half a translation along the 
a, b and c unit cell axis, having four molecules of (R,S)-3 in the unit cell (cell 
lengths a ≠ b ≠ c where a = 8.08 Å, b = 8.90 Å, c = 14.57 Å, and cell angles α = 
β =   = 90˚). The crystal structure is comprised of homochiral 21 columns in 
which each molecule is held together by a hydrogen bond between the hydroxyl 
hydrogen and corresponding tertiary amine on an identical molecule with van 
der Waals forces being responsible for the interactions between the homochiral 
columns. 
a 
 
b 
 
c 
 
d 
 
Figure 4.24 Crystal structure of (R,S)-2 showing a) molecular packing along the b axis and the 
contents of the unit cell along the b) a axis c) b axis and d) c axis. Blue and thin red lines 
indicate hydrogen bonging to other molecules and molecules not shown respectively. 
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4.7.3 Conclusion: N-Methylephedrine (3) Characterisation 
N-Methylephedrine (3) was investigated for use as a model chiral system for the 
CIAT process as it has been listed in the literature as a conglomerate and has 
the potential to undergo racemisation at its 2° alcohol and 3° amine chiral 
centres using available organometallic complexes. The pure enantiomers were 
obtained from commercial suppliers (Sigma Aldrich, > 99% ee) and the 
racemate prepared by mixing and recrystallising equimolar quantities of the two 
enantiomers from the melt. Calorimetry was used to investigate the melting 
behaviour of the racemate and the pure enantiomers obtained by solvent 
evaporation from toluene, and to construct the binary phase diagram which 
gave a clear indication the conglomerate formation as a single eutectic occurred 
at 0% ee. Coincidence of the experimental liquidus data with the predicted ideal 
liquidus, and the close agreement between the calculated entropy of mixing with 
that of an ideal system, suggested that the enantiomers behave close to ideally 
in the liquid phase which is generally observed for conglomerates. 
The findings of the calorimetry data were confirmed by powder XRD and infra-
red spectroscopy with the racemate and pure enantiomer having identical 
spectra since the former is a mechanical mixture of discreet enantiopure solid 
phases. The crystal structure of the pure enantiomer, obtained from the 
literature [150], proved the existence of a conglomerate showing that (R,S)-3, and 
hence rac-3, crystallises in the non-centrosymmetric primitive orthorhombic 
space group P212121 which happens to be the most frequently observed chiral 
crystal structure for organic molecules.  
Despite having two chiral centres with differing functionality, which upon 
racemisation would yield two diastereomeric forms of 3 in addition to the two 
enantiomers, the characterisation results described above suggested that 3 was 
a suitable candidate for use as a model chiral system in the CIAT process. 
However, subsequent investigations (results not presented) showed that the 
pure enantiomers of 3 could not be racemised by any of the organometallic 
catalysts tested.  Several iridium and ruthenium-based catalysts were trialled 
under a range of different conditions however no appreciable drop in ee was 
observed even when the substrate was refluxed for long durations of time 
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suggesting that the quaternary iminium intermediate species necessary for 
racemisation could not be generated (the reactions were monitored by 
polarimetry). Although it was hoped that this would not be the case, the 
behaviour observed was anticipated since there are few examples of tertiary 
amine racemisation, and as a result of these findings 3 was not investigated any 
further. 
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4.8 Chapter Summary 
The investigation into coupling preferential crystallisation with in-situ solution 
phase racemisation required a model chiral system that crystallises as a 
conglomerate and has the potential to undergo racemisation in solution with 
available organometallic complexes. A thorough search of the literature 
revealed only three suitable candidates that satisfied the selection criteria 
outlined in the chapter. 1-indanol (1), hydrobenzoin (2) and N-methylephedrine 
(3) were investigated for use as model chiral systems for development of the 
CIAT process as they have all been reported to exist as conglomerates in the 
literature.  
Calorimetric data were obtained for each of the systems investigated allowing 
for comparison of their racemate and pure enantiomer temperatures and fusion 
(∆  
    
 
and ∆  
     
 
 respectively) and identification of the eutectic ee by 
binary phase diagram construction, and calculation of the liquid phase entropy 
of mixing,    
 , as these can be used as characterisation techniques for chiral 
heterogeneous equilibria. The ideal liquid curves and liquid phase entropy of 
mixing were also identified using the calorimetric data to examine the proximity 
of chiral system to ideality. In addition to melting behaviour, the solid state 
structure of both the racemate and pure enantiomer were investigated by 
comparing their powder XRD and FT-IR spectra and identifying their crystal 
structures. 
1 was found to be and unstable model system as it was shown to crystallise as 
a stable racemic compound despite being listed as a resolvable conglomerate 
[9]. A difference of 18.8°C and 1.8 kJ mol-1 between the pure enantiomer and 
racemate melting points implied the presence of a racemic compound which 
was confirmed by binary phase diagram construction, the eutectic occurring at 
~30% ee, and PXRD and FT-IR, the racemate and pure enantiomer having 
different spectra. Single crystal XRD analysis showed that the racemate of 1 
crystallises in the centrosymmetric body centred tetragonal space group I41/a, 
whilst its enantiomers crystallise in the centrosymmetric monoclinic space group 
P21.
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Further investigation revealed that 1 is in fact able to form a metastable 
conglomerate under the correct conditions. DSC was used to obtain this by 
using a prescribed programme in which the mixtures of enantiomers were held 
in their molten state well in excess of the melting point of the pure enantiomer 
(90°C) before being cooled to 0°C under a controlled cooling rate. The 
conglomerate was obtained for non-racemic mixtures of 1 enantiomers (the 
conglomerate for 0% ee could not be obtained as it remained molten) with a 
reduction in solidus temperature (and liquidus temperatures at ees below the 
racemic compound eutectic) from ~51 to ~37°C, and construction of the 
complete binary phase diagram yielding a single eutectic at 0% ee, confirming 
the ability of 1 to form a metastable conglomerate. 
Although chiral discrimination in the solid phase of 1 was shown to be possible, 
the condition required to obtain the conglomerate i.e. the prolonged period of 
low temperature cooling, conflicted with the condition requirements of the 
racemisation catalysts. Furthermore, the conglomerate could only be obtained 
in the melt, and 1 was shown to be extremely solubility in all of the organic 
solvents tested therefore it was not taken forward in the CIAT investigation. 
Despite having two chiral centres, 2, was proposed as a possible candidate as it 
has been shown to crystallise as a conglomerate and has been resolved by 
preferential crystallisation [9], and has the potential to undergo racemisation. 2 
crystallised from toluene was confirmed to be a conglomerate as the difference 
between its racemate and enantiomer melting point was greater than 20°C 
(26.9°C), the binary phase diagram contained only a single eutectic at 0% ee, 
and the PXRD and FT-IR spectra for the racemate and enantiomers were 
identical. The presence of two chiral centres complicates is use as a model 
CIAT system as a meso form of 2 one results upon racemisation therefore this 
must be considered by identify its solubility relative to the enantiomers to ensure 
that the latter is the most stable and hence will be the first to achieve 
supersaturation. Furthermore, since CIAT involves seeding a racemising i.e. 
equilibrated solution of enantiomers, the solubility of the racemisation mixture of 
2 must be determined (as oppose to that of the racemate which would be 
required if the model system had a single chiral centre) to identify suitable 
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conditions for CIAT. In spite of these potential complications, 2 was selected as 
model system for investigation. 
Also having two chiral centres, albeit with different functionality, 3 was 
considered as it has been shown to crystallise as a conglomerate , despite 
initial reservations about the ability of the tertiary chiral amine stereogenic 
centres potential to undergo racemisations. 3 crystallised from toluene was 
confirmed to be a conglomerate as the difference between its racemate and 
enantiomer melting point was greater than 20°C (23.4°C), the binary phase 
diagram contained only a single eutectic at 0% ee, and the PXRD and FT-IR 
spectra for the racemate and enantiomers were identical. Even with the ability 
of the enantiomer of 3 to be resolved by seeding, further investigation (results 
not included) showed that it was unable to undergo racemisation. Several 
different iridium and ruthenium-based racemisation catalysts (see section 5.3.2) 
were trialled under a range of different conditions; however, even under reflux 
for prolonged reaction times, racemisation of 3 was not observed. It was 
therefore unable to be used as a model CIAT system and is not discussed any 
further. 
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5 Racemisation Catalyst Selection 
 
 
5.1 Introduction 
To recycle the waste enantiomer in-situ during the CIAT process, a suitable 
racemisation catalyst was required that can efficiently convert the optically 
active solution that results after enantio-selective crystallisation, back to one 
that is racemic. Organometallic complexes based on transition metals such as 
ruthenium, rhodium and iridium, have shown great promise as racemisation 
catalysts in the DKR of chiral alcohols and amines, in many cases giving 
quantitative yields of a single enantiomer from an initially racemic solution. Their 
ability to racemise a wide range of functionally related compounds with low 
catalysts loadings (~1-5 mol%), high functional group tolerance, requirement of 
mild conditions, and high solubility in organic solvents, make them a suitable 
candidate for CIAT. Other racemisation techniques, such as acid/base or heat 
catalysed racemisations, tend to be specific to each system requiring chiral 
centres that can be easily racemised e.g. due to the presence of low pKa chiral 
protons, and are thus limited in their application.  
Racemisation of optically active alcohols and amines by organometallics 
proceeds by dehydrogenation at the chiral centre to produce the corresponding 
ketone/imine followed by rehydrogenation either side of the planar intermediate. 
Typically, racemisation with these complexes occurs via inner-sphere electron 
transfer in which the active catalytic species is first generated by the addition of 
base (or thermal dissociation in the case of dimeric organometallics) which 
leads to ligand exchange with the optically active substrate, followed by hydride 
elimination and subsequent addition at the stereogenic carbon. Ruthenium-
based complexes are the most widely used for alcohol racemisation particularly 
in DKRs where a number of different catalysts have been used successfully [89, 
90, 98, 99, 101, 102, 104, 106, 109, 110, 115, 151]. Rhodium [116], palladium [14, 113], aluminium 
[117] and vanadium-based [111] complexes have also been shown to racemise 
chiral alcohols and have been utilised in DKRs; however, their use has been 
limited compared with those based on ruthenium. 
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5.2 Objectives 
Organometallic complexes were screened to identify a suitable catalyst for the 
racemisation of the chiral diol, 2, the model system identified in chapter 4, to be 
used in the CIAT process. Due to their success in DKRs and hydrogen transfer 
reactions, three potential candidates were investigated: chloro(indenyl)-bis-
(triphenylphosphine)-ruthenium(II) (4); chlorodicarbonyl-(1,2,3,4,5-pentaphenyl-
cyclopentadienyl)-ruthenium(II) (5); and chlorocarbonyl-triphenylphosphene-
(1,2,3,4,5-pentaphenylcyclopentadienyl)-ruthenium(II) (6). 
Racemisation of 2 was attempted with each catalyst under a range of 
conditions, primarily varying the temperature and catalysts load to identify a 
complex that was capable of giving sufficient rates of conversion of the pure 
enantiomer, (S,S)-2, to the racemate, rac-2. For catalysts that were shown to 
successfully racemise 2, observed kinetics for the overall reaction were 
identified, the effect of temperature and catalysts load on the reaction rate 
considered, and a possible catalytic cycle proposed. Since, as previously 
discussed, racemisation of 2 leads to the formation of meso-2 (in addition to the 
antipode) and other reaction intermediates, the relative composition of the 
resulting mixture was also determined to allow for characterisation of its 
solubility in the subsequent chapter which was necessary to identify conditions 
for CIAT.  
Racemisation of 3, which was shown to crystallise as a conglomerate from 
toluene, was also attempted using the complexes listed above under a range of 
different conditions (results not given). However; in each case no racemisation 
was observed, even when refluxed for long durations of time, which was most 
likely a due to the resistance of its tertiary chiral amine for which few examples 
of racemisation by organometallics exists. 
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5.3 Racemisation Catalyst Selection 
5.3.1 Selection Criteria 
Selection of a suitable organometallic complex for racemisation of 2 was 
dependent on satisfying a number of criteria: 
 Able to efficiently racemise the selected model system 
 Racemisation rate equal to or in excess of crystallisation rate 
 Remains undersaturated in solution for the duration of the CIAT process 
 Does not inhibit chiral discrimination in the solid phase 
 Minimal influence on crystallisation characteristics 
 Cheap to obtain or synthesise  
As CIAT consists of coupling preferential crystallisation with in-situ solution 
phase racemisation, the relative rates of the two processes had to be 
considered. For the process to be successful the rate of racemisation had to 
exceed that of crystallisation, i.e. the rate at which solute is deposited from 
solution. In an ideal case the rate of racemisation would be fast enough to 
maintain a racemic or near racemic solution phase ee, which would allow the 
process to operate close to equilibrium between the solid and solution phases 
potentially leading to quantitative yields of the seeded enantiomer.  
If the racemisation rate were not to exceed that of crystallisation, eventually 
growth of the seed crystals and secondary nuclei formation of the desired 
enantiomer would lead to an rise in the ee of its antipode in solution which, in 
turn, would increase its chance of spontaneous crystallisation as its degree of 
supersaturation would be greater than that of the desired enantiomer. To 
compensate for the latter case occurring, the crystallisation conditions could of 
course be tuned (to a certain degree) so that the relative rates of the two 
processes are as required; however, catalysts found to give slow rates of 
racemisation e.g. in the order of days, would be unsuitable for CIAT as even 
with modified crystallisation conditions, it is likely that this would result in 
sufficient time for the nucleation induction period to elapse. 
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Considering the preferential crystallisation of 2 from ethanol reported in the 
literature [143], a crystal yield of approximately 8% of the desired enantiomer was 
recovered after allowing the process to run for 20 min, which corresponds to a 
4% increase in the solution phase ee of the undesired enantiomer in this time 
period. Therefore, in theory, for a crystal yield of 100% of the desired 
enantiomer 250 min would be required based on the observed rate of 
crystallisation (assuming size independent growth). For CIAT to be successful 
the selected catalyst would thus need to be able to completely racemise the 
pure enantiomer within this time period, ideally with a racemisation time 
considerably less than this for the reasons described above. 
In addition to achieving fast rates of racemisation, the selected catalysts also 
had to exhibit sufficient solubility in the process solvent. Since the driving force 
for crystallisation during CIAT is generated by cooling, it was essential that the 
catalyst remained dissolved for the duration of the process and did not itself 
become supersaturated and precipitate from solution. On the other hand, the 
presence of the catalyst in solution had to have minimal influence of the 
crystallisation characteristics of both the desired and undesired enantiomer, 
particularly, the ability of the racemate to form a conglomerate or the seed 
crystals to grow, or the potential for the catalyst to act as centres for nucleation. 
Finally, by their very nature, being comprised of precious metals, the 
organometallic complexes earmarked for use as CIAT catalysts are often 
expensive to purchase or synthesise. Therefore the ideal candidate had to be 
available for the investigation in sufficient quantities (tens of grams) at a 
reasonable cost. 
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5.3.2 CIAT Candidates 
 
 
Figure 5.1 Organometallic complexes investigated for use as a racemisation catalyst in the 
CIAT process: Chloro(indenyl)-bis-(triphenylphosphine)-ruthenium(II) (4); chlorocarbonyl-
triphenylphosphene(1,2,3,4,5-pentaphenylcyclopentadienyl)-ruthenium(II) (5); chlorodicarbonyl-
(1,2,3,4,5-pentaphenylcyclopentadienyl)-ruthenium(II) (6); 
 
The ruthenium-based complexes 4-6 were investigated for use in the CIAT 
process as they have all been shown to be capable of racemising a wide range 
of chiral alcohols and have been successfully used in DKRs ([107, 126, 152]). Each 
of the complexes are active in toluene, which as a result has been earmarked 
for use as the CIAT process solvent (see section 5.3.3 for discussion), being 
capable of efficient racemisation at room temperature, in some cases within 30 
min with low catalyst loads of 0.5 mol%. 
Generation of the active catalytic species of 4-6 takes place by the addition of 
base, typically t-BuOK or KOH, which results in ligand loss, and hence the 
formation of a reactive 16 electron (16e-) complex, leaving it susceptible to 
subsequent ligand re-addition which leads to racemisation of the substrate. 
Despite the high activities seen, one drawback associated with the use of 
ruthenium-based catalysts (4 and 6) is that they require dry anaerobic 
conditions. 5 on the other hand, is the only air stable catalyst that has been 
reported in the literature [126]. Due to the similarities seen in the CIAT obtained 
for catalysts 4 and 6, and since a great deal of work was done using 4, the 
results for catalyst 6 are not presented in the subsequent chapters. 
The iridium-based complexes pentamethylcyclopentadienyl iridium(II) dichloride 
dimer ([Cp*IrCl2]2) and pentamethylcyclopentadienyl iridium(II) diiodide dimer 
([Cp*IrI2]2) were investigated due to their success in hydrogen transfer reactions 
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and DKRs ([16, 17, 144, 152-154]); however all attempts at racemising 2 were 
unsuccessful even when the reaction mixture was refluxed for 24 h under 
relatively high catalyst loads (0.117 mol l-1, 3 mol%). Shvo’s catalyst (1-
Hydroxy-tetraphenyl-cyclopentadienyl-(tetraphenyl-2,4-cyclopentadien-1-one)-
μ-hydro-tetracarbonyl-diruthenium(II)) was also considered due to its use in 
hydrogen transfer and DKR [61, 91-94, 118], and proved successful at racemising 2 
within 1 h (0.117 mol l-1, 80°C, 2 mol%). However the high cost of the catalyst, 
coupled with the fact that it is structurally analogous to 5 (Shvo’s catalyst 
essentially being a dimer of 5) meant that was not used for CIAT (results for Ir-
based and Shvo’s catalyst not given). 
 
5.3.3 Solvent Selection 
As previously discussed (see section 4.3.1) toluene was chosen to be the CIAT 
process solvent as it has been successfully used for racemisation using a wide 
range of catalysts including 4-6. It has been shown to have the ability to 
dissolve a wide range of organometallics, whilst also remaining inert to the 
catalytic cycle. As will be seen in chapter 6, it is also suitable for the 
crystallisation of 2 as a conglomerate, allowing for its complete dissolution upon 
heating, and deposition of a sufficient quantity of material upon cooling. 
 
5.4 Methodology and Analytical Techniques 
5.4.1 Catalyst Preparation 
4 and 5 were synthesised using the literature procedures given by Oro et al [155] 
and Ko et al [126] respectively. See section 11.2 for a description of the synthetic 
routes used.  
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5.4.2 Racemisation 
 
 
Scheme 5.1 Conditions for (S,S)-2 racemisation using Ru-based complexes 4 and 5. 
 
Procedure for racemisation of (S,S)-hydrobenzoin ((S,S)-2)) with ruthenium-
based catalysts 4-5 (0.93 mmol scale): To a 25 ml Schlenk flask equipped with 
a reflux condenser, thermometer and inert gas supply (catalysts 4 and 5, N2 or 
Ar) was dissolved 0.93 mmol of (S,S)-2) (0.2 g) and 10 mol% base (t-BuOK or 
KOH) in 8 ml of dry toluene at 50-80°C. 0.5-4 mol% of 4 or 5 was then added 
and the reaction left to proceed for 1 h.  
Sampling procedure for (S,S)-hydrobenzoin ((S,S)-2): 0.5 ml samples of the 
reaction mixture, obtained using a glass syringe through an air tight septum, 
were quenched with 1 M HCl and topped up with diethyl ether to ensure 
compete dissolution of the substrate (due to a low solubility in toluene at room 
temperature). The organic top layer was separated, evaporated, and 
subsequently dried under vacuum. The samples were then dissolved in propan-
2-ol and analysed by chiral HPLC (see section 11.1.5 for HPLC method details). 
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5.5 Racemisation of (S,S)-Hydrobenzoin ((S,S)-2) 
5.5.1 Chloro(indenyl)-bis-(triphenylphosphine)-ruthenium(II) (4) 
5.5.1.1 Reaction Rate 
Figure 5.2 shows the progress of the racemisation of (S,S)-2 by complex 4 
(0.117 mol l-1, 2 mol% 4, 60°C). It is evident that 4 is highly active under the 
conditions used as complete racemisation of the substrate has occurred after 5 
min. As expected, in addition to forming its antipode, the reaction of (S,S)-2 with 
4 also leads to the formation of near equal amounts meso-2 and the di-ketone 
intermediate benzil (1,2-diphenylethane-dione). Interestingly, benzaldehyde was 
also seen to be formed which indicates that the alkane C-C bond has 
undergone cleavage due to the action of the catalyst which could have been a 
result of (S,S)-2 acting as a bidentate ligand due to it possessing two chiral 
centres.  
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Figure 5.2 Racemisation of (S,S)-2 with 4 (0.117 mol l
-1
, 2 mol% 4, 60°C) (● (S,S)-2,  ▲ (R,R)-
2, ▼ meso-2, ■ benzil,  benzaldehyde). 
 
Using differential analysis [156] the observed kinetics for the racemisation of 
(S,S)-2 by 4 were estimated. As the reaction proceeded at such a fast rate it 
was difficult to obtain data points before equilibrium was achieved. 
Consequently, the values used for estimation of the racemisation rate were 
taken from the curve that was fitted to the experimental data. It is possible that 
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that racemisation rate could have been reduced by lowering the temperature or 
catalysts load; however, with regards to the former, the low solubility of the pure 
enantiomer (S,S)-2 did not permit dissolution bellow ~50°C, whereas reduction 
of the catalyst load to 0.5 mol% did not result in complete racemisation. 
Using the OriginPro software package, the data from Figure 5.2 was fitted with 
an exponential decay function whose derivatives at selected points were 
subsequently calculated to obtain the rate of change of (S,S)-2 concentration 
with respect to time (Table 5.1). Logarithms of the derivatives and the 
corresponding concentrations were then taken and plotted to give Figure 5.3. 
Using this the order, n, and observed rate constant, kobs, of the racemisation 
reaction were obtained from the y-intercept and slope of the fitted line and 
estimated to be 2.183 and 12.877 l1.183 mol-1.183 s-1 respectively giving the 
racemisation rate function for (S,S)-2 by 4 (Equation 5.1). 
 
Table 5.1 Differential analysis of (S,S)-2 racemisation with 4 (0.117 mol l-1, 2 mol% 4, 60°C). 
Time 
(min) 
Concentration (S,S)-
hydrobenzoin (C(S,S)-2) 
(mol l
-1
) 
log10(C(S,S)-2) dC(S,S)-2/dt log10(-dC(S,S)-2/dt) 
0.0 0.117 -0.933 -0.107 -0.970 
0.5 0.077 -1.112 -0.055 -1.259 
1.0 0.057 -1.242 -0.028 -1.556 
1.5 0.047 -1.327 -0.014 -1.852 
 
 
146 
 
-1.4 -1.3 -1.2 -1.1 -1.0 -0.9
-2.00
-1.75
-1.50
-1.25
-1.00
lo
g
1
0
(-
d
C
(S
,S
)-
2
/d
t)
log
10
(dC
(S,S)-2
)
 
Figure 5.3 log10(-dC(S,S)-2/dt) vs. log10dC(S,S)-2 for the racemisation of (S,S)-2 by 4. 
 
Estimated rate function for the racemisation of (S,S)-2 by 4: 
 
                      
  (      
      
          
)        
                Equation 5.1 
 
5.5.1.2 Temperature Dependence 
As the proposed CIAT process relies on cooling to induce supersaturation of the 
desired enantiomer, the temperature dependence of the racemisation rate was 
investigated to ensure it remains sufficiently fast to maintain a racemic or near 
racemic solution composition during CIAT as the temperature is reduced. Figure 
5.4 shows the progress of the racemisation of (S,S)-2 by 4 at 50°C, 60°C and 
70°C (0.117 mol l-1, 2 mol% 4). As expected, the time take for complete 
racemisation reduces with an increase in temperature occurring within 10 min, 5 
min, and 2 min, at reaction temperatures of 50°C, 60°C and 70°C respectively 
highlighting the suitability of 4 for use in the proposed CIAT process. Ideally the 
reaction rate would have been investigated over a wider range of temperatures; 
however as is implied from examination of Figure 5.4, the racemisation rate 
becomes immeasurably fast at beyond 70°C therefore it would not be possible 
to accurately deduce any kinetic information using data obtained under this 
condition. On the other hand, as mentioned previously, at temperatures less 
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than 50°C, (S,S)-2 becomes insoluble in toluene therefore this could not be 
performed. A temperature difference of 5°C between each successive 
measurement was attempted; however, it was difficult to resolve any differences 
between the data generated therefore 10°C intervals had to be selected. 
 
0.00
0.04
0.08
0.12
0.00
0.04
0.08
0.12
0 5 10 15 20 25
0.00
0.04
0.08
0.12
a
b
c
C
o
n
c
e
n
tr
a
ti
o
n
 (
m
o
l 
l-1
)
Time (min)
 
Figure 5.4 Racemisation of (S,S)-2 by 4 at a) 50°C, b) 60°C and c) 70°C (0.117 mol l
-1
, 2 mol% 
4 (● (S,S)-2,  ▲ (R,R)-2, ▼ meso-2, ■ benzil,  benzaldehyde). 
Using the same method described in the previous section, the observed kinetics 
for the racemisation were estimated at the three temperatures examined (Figure 
5.5). The observed rate constants for each temperature (Table 5.2 Graphically 
determined observed rate constants for the racemisation of (S,S)-2 with 
catalysts 4 for a range of temperatures (0.1167 mol l-1, 2 mol%)) show that the 
rate of racemisation is approximately doubled for an increase 10°C; however, 
the observed rate constant for 70°C is less than expected, considering those 
obtained at the lower temperatures, which is likely due to the rate of 
concentration change of (S,S)-2 being faster than that which was observed 
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between the concentration at t = 0, and the first sample that was taken. Using 
the data in Table 5.2, the activation energy, EA, and pre-exponential factor, A, 
were estimated as being 56.8 kJ mol-1 and 9.5x109 l1.183 mol-1.183 s-1 respectively 
from the slope and y-intercept of an Arrhenius plot (Figure 5.6) leading to an 
expression for the temperature dependency of the observed racemisation rate 
constant (Equation 5.2).  
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Figure 5.5 log10(-dC(S,S)-2/dt) vs. log10dC(S,S)-2 for the racemisation of (S,S)-2 by 4 at ▲ 50°C, ● 
60°C and ■ 70°C 
 
Table 5.2 Graphically determined observed rate constants for the racemisation of (S,S)-2 with 
catalysts 4 for a range of temperatures (0.1167 mol l-1, 2 mol%)  
 
 
Temperature (°C) 
50 60 70 
Rate constant, kobs 
(l
1.183
 mol
-1.183
 s
-1
) 
6.097 12.877 20.845 
 
 
149 
 
0.00290 0.00295 0.00300 0.00305 0.00310
1.8
2.0
2.2
2.4
2.6
2.8
3.0
3.2
ln
 k
1/T
 
Figure 5.6 Natural log of the observed racemisation rate constant, kobs, vs. 1/T, for the 
racemisation of (S,S)-2 with 4. 
 
Estimated temperature dependency of the observed rate constant for the 
racemisation of (S,S)-2 by 4: 
 
           
   
               (
        
  ) Equation 5.2 
 
 
5.5.1.3 Catalysts Load 
To investigate the dependency on the racemisation rate on the catalyst loading 
used, racemisation of (S,S)-2 was performed with 1, 2 and 4 mol% of 4 (0.117 
mol l-1, 60°C) (Figure 5.7). As expected, the time taken for complete 
racemisation is reduced from 10 to 2 min with catalyst quantity. Examination of 
the observed rate constants, kobs (Table 5.3), determined using the graphical 
technique applied previously, shows that the rate is approximately three times 
as fast when the concentration of the catalyst is doubled. Interestingly, when the 
racemisation was performed using 4 mol% of 4, a higher level of benzaldehyde 
was observed than when lower quantities of 4 were used. Initially it was 
postulated this could be due to competition between racemisation of (S,S)-2 to 
(R,R)-2 / meso-2, with the C-C cleavage reaction required to form 
benzaldehyde which may have been promoted by higher catalyst loadings. 
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However, repeats of these runs did not support this as no trends could be 
observed between benzaldehyde formation and catalyst load. In fact, the high 
levels of benzaldehyde seen occurred randomly from sample to sample, with 
discontinuities observed within the same run (as can be seen in from 5 to 9 min 
in Figure 5.7). It is therefore likely that, due to the strong chromophore exhibited 
by benzaldehyde that this was due to analytical deviations whereby small 
differences in the quantity of benzaldehyde present in each sample gave rise to 
large difference in the resulting HPLC spectra. Compositional analysis at 
different wavelengths was attempted yet this was not successful at resolving 
different components of the racemisation.  
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Figure 5.7 Racemisation of (S,S)-2 by 4 a) 1 mol% , b) 2 mol% and c) 4 mol% 4 (0.117 mol l
-1
, 
60°C) (■ benzil, ● (S,S)-2,  ▲ (R,R)-2,  benzaldehyde, ▼ meso-2). 
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Table 5.3 Graphically determined rate constants for the racemisation of (S,S)-2 with catalysts 4 
for a range catalyst loadings (0.1167 mol l
-1
, 60°C) 
 
Catalyst mol% 
1 2 4 
Rate constant, k 
(l
1.183
 mol
-1.183
 s
-1
) 
3.614 12.877 35.156 
 
 
5.5.2 Chlorocarbonyl-triphenylphosphene(1,2,3,4,5-
pentaphenylcyclopentadienyl)-ruthenium(II) (5) 
5.5.2.1 Reaction Rate 
Figure 5.8 shows the progress of (S,S)-2 racemisation by complex 5 (0.117 mol 
l-1, 2 mol% 5, 60°C). As with the complex investigated in the previous section, 
efficient racemisation takes place resulting in the enantiomers of 2 becoming 
equimolar after ~25 min has elapsed. In addition (R,R)-2 and meso-2, 
significant quantities of benzil, stilbene and benzaldehyde were also formed. 
Using the data presented in Figure 5.8, the observed kinetics for the 
racemisation of (S,S)-2 by 5 were estimated using the methodology described 
in section 5.5.1.1 with the resulting values given in Table 5.4 and plotted in 
Figure 5.9. The reaction order, n, and observed rate constant, kobs, were 
obtained from the y-intercept and slope of the fitted line and estimated to be 
0.984 and 1.266 l0.984 mol-0.984 s-1 respectively giving the racemisation rate 
function for (S,S)-2 by 5 (Equation 5.3). 
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Figure 5.8 Racemisation of (S,S)-2 with 5 (0.117 mol l
-1
, 2 mol% 5, 60°C) (■ benzil, ● stilbene,▲ 
(S,S)-hydrobenzoin, ▼(R,R)-hydrobenzoin,  benzaldehyde,  meso-hydrobenzoin) 
 
Table 5.4 Differential analysis of (S,S)-2 racemisation with 5 (0.117 mol l-1, 2 mol% 5, 60°C). 
Time 
(min) 
Concentration (S,S)-
hydrobenzoin (C(S,S-HB)) 
(mol l
-1
) 
log10(C(S,S-HB)) dC(S,S-HB)/dt 
log10(-dC(S,S-
HB)/dt) 
0 0.117 -0.933 -0.0164 -1.786 
2 0.098 -1.008 -0.0122 -1.914 
5 0.070 -1.154 -0.0078 -2.106 
9 0.056 -1.251 -0.0044 -2.359 
15 0.039 -1.408 -0.0018 -2.742 
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Figure 5.9 log10(-dC(S,S)-2/dt) vs. log10dC(S,S)-2 for the racemisation of (S,S)-2 by 5. 
 
Estimated rate function for the racemisation of (S,S)-2 by 5: 
 
                      
  (     
      
          
)        
                Equation 5.3 
 
 
 
 
5.5.2.2 Temperature Dependence 
 
Figure 5.10 shows the progress of (S,S)-2 racemisation by 5 at 50°C, 60°C and 
70°C (0.117 mol l-1, 2 mol% 5). As expected, the time taken for complete 
racemisation reduces with an increase in temperature occurring within < 60 min, 
~25 min, and ~9 min, at reaction temperatures of 50°C, 60°C and 70°C 
respectively. The observed kinetics were estimated at the three temperatures 
examined (Figure 5.11) leading to the rate constants presented in Table 5.5. As 
the temperature is increased to 60°C and 70°C, the estimated rate is seen to 
increase by a factor of ~4 and ~6 respectively. Unlike complex 4, the relative 
levels of benzaldehyde remain consistently low and do not appear to be 
influenced by a change in the process temperature. Using the data in Table 5.5 
 
154 
 
the activation energy, EA, and pre-exponential factor, A, were estimated as 
being 146.0 kJ mol-1 and 1.2x1023 l0.984 mol-0.984 s-1 respectively from the slope 
and y-intercept of an Arrhenius plot (Figure 5.12) leading to an expression for 
the temperature dependency of the observed racemisation rate constant 
(Equation 5.4). 
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Figure 5.10 Racemisation of (S,S)-2 by 5 at a) 50°C, b) 60°C and c) 70°C (0.117 mol l
-1
, 2 mol% 
5) (■ benzil, ● stilbene,▲ (S,S)-hydrobenzoin, ▼(R,R)-hydrobenzoin,  benzaldehyde,  meso-
hydrobenzoin). 
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Figure 5.11 log10(-dC(S,S)-2/dt) vs. log10dC(S,S)-2 for the racemisation of (S,S)-2 by 5at ▲ 50°C, ● 
60°C and ■ 70°C. 
 
 
Table 5.5 Graphically determined observed rate constants for the racemisation of (S,S)-2 with 
catalysts 5 for a range of temperatures (0.1167 mol l-1, 4 mol% 5)  
 
Temperature (°C) 
50 60 70 
Rate constant, k 
(l
0.984
 mol
-0.984
 s
-1
) 
0.312 1.266 7.454 
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Figure 5.12 Natural log of the observed racemisation rate constant, k, vs. 1/T, for the 
racemisation of (S,S)-2 with 5. 
 
Estimated temperature dependency of the observed rate constant for the 
racemisation of (S,S)-2 by 5: 
 
           
   
                (
       
  ) Equation 5.4 
 
 
 
5.5.2.3 Catalyst Load 
 
Racemisation of (S,S)-2 was performed with 1, 2 and 4 mol% of 5 (0.117 mol l-1, 
60°C) (Figure 5.13). Increasing the catalyst loading resulted in only a slight 
reduction in the time required for the enantiomers of 2 to become equimolar 
when 2 and 4 mol% 5 was used. However; unlike complexes 4, complete 
racemisation of (S,S)-2 was not achieved over the duration of time in which the 
reaction was monitored when 1 mol% of 5 was used indicating its lower relative 
activity. The rate constants determined at each catalyst loading (Table 5.6) 
indicate that the reaction rate is approximately 100% and 25% greater when the 
quantity of 5 is successively doubled from 1 to 4 mol%. Despite this, efficient 
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racemisation could still be achieved at => 2 mol% 5 making it a suitable 
candidate for CIAT. 
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Figure 5.13 Racemisation of (S,S)-2 by 5 a) 1 mol% , b) 2 mol% and c) 4 mol% 5 (0.117 mol l
-1
, 
60°C) (■ benzil, ● stilbene,▲ (S,S)-hydrobenzoin, ▼(R,R)-hydrobenzoin,  benzaldehyde,  
meso-hydrobenzoin). 
 
Table 5.6 Graphically determined rate constants for the racemisation of (S.S)-2 with catalysts 5 
for a range catalyst loadings (0.1167 mol l-1, 60°C) 
 
 
Catalyst mol% 
1 2 4 
Rate constant, k 
(l
0.984
 mol
-0.984
 s
-1
) 
0.494 1.028 1.266 
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5.5.3 Catalytic Cycle  
Due to the structural resemblances of complexes 4 and 5, and with each 
requiring base activation, it is likely that racemisation proceeds via similar 
mechanisms. As an example, the proposed mechanism for the racemisation of 
(S,S)-2 by catalyst 4 is given in Scheme 5.2 to describe the catalytic cycle of the 
Ru-based complexes investigated.  
Activation of the precatalyst 4 occurs via the addition of t-BuOK, resulting in loss 
of the Cl ligand to produce KCl, which in turn leads to the formation of the 
ruthenium tert-butoxide complex 4a. The tert-butoxide group is then exchanged 
for the chiral diol (S,S)-2 forming the sec-alkoxide species 4b.  For the next 
stage of the cycle, moving from 4b to 4c or 4d, two mechanisms have been 
suggested [157, 158]. 4b is an 18e- species i.e. it is coordinatively saturated, 
therefore formation of the η2-π-coordinated ketone complex via β-hydride 
elimination is likely to be due to either η5 to η3 ring slippage [100, 114], or by loss of 
a ligand (PPh3 in this example). Considering complex 4, the indenyl ligand is 
known to undergo η5 to η3 ring slippage [159] which results from the stabilisation 
of the benzene ring due to the attainment of full aromaticity; therefore it is 
possible that 4c occurs as an intermediate. Ring slippage is less likely for 5, 
which instead exhibit a pentaphenylcyclopentadienyl ligand, with recent studies 
suggesting that β-hydride elimination does in fact occur by ligand loss forming a 
16e- species which leaves a vacant coordination site for the hydride [160, 161]. 
From 4c/4d to 4e, hydride re-addition from Ru to either side of the planar 
ketone results in racemisation of the stereogenic centre and formation of the η1- 
coordinated ketone complex. This is then exchanged with a molecule of (S,S)-2 
and the catalytic cycle is repeated. 
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Scheme 5.2 Suggested catalytic cycle for the racemisation of (S,S)-2 using complex 4 as an 
example. 
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5.6 Chapter Summary 
Three ruthenium-based organometallic complexes, chloro(indenyl)-bis-
(triphenylphosphine)-ruthenium(II) (4), chlorodicarbonyl-(1,2,3,4,5-
pentaphenylcyclopentadienyl)-ruthenium(II) (5) and chlorocarbonyl-
triphenylphosphene(1,2,3,4,5-pentaphenylcyclopentadienyl)-ruthenium(II) (6) 
(results not presented) were investigated for use as racemisation catalysts in 
the proposed CIAT process with the model enantiomeric compound, 
hydrobenzoin (2), identified in the previous chapter. Racemisation of (S,S)-2 
was performed using each of the complexes in toluene under a range of 
different conditions to quantify their rates of reaction and to determine the 
dependency of these rates on temperature and catalyst loading. Temperature 
was varied as the proposed CIAT process involves controlled cooling to 
generate supersaturation of the desired enantiomer therefore it was necessary 
to identify whether each of the complexes remained active as the temperature is 
reduced. It was also necessary to investigate the effect of catalyst loading to 
identify the levels of catalyst that would be required to perform CIAT. 
Each of the complexes investigated were shown to efficiently racemise (S,S)-2. 
4 was the most active catalyst with complete racemisation occurring within 2 
min at temperatures and catalysts loads greater than 60°C and 2 mol% 
respectively. At the lowest temperature and catalyst loading examined (50°C 
and 1 mol%) the complex remained highly active allowing for complete 
racemisation within 5 min highlighting its suitability as a racemisation catalyst 
for the CIAT process. 
5, the only air stable complex investigated, was shown to be the least active of 
each of the catalysts investigated. At the highest temperature and catalyst 
loading examined (70°C and 4 mol%) racemisation could be achieved within 9 
and 25 min respectively. However, at 50°C (2 mol%) and 1 mol% (60°C) 
complete racemisation was not observed within the duration of each 
experimental run (60 min). Despite this, the proportion of by-products formed 
was relatively low and therefore, if sufficient quantities were used, and the 
process conditions were tailored to be in favour of racemisation (i.e. slow 
cooling ramp to allow adequate time for racemisation), being the most robust 
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catalyst due to its inherent stability, 5 was shown to be a suitable candidate for 
used as a catalysts in the proposed CIAT process.  
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6 Hydrobenzoin Crystallisation for CIAT 
 
 
6.1 Introduction 
In developing a preferential crystallisation process for two enantiomers, it is 
necessary to identify the phase equilibria for the three component system, i.e. 
both enantiomers and the solute, by constructing the ternary phase diagram 
which is then used to identify the conditions for the process. For a racemising 
system however, the ternary phase diagram is modified so that the regions in 
which the pure solid phase components exists cannot be accessed; hence, for 
CIAT an alternative approach must be taken. 
CIAT involves introducing optically pure seed crystals into a supersaturated 
solution of racemising enantiomers. Therefore it is essential to identify the solid-
solution phase equilibria of the racemate, i.e. the equilibrium and metastable 
solubility temperatures of the two enantiomers for a range of concentrations 
allowing for construction of the racemic solubility curve. Using this information, 
conditions can be selected so that enantiopure crystals will be added to the 
system whilst it is in the metastable zone. Within this region a thermodynamic 
driving force for crystallisation exists but, for a homogenous solution free of any 
foreign matter, spontaneous nucleation will not be observed until a 
characteristic induction time period has elapsed. However, introducing seeds to 
the system will lead to selective deposition of solute through seed growth and 
secondary nuclei formation, since the energy barrier for two-dimensional crystal 
formation is lower than that which needs to be overcome to form three-
dimensional nuclei. 
In the previous chapter it was shown that, as a result of possessing two 
stereogenic centres, racemisation of the selected model conglomerate 
hydrobenzoin (2) with either catalyst 4 or 5 results in the formation of its 
antipode but also near equivalent quantities of the corresponding meso 
stereoisomer (small amounts of other reaction intermediates were also 
observed). Consequently, to determine suitable conditions for CIAT, identifying 
the equilibrium solubility curve for the racemate of 2 would not have provided 
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the required information. Instead, it was necessary to determine that of the 
equilibrated mixture that resulted upon complete catalytic transformation of 2 
using catalyst 4 or 5, 4-racmix-2 and 5-racmix-2 respectively. 
 
6.2 Objectives 
Conditions for were identified for CIAT of 2 by catalyst 4 and 5 by identifying the 
crystallisation and dissolution temperatures for the mixtures that resulted upon 
catalytic conversion in toluene, 4-racmix-2 and 5-racmix-2,  as shown in the 
previous chapter. Doing this for a range of concentrations led to construction of 
the solubility diagram for each system and hence determination of their MSZW 
allowing for CIAT conditions to be selected whereby the seed could be 
entrained in a supersaturated solution of the reaction mixture without 
spontaneous crystallisation of the undesired species.  
In addition to identifying the solid-solution phase equilibria of 4-racmix-2 and 5-
racmix-2, enantiopure (S,S)-2 and (R,R)-2 seed crystals for use in the CIAT 
process were prepared and characterised.  
 
6.3 Methodology and Equipment 
6.3.1 HEL Automate Parallel Vessels 
The solubility of 4-racmix-2 was identified using the HEL Automate reactor 
system (Figure 6.1) consisting of four 30 ml parallel jacketed glass vessels. 
Each reactor was equipped with a variable speed agitator, a PT100 
thermocouple, a turbidity probe and inlet ports, with the system being fully 
automated and controlled via HEL WinIso software located on an external PC. 
Heating and cooling was provided by a Julabo HD oil bath which circulates the 
heat transfer fluid sequentially through each reactor. Additional heating was 
supplied by way of an internal hot plate to account for heat loss from the fluid as 
it is circulated.  
The turbidity probes were used to identify the crystallisation and dissolution 
temperatures. An LED emits a beam of red light through a length of quartz fibre 
housed within the probe shaft. A mirror at the base of the probe, submerged in the 
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process solution, reflects the light beam back to a signal converter logging the data. 
As crystals appear in the solution, the transmission of the light beam is hindered 
reducing the intensity of the signal. The probe was calibrated by recording the 
signal produced when submerged in a clear solution and a slurry, allowing this to 
be used to determine the dissolution and crystallisation temperatures respectively 
of the system under a prescribed temperature programme.   
 
Figure 6.1 HEL Automate parallel overhead-stirred jacketed reactor system (30 ml scale) used 
to conduct determine the solubility curve of 4-racmix-2. 
 
6.3.2 Crysta16 
The solubility of 5-racmix-2 was identified using the Crystal16 system (due to 
technical problems that occurred with the turbidity probes on the HEL Automate 
rig). This consists of 16 parallel 1.3 ml vessels with magnetic stirring, on-line 
turbidity measurement, and heating provided by way of four independently 
controlled aluminium blocks 
 
6.3.3 Racemisation Mixture Preparation 
The equipment used to determine the solubility of 4-racmix-2 and 5-racmix-2 
described in the previous sections rely on using optical turbidity analysis to 
identify the crystallisation and dissolution temperatures. Consequently, to 
determine these points it is essential that the system being examined permits 
transmission of the light source when the solution is free of solid. However, 
when catalyst 4 or 5 was added to 2, a dark opaque solution resulted through 
which the incident light was unable to travel (see Figure 7.1 in chapter 7 for an 
image of the CIAT process solution containing 4-racmix-2 and 4). Consequently 
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it was not possible to determine the solubility of the mixtures with the catalysts 
present in solution therefore 4 and 5 had to be removed without altering the 
equilibrated composition. 
To prepare material for the solubility measurements, a known quantity of (S,S)-
2 was first racemised by catalysts 4 and 5 for 1 h in toluene (60°C, 4 mol% 
catalyst, argon atmosphere for 4) to yield the equilibrated reaction mixtures 4-
racmix-2 and 5-racmix-2. This was then immediately crash cooled to -40°C whilst 
stirring using a bath of dry ice in isopropanol leading to crystallisation of the 
mixture. The solids were filtered under vacuum, and washed twice with toluene 
that had also been cooled to -40°C, which separated the catalyst rich liquor 
leaving white crystals. After drying for 24 hr, the product was weighed and 
compared with that of (S,S)-2 used at the beginning of the process to determine 
whether any mass had been lost by remaining dissolved in solution. Due to the 
low temperatures used to deposit the crystals from solution, in conjunction with 
the relatively large scales used (~100 g of starting material), negligible losses 
were observed indicating that there was an insignificant change in the 
composition of 4-racmix-2 and 5-racmix-2. Furthermore, due to the high solubility 
of the catalyst in toluene, it was efficiently separated allowing the solubility of 
the mixture to be determined since it yielded a clear solution upon dissolution.  
Figure 6.2 and Figure 6.3 show the chiral HPLC chromatograms for 4-racmix-2 
and 5-racmix-2 respectively after preparation using the method described. 
Analysis of the chromatograms shows that for 4-racmix-2 and 5-racmix-2 
approximately 35% and 33% were comprised of the enantiomers (S,S)-/(R,R)-2 
respectively, whilst the remainder consisted of meso-2 with very small amounts 
of benzaldehyde and some unknown present. Comparison of this data with that 
presented in chapter 5 shows that there was in fact a slight change in the 
composition, with the small quantities of benzil and stilbene not being seen. 
However, since they were present in very low amounts, their effect on the 
equilibrium solubility temperature of the significantly more dominant 
enantiomers and meso form would be minimal (although this many have had a 
minor effect on the crystallisation kinetics). However; this was satisfactory for 
the investigation leading to it being used for the solubility analysis, and also as a 
starting material for the subsequent CIAT experiments.  
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Figure 6.2 Catalyst 4 hydrobenzoin racemisation mixture (5-racmix-2).with a composition of 
approximately 35% (R,R)-/(S,S)-2, 28.5% meso-2, 0.5% benzaldehyde and 1% unknown. 
 
Figure 6.3 Catalyst 5 hydrobenzoin racemisation mixture (5-racmix-2).with a composition of 
approximately 33% (R,R)-/(S,S)-2, 31.5% meso-2, 2% benzaldehyde, 0.5% unknown. 
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6.3.4 Solubility Measurements 
The methodology used for determining the solubility of 4-racmix-2 and 5-racmix-2 
using both the HEL Automate and Crystal 16 system was identical; however this 
was performed at differing scales of 30 ml and 1.3 ml respectively. Known 
quantities of the equilibrated mixtures and toluene were added to the respective 
vessels and sealed to give a range of concentrations to be examined. A 
temperature programme was applied which consisted of initially holding the 
system at least 15°C above the equilibrium saturation temperature (an estimate 
of which was determined during preliminary runs) for at least 1 h to ensure that 
no solution phase molecular order remained which would act to influence the 
crystallisation kinetics by reducing the MSZW. The solution was then cooled at 
a controlled rate of -0.25°C min-1, -0.5°C min-1, -0.75°C min-1 and -1°C min-1, to 
at least 10°C below the temperature at which crystallisation was observed by 
the on-line turbidity analysis, where it was held isothermally for a further 1 h to 
ensure crystallisation was complete so that the solid and solution phases were 
in equilibrium. Using rates of heating opposite but equal in magnitude to those 
applied when cooling, the solution temperature was increased to the initial 
starting temperature and the dissolution point recorded.  
The cycle of controlled cooling and heating was repeated a number of times to 
obtain average values for the crystallisation and dissolution temperatures as a 
function of cooling rate. This data was then plotted, linearly fitted, and 
extrapolated to a theoretical cooling rate of 0°C min-1, i.e. an infinitely slow rate 
thus eliminating the influence of the rate of temperature change on the 
crystallisation and dissolution temperatures, yielding the true equilibrium and 
metastable solubility temperatures for a given concentration which allowed the 
solubility diagram to be constructed (section 6.4).  
 
6.3.5 Seed Preparation 
To prepare the seed crystals used in the CIAT experiments, (S,S)-2 was 
dissolved in toluene and held isothermally for 1 h to ensure that no solution 
phase order remained. This was then left to cool to room temperature resulting 
in deposition of the solute which was subsequently filtered, washed twice with 
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toluene, and dried. To minimise the possibility of impurities being present in the 
solid, the recrystallisation procedure described was repeated 5 times and the 
resulting liquor discarded. On the final run, after holding the solution 
isothermally it was crash cooled to -40°C whilst stirring using a bath of dry ice in 
isopropanol yielding very fine crystals which were filtered and washed twice with 
room temperature toluene. By cooling to this temperature at such a fast rate, 
the aim was to produce small crystals with an even CSD and hence a large 
surface area as it was postulated that this would lead to higher rates of selective 
solute removal during CIAT which, in turn, would result in the undesired species 
being transformed by the action of the catalyst at a quicker rate therefore 
lowering their concentrations in solution which would reduce the likelihood of 
them reaching their metastable limits and crystallising. By washing the filtered 
crystals with room temperature toluene, the aim was to give a smooth surface 
on the seed crystals so that any high energy sites were reduced, and also to 
dissolve any micro-nuclei since the presence of either could have potentially 
acted as nucleation sites for the undesired species during CIAT. The seed 
crystals obtained were analysed using chiral HPLC and DSC to ensure enantio-
purity, the results being presented in section 6.5.  
 
6.3.6 Solvent Selection 
As mentioned in chapter 5, toluene was earmarked to be the process solvent for 
the CIAT investigation as it was known to be inert to the catalytic process for a 
number of different organometallic complexes. In preliminary runs, it was also 
shown to be suitable for crystallisation of 2 and its enantiomers allowing a 
sufficient quantity to be dissolved upon heating which was readily deposited 
when cooled.  
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6.4 Hydrobenzoin Solubility in Toluene 
6.4.1 Chloro(indenyl)-bis-(triphenylphosphine)-ruthenium(II) (4) 
Racemisation Mixture (4-racmix-2) in Toluene 
Table 6.1 gives the average observed crystallisation and dissolution 
temperatures, TCryst and TDiss respectively, as a function of cooling rate for a 
range of 4-racmix-2 concentrations in toluene which were determined by 
turbidimetric measurements using the HEL Automate parallel reactor system 
(see section 11.5 for raw data). Using this information, for each concentration 
TCryst and TDiss were plotted against cooling rate and fitted with a linear trend line 
which was extrapolated to a cooling rate of 0°C min-1 to give the equilibrium and 
metastable solubility temperatures allowing the MSZW for a given concentration 
to be identified (Figure 6.4).  
As discussed in the methodology section, the rate of cooling affects the 
observed temperatures TCryst and TDiss as a result of the kinetics of each 
process. For Tcryst, examination of the values presented in Table 6.1 and their 
corresponding plots in Figure 6.4, show that for a given concentration the 
observed crystallisation temperature is inversely proportional to the cooling rate.  
To deposit crystals from a solution, it is first necessary to create a 
thermodynamic driving force, either by cooling or through evaporation of 
solvent, which leads to the solution becoming supersaturated i.e. the system 
exists away from equilibrium between the solid and solution phases since there 
is more solute dissolved than the solution can accommodate. However, 
instantaneous crystallisation is not observed as soon as supersaturation is 
achieved since nuclei of a critical radius, rc, must first be formed which consist 
of three-dimensional clusters of molecules for whom the rates of molecular 
addition and molecular dissolution are equivalent. In order for the clusters to 
grow, the critical free energy barrier ∆Gcrit, must be overcome which 
subsequently leads to a reduction the total free energy of the system and hence 
the formation of thermodynamically stable macroscopic crystals (see section 2.3 
for a more detailed discussion). Therefore in short, crystallisation is governed by 
the kinetics of critical nuclei formation, and the necessity for these nuclei to 
reach a size at which they become stable (which in turn are influenced by the 
characteristics of the system).  
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When supersaturation is generated by continuously cooling a solution (or by 
solvent removal), the degree of sub-cooling reduces the critical nuclei radius 
lowering the crystallisation energy barrier, whilst the rate at which this occurs 
determines the crystallisation temperature (assuming the solution is truly 
homogeneous) since sufficient time is required for the formation of critical nuclei 
through solute-solute addition. Therefore, as the rate of cooling is increased, 
crystallisation is observed at lower temperatures with the relationship between 
the two being linear as can be seen in Figure 6.4.  Conversely, reducing the 
rate of cooling results in an increase in the crystallisation temperature to a point 
where the rate cannot be lowered any further, i.e. infinitely slow cooling, which 
corresponds to the true thermodynamic crystallisation temperature or, more 
precisely, the metastable solubility temperature.  
Figure 6.4 shows that for each concentration examined, the dissolution 
temperature was seen to increase linearly with cooling rate. For dissolution to 
occur, the solvent surrounding each crystal must be undersaturated so that 
mass can be transferred from the solid surface into the solution phase, which is 
dependent on the magnitude of interaction between the solute and solvent, i.e. 
the enthalpy of mixing that results, the entropy change associated with the 
phase change, the surface energy of a given crystal face, and the system 
temperature. Since no thermodynamic barrier exists, dissolution would be 
expected as soon as the solution becomes undersaturated; however, in practice 
this is also seen to have a dependency on the rate of heating which the system 
experiences and is also affected by to crystal size.   
As crystal size is reduced, the ratio of molecules in contact with the solution 
relative to those in the bulk is increased hence the observed rate of mass 
transfer is also increased i.e. for two populations of crystals with the same total 
mass but different sizes, those that are smaller will dissolve first since there is 
less mass per crystal despite the kinetics of molecular mass transfer for the two 
populations being identical. Below a certain size threshold, the comparatively 
high surface to volume ratio results in high surface energies leading to a solvent 
being able to dissolve more solute than is observed at the macroscopic scale 
hence the observed equilibrium solubility is increased. For macroscopic crystals 
of the same size, as the cooling rate is increased, dissolution is seen to occur at 
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higher temperatures as shown in Figure 6.4 since there is insufficient time for 
the entire crystal mass to be transferred into the solution phase; however, due 
to the lack of thermodynamic energy barrier, less of a temperature rate change 
dependency is seen for dissolution temperatures compared with those for 
crystallisation. 
For similar reasons, less variability is seen for the observed dissolution 
temperatures as is shown by the size of the standard error displayed in Figure 
6.4. Despite being thermodynamically favourable, the formation of critical nuclei 
is governed by the likelihood of a group of molecules in solution colliding and 
ordering together in a cluster. This results in a probability distribution with time 
for a given set of conditions which therefore leads to a certain degree of 
variation in crystallisation temperature. On the other hand, since the observed 
rate is simply a result of crystal size, with no barrier hindering the process, little 
variation is seen in the temperature at which dissolution occurs.  
Using the data presented in Figure 6.4, the equilibrium and metastable solubility 
temperatures, and hence the MZSW, were obtained at a zero cooling rate (see 
Table 6.2 for values). As would be expected, the temperature at which these 
occur increases with solution concentration since the amount of solute a solvent 
can accommodate is determined by the system temperature as described by 
the free energy change for the solubility process. It is also evident that the 
MSZW, i.e. the difference between the equilibrium and metastable solubility 
temperature within which the system is supersaturated but instantaneous 
homogeneous crystallisation does not take place, becomes narrower as 
concentration is increased. From a molecular perspective, at a higher solution 
concentration there is a greater likely hood of successful clustering due to the 
increased collision frequency. Furthermore, the critical nuclei size is reduced 
with temperature so the critical free energy barrier to crystallisation is lower. 
Therefore, for a higher concentration and hence higher temperature, upon 
generation of supersaturation, crystallisation is observed to occur sooner which 
leads to the MSZW being reduced.  
Figure 6.5 shows the solubility curve for 4-racmix-2 which was constructed by 
plotting the equilibrium and metastable solubility temperatures (obtained from 
Figure 6.4) against their corresponding solution concentrations which gives light 
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to the trends described above. As predicted by the van’t Hof expression, these 
show a clear exponential relationship illustrating that the magnitude of 
dissolution becomes more sensitive as the temperature increases, whilst the 
MSZW becomes increasingly narrower. Figure 6.5 was used as a basis to 
select the seeding conditions during the CIAT experiments for 2 by catalyst 4 
presented in chapter 7. In order to grow the seed, temperatures had to be 
selected for a given concentration which resulted in the system being within the 
MSZW so that a driving force for crystallisation existed. As will be seen in 
chapter 7, in some of the isothermal CIAT runs, sub-cooling beyond the 
metastable limit was possible so long as the rate of cooling was sufficient to 
widen the MSZW. For the polythermal temperature programmes utilised during 
CIAT, due to the longer run times potentially leading to the nucleation induction 
time being achieved, attempts were made to allow the system to stay as close 
to the equilibrium solubility curve as possible to minimise the chance of 
spontaneous nucleation occurring.  
Through close examination of Figure 6.5, it is evident that upon extrapolation to 
higher concentrations, the solubility and metastability curves would be expected 
to intersect at which point the MSZW = 0°C and hence TCryst = TDiss, whilst 
continuing beyond this point TCryst would be seen to be greater than TDiss which 
is clearly impossible since no crystallisation driving force would exist above the 
equilibrium solubility temperature. Although a reduction in MSZW would be 
anticipated as temperature is increased, due to the reduction in the nuclei 
critical radius, this observation is likely due to experimental issues which 
occurred whilst the data was being obtained. For the higher concentration data, 
examination of the interior of the vessel at the end of the runs revealed that 
when the temperature was reduced beyond the metastable limit, unavoidable 
crystallisation occurred on the agitator above the solution level. Consequently, 
since some of the solute was no longer in contact with the solution, the 
temperature at which dissolution was seen to occur was reduced as there was 
less solute to dissolve. Therefore at higher concentrations (> 0.4 mol l-1) it is 
likely that the equilibrium solubility temperature has been underestimated. 
However, despite this all CIAT runs were performed well below this 
concentration and, furthermore, the CIAT experiments were not preceded by 
crystallisation which would have resulted in solute depositing on the agitator. 
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Table 6.1 Average crystallisation (cloud point), TCryst, and dissolution (clear point), TDiss, 
temperatures for the hydrobenzoin racemisation mixture, obtained using catalyst 4 (4-racmix-2), 
in toluene (see section 11.5 for raw data). 
Cooling 
rate 
(°C min
-1
) 
Concentration (mol l
-1
) 
0.0467 0.117 0.233 
TCryst TDiss TCryst TDiss TCryst TDiss 
0.25 7.8 24.2 22.4 36.1 36.2 44.5 
0.5 5.4 24.6 21.3 38.0 32.5 49.4 
0.75 3.8 25.1 20.6 40.9 30.7 50.1 
1 2.4 25.4 16.9 41.0 27.2 51.3 
 
 
Cooling 
rate 
(°C min
-1
) 
Concentration (mol l
-1
) 
0.350 0.467 
TCryst TDiss TCryst TDiss 
0.25 45.1 52.5 49.7 55.9 
0.5 38.5 54.9 47.2 58.4 
0.75 36.1 54.8 43.1 57.9 
1 34.4 58.2 40.8 62.2 
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Figure 6.4 Average crystallisation, Tcryst, and dissolution, TDiss, temperatures vs. cooling rate for 
five concentrations of 4-racmix-2 in toluene. 
 
Table 6.2 Equilibrium and metastable solubility temperatures for 4-racmix-2 in toluene obtained 
from the data given in Figure 6.4  
Concentration 
(mol l
-1
) 
Equilibrium Solubility 
Temperature (°C) 
Metastable Solubility 
Temperature (°C) 
Metastable Zone 
Width (°C) 
0.0467 23.8 9.4 14.5 
0.117 34.5 24.5 10.0 
0.233 43.6 38.9 4.7 
0.350 50.8 47.2 3.6 
0.467 54.0 52.9 1.1 
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Figure 6.5 Solubility diagram for 4-racmix-2 in toluene. 
 
 
6.4.2 Chlorocarbonyl-triphenylphosphene(1,2,3,4,5-
pentaphenylcyclopentadienyl)-ruthenium(II) (5) racemisation 
mixture (5-racmix-2) in toluene 
Table 6.3 gives the average observed crystallisation and dissolution 
temperatures, TCryst and TDiss respectively, as a function of cooling rate for a 
range of 5-racmix-2 concentrations in toluene which were determined by 
turbidimetric measurements using the Crystal16 parallel reactor system (see 
section 11.7.1 for raw data). Using this information, for each concentration TCryst 
and TDiss were plotted against cooling rate and fitted with a linear trend line 
which was extrapolated to a cooling rate of 0°C min-1 to give the equilibrium and 
metastable solubility temperatures allowing the MSZW for a given concentration 
to be identified (Figure 6.4).  
Through comparison of the solubility data presented for 5-racmix-2 with that of 4-
racmix-2, it is evident that the same characteristic solution crystallisation 
relationships exists which were discussed in the previous section. However; it is 
apparent that there is a greater variability in the 5-racmix-2 data as is shown by 
 
176 
 
the size of the standard error bars in Figure 6.4, the magnitude of which being 
larger at lower concentrations.  
This can attributed to the scale at which the solubility measurements were 
determined. 5-racmix-2 solubility was determined using a 1.3 ml scale solution 
with the Crystal16 system, whereas 4-racmix-2 was at 30 ml using the HEL 
Automate. As previously discussed, in a supersaturated solution a probability 
distribution exists for nuclei formation with time. Essentially, the 30 ml scale 
experiments for 4-racmix-2 can be approximated as being 23 1.3 ml volumes; 
therefore, there are 23 volumes within which nucleation will result in the entire 
solution crystallising. Hence, for the 30 ml scale the probability distribution for 
nucleation occurring within any of the volume elements becomes cumulative so 
that the variability is reduced with scale [162]. It can be seen in Figure 6.4 that the 
variability also appears to be more significant at lower concentrations. As 
mentioned previously, to form critical nuclei it is necessary for an ordered 
cluster to form through successful bi-molecular collisions. At low concentrations, 
the frequency of these collisions is reduced therefore more variation would be 
expected in the crystallisation temperatures.  
Figure 6.7 shows the solubility curve for 5-racmix-2 which was constructed by 
plotting the equilibrium and metastable solubility temperatures (obtained from 
Figure 6.5) against their corresponding solution concentrations. As with 5-racmix-
2, the solubility curve was used to identify the conditions for CIAT of 2 using 
catalyst 5 presented in chapter 7. However; the greater variability seen in the 
crystallisation temperatures, and hence the larger MSZW, had to be considered 
when selecting seeding temperatures. 
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Table 6.3 Average crystallisation (cloud point), TCryst, and dissolution (clear point), TDiss, 
temperatures for the hydrobenzoin racemisation mixture, obtained using catalyst 5 (5-racmix-2), 
in toluene.  
Cooling rate 
(°C min
-1
) 
Concentration (mol l
-1
) 
0.078 0.155 
TCryst TDiss TCryst TDiss 
0.25 11.2 32.3 24.0 43.7 
0.5 12.9 32.3 20.9 43.9 
0.75 6.9 32.8 18.3 44.4 
1 4.8 33.1 16.1 44.9 
 
Cooling rate 
(°C min
-1
) 
Concentration (mol l
-1
) 
0.233 0.311 
TCryst TDiss TCryst TDiss 
0.25 29.3 47.0 34.5 50.8 
0.5 27.3 48.1 30.4 50.9 
0.75 23.5 48.5 24.4 51.2 
1 20.8 48.9 23.1 51.7 
 
0.00 0.25 0.50 0.75 1.00
0
10
20
30
40
0.00 0.25 0.50 0.75 1.00
10
20
30
40
50
0.00 0.25 0.50 0.75 1.00
10
20
30
40
50
60
0.00 0.25 0.50 0.75 1.00
10
20
30
40
50
60
0.078 mol l
-1
0.115 mol l
-1
Cooling Rate (°C min
-1
)
T
e
m
p
e
ra
tu
re
 (
°C
)
 T
Cryst
 T
Diss
0.233 mol l
-1
0.311 mol l
-1
 
Figure 6.6 Crystallisation, Tcryst, and dissolution, TDiss, temperatures vs. cooling rate for four 
concentrations of 5-racmix-2 in toluene 
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Table 6.4 Equilibrium and metastable solubility temperatures for 5-racmix-2 in toluene obtained 
from the data given in  
Concentration 
(mol l
-1
) 
Equilibrium Solubility 
Temperature (°C) 
Metastable Solubility 
Temperature (°C) 
Metastable Zone 
Width (°C) 
0.078 31.9 15.3 16.6 
0.155 43.2 26.4 16.8 
0.233 46.7 32.5 14.1 
0.311 50.4 38.1 12.3 
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Figure 6.7 Solubility diagram for 5-racmix-2 in toluene 
 
6.5 Seed Characterisation 
Seed crystals for CIAT were prepared using the methodology outlined in section 
6.3.5. As a result of their equivalent solubilities, it was essential to show that the 
counter enantiomer and meso forms of 2 were absent from the seed crystals 
since their presence during CIAT would increase the likelihood of them 
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crystallising since the energy barrier is lower for two-dimensional crystallisation 
compared with that of three-dimensional nuclei formation.  
Figure 6.8 shows the chiral HPLC chromatogram for the (SS)-2 seed crystals 
prepared for CIAT. It is evident that, using the prescribed methodology, a high 
enantiomeric purity was obtained. Based on peak area the seed crystals were 
shown to be composed of > 99% (S,S)-2 with the remainder being attributed to 
benzaldehyde and an unknown species which could not be identified. Despite 
many recrystallisations, it was not possible to completely eliminate these 
impurities; however, as shown by the chiral HPLC chromatograms for 4-racmix-2 
and 4-racmix-2, the mixtures are predominantly composed of the two 
enantiomers and meso form of with low levels of other reaction by-products 
(Figure 6.2 and Figure 6.3). Since the latter were present in low quantities, it 
was anticipated that their concentrations would not permit them to reach 
supersaturation under the conditions used to perform CIAT. Furthermore, since 
the seed crystals did not contain any (R,R)-2, which being the antipode exhibits 
the same solubility and hence would be supersaturated during CIAT, it was 
concluded that a composition > 99% (S,S)-2 was sufficient for the CIAT 
experiments.  
To complement the chiral HPLC analysis, the DSC and 1H-NMR spectra for the 
(S,S)-2 seed crystals were also identified (see section 11.2.2 for 1H-NMR). 
Analysis of the DSC curve in Figure 6.9 shows that a peak occurs at 148.47°C 
which corresponds to the pure enantiomer melting point. Furthermore, its sharp 
nature combined with a lack of any other peaks at lower temperature backs the 
findings of the HPLC analysis. Similar conclusion can be drawn from the 1H-
NMR spectra; however, due to the higher sensitive of the technique, some 
peaks with negligible intensities relative to that generated by (S,S)-2 can be 
observed which can be attributed to the < 1% impurities identified by chiral 
HPLC. Figure 6.10 shows a microscope image of the (S,S)-2 seed crystals 
illustrating their elongated plate-like like habit which is often a characteristic 
feature of non-centrosymmetric chiral crystals. Particle size analysis was also 
performed using an imaging technique however the results of which are not 
presented.  
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Figure 6.8 Chiral HPLC chromatogram for (S,S)-2 seed crystals. 
100 110 120 130 140 150 160
-10
-9
-8
-7
-6
-5
-4
-3
 
Figure 6.9 DSC spectra for the (S,S)-2 seed crystals. 
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Figure 6.10 (S,S)-2 seed crystals. 
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6.6 Chapter Summary 
As the proposed CIAT process involves seeding an supersaturated solution of 
equilibrated 2 stereoisomers, for which the presence of two chiral centres yields 
both the enantiomers (S,S)-2 / (R,R)-2 and the corresponding diastereomer 
meso-2, it was necessary to determine the solubility and MSZW of the mixtures 
that resulted upon catalytic transformation of 2 by catalysts 4 and 5 in the 
selected process solvent toluene, 4-racmix-2 and 5-racmix-2, to identify the 
conditions under which CIAT would be performed.  
For a range of concentrations of 4-racmix-2 and 5-racmix-2 in toluene, the 
crystallisation and dissolution temperatures were identified by turbidimetric 
analysis under varying cooling rates. Using this information, the equilibrium and 
metastable solubility temperatures were obtained from the data extrapolated to 
a zero cooling rate allowing the MSZW to be determined. This yielded the 
solubility curves for both 4-racmix-2 and 5-racmix-2 which were used as a basis to 
select the seeding conditions used during the CIAT experiments. Due to 
differences in the scales of the equipment used to identify the solubility of each 
mixture, with 4-racmix-2 being determined using a 30 ml solution volume and 5-
racmix-2 using 1.3 ml of solution, significantly more variation was seen in the 
crystallisation temperatures of the latter despite the collection of a greater 
number of data points, which had to be considered when designing the 
experiments for CIAT of 2 using catalyst 5. 
In addition to solubility measurements, the methodology used to prepare the 
seed crystals used in the CIAT investigation was also presented and justified. 
Characterisation data for the (S,S)-2  seed showed that it exhibited > 99% purity 
with no (R,R)-2 or meso-2 present; however, < 1% benzaldehyde and an 
unknown species were shown to be present which could not be eliminated 
despite many attempts. 
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7 Crystallisation-Induced Asymmetric Transformation (CIAT) 
using Racemisation Catalysts 
 
 
7.1 Introduction 
Crystallisation-Induced Asymmetric Transformation (CIAT) is a method of 
obtaining a single enantiomer from an initially racemic mixture of a 
conglomerate forming chiral system. Establishing a dynamic equilibrium 
between two stereoisomers in a supersaturated solution, and subsequently 
seeding with pure crystals of the desired enantiomer, leads to enatioselective 
growth whilst the undesired antipode remains dissolved in solution. Removal of 
the seeded enantiomer from solution through growth and secondary nucleation 
results in the composition becoming non-racemic which, in turn, causes the 
excess enantiomer to racemise thus re-forming an equimolar mixture and re-
establishing solution phase equilibrium. If the rate of racemisation is sufficiently 
fast and exceeds that of crystallisation the ternary phase equilibria is modified 
so that the regions of the phase diagram where a given enantiomer is in excess 
cannot be accessed. Therefore, the solution phase remains observably racemic 
whilst the desired enantiomer is crystallised with the antipode remaining 
dissolved and being readily converted; hence, a quantitative yield of a single 
enantiomer can theoretically be achieved if the process is operated to 
completion.  
Previous examples of CIAT demonstrated in the literature (see section 3.4.1) 
have all utilised asymmetric molecules whose chiral centres are easily 
racemised typically due to the presence of low pKa chiral protons which are 
liable to be removed by the addition of base to the process solution. Once 
dehydrogenated, a planar intermediate results (ketones and imines for alcohols 
and amines respectively) which is subsequently non-selectively rehydrogenated 
reducing optical activity and eventually leading to the formation of a racemate. 
Due to racemisation by this method being system specific, in addition to the 
prerequisite of conglomerate formation (~10% of chiral compounds), the 
application of CIAT has remained underutilised for the industrial scale 
production of single enantiomers from synthesised racemates.  
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7.2 Objectives 
Using the information presented in the previous chapters, it was possible to 
move forward and perform the primary investigation into the possibility of 
coupling solution phase organometallic catalysed racemisation with preferential 
crystallisation in a CIAT process. CIAT was attempted using the model chiral 
system 2, and the three ruthenium-based complexes 4, 5 and 6 (results for 6 
not presented), under a range of different process conditions, based on the 
racemisation mixture–toluene phase equilibria, to initially attempt to identify the 
key parameters that result in only a single enantiomer being produced, and to 
ultimately try to identify the optimum operating conditions under which the 
maximum quantity of the desired enantiomer could be obtained. The 
parameters varied during the investigation were selected due to their 
fundamental influence on the success of preferential crystallisations, whilst also 
considering the combined effect of in-situ solution phase racemisation with 
variable rates. In the following sub-sections, the general procedure used for 
each CIAT experiment is outlined and the parameters varied discussed. 
 
7.2.1 General Methodology 
CIAT Equipment: The CIAT experiments were performed using the HEL 
Automate reactor system described in section 6.3.1. CIAT runs for catalysts 4 
were performed under an inert atmosphere using argon supplied by an external 
gas cylinder. 
Procedure for CIAT of 2 using racemisation catalysts 4: A prescribed quantity of 
the racemisation mixture (see section 6.3.3 for preparation details and section 
7.2.2.2 for quantities of each mixture used) and base (tBuOK or KOH for 
activation of the catalyst) was added to the glass automate vessel. The reactor 
head was lowered and sealed after which the vessel was purged with argon 
through an airtight port for 1 h followed by the addition of 30 ml of dry toluene by 
syringe to form the initial process slurry. The prescribed temperature 
programme was then applied (see section 7.2.2.1 for details) which for all runs 
began by heating the reactor contents to the maximum temperature, Tmax, whilst 
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stirring for 1 h to ensure complete dissolution of the racemisation mixture and 
base. At the end of the isothermal stage, catalyst 4 was added to the vessel and 
the contents cooled after which seed crystals of (S,S)- or (R,R)-2 were added at 
the seed temperature, Tseed, which was selected to be in proximity to the 
saturation temperature of the racemisation mixture, Tsat. In some of the runs 
performed the racemisation catalyst was introduced after the addition of seed 
crystals at Tseed which allowed for a prescribed initial excess of the desired 
enantiomer to be added to the reactor at the beginning of the process (since 
any excess enantiomer would be racemised in the unsaturated solution where 
the catalyst was added prior to seed at temperatures above Tsat). With the seed 
crystals and catalyst present in the vessel, the temperature programme was 
applied, either consisted of maintaining a constant temperature for a period of 
time, cooling, or cycling the temperature of the reactor to induced growth of the 
seed crystals. Once complete, the vessel contents was immediately filtered at 
the final temperature, Tfilt, yielding a solid which was washed twice with chilled 
toluene and dried under vacuum to give crystals of the final product. 
Procedure for CIAT of 2 using racemisation catalyst 5: The same procedure 
described for catalyst 4 was used; however, since 5 is known to be air stable it 
was not necessary to perform the experiments under inert conditions. 
Process Analysis: The dried samples obtained at the end of CIAT runs were 
weighed and analysed using chiral HPLC to determine the stereoisomeric 
composition. In some instances PXRD was used to determine the diffraction 
pattern of the samples which was compared with that of the enantiopure seed 
material. Due to the dark colour that resulted upon addition of the catalyst to the 
solution (Figure 7.1), it was not possible to monitor the progress of the 
experimental runs using online-analytical techniques such as FBRM, turbidity or 
polarimetry. 
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Figure 7.1 HEL Automate reactor vessel illustrating the dark colour solution that resulted upon 
addition of catalysts 4 and 5 to substrate 2 which prevented the use of on-line analytical 
techniques 
 
7.2.2 Significant Process Parameters 
Using the methodology given above, several experimental conditions were 
varied or were of significance to the investigation and had to be considered:  
 Cooling programme 
 Seed conditions 
 Catalyst load 
 Solution concentration 
 Stirring rate 
These are discussed at greater depth in the following sub-sections. Precise 
details of the conditions used for each run are presented with the corresponding 
results in tables from section 7.3 onwards. 
 
7.2.2.1 Cooling Programme and Seeding Conditions 
As a result of the competition between the enantio-selective crystallisation rate, 
i.e. the rate removal of the desired enantiomer from solution, and the 
racemisation rate, i.e. the rate at which it is replaced, investigation of the 
optimum cooling programme and seeding conditions was perhaps the most 
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important attribute of the CIAT process which needed to be investigated. 
Ideally, the racemisation rate would be sufficiently fast to allow the solution 
phase stereoisomers to remain equilibrated whilst the desired enantiomer is 
crystallised from solution. In doing so, equimolar quantities of each enantiomer 
would be maintained in solution which would minimise the chance of the 
undesired enantiomer spontaneously nucleating as long as the system 
remained far from the metastable solubility limit. As the racemisation rate 
becomes slower relative to that of crystallisation, there is the possibility that the 
antipode’s concentration relative to the seeded enantiomer would increase in 
solution until eventually it would reach its metastable limit, with the rate at which 
this occurs increasing with the difference between the observed kinetics of 
racemisation and crystallisation.  
As shown in chapter 5, the racemisation rate using each of the catalysts 
investigated is favoured by a high temperature. Conversely, in chapter 6, as 
expected the likelihood of spontaneous nucleation was shown to increase with 
higher temperatures as the MSZW becomes smaller. Therefore, considering 
temperature alone, the most favourable conditions would be a compromise 
whereby the temperature invokes a sufficient rate of racemisation whilst 
allowing the solution to remain metastable, ideally close to equilibrium between 
the solid and liquid phases so that the driving force for crystallisation is low but 
maintained. It is also necessary that the increase in racemisation time that 
results upon cooling of the solution is also accounted for when the temperature 
profile is applied. 
In conjunction with CIAT process temperature, the seeding regime i.e. the 
position within the temperature programme at which the enantiopure seed 
crystals are introduced to the system, is also of key importance to the success 
of the proposed process. Seeding an enantiomeric system has the benefit that 
the enantiopure crystals are half as soluble as the racemate therefore a certain 
quantity can be introduced above the racemic saturation temperature, Tsat, with 
the degree of dissolution occurring being determined by the ternary phase 
equilibria. For CIAT however, the racemisation catalyst is present therefore 
addition and subsequent partial dissolution of enantiopure seed above Tsat  
would result in the solution deviating from a racemic composition which, in turn, 
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would lead to racemisation of the excess enantiomer and dissolution of double 
the amount seed compare with preferential crystallisation. On the other hand, if 
the seed crystals were introduced below Tsat, i.e. whilst the solution is 
metastable, the chance of spontaneous nucleation is increased due to the 
presence of the seed lowering the energy barrier to crystal formation. 
Consequently, theory would suggest that seeding temperatures should be 
selected to be close to but below Tsat.  
In practice, for polythermal CIAT cooling programmes, the seed could be 
introduced above Tsat as long as a sufficient quantity was used to offset the 
effects of the ternary phase equilibria so that some enantiopure solid would 
remain after racemisation of the excess in solution occurred.  However; the 
doubling of solubility that would occur upon racemisation would have to be 
considered when prescribing the seed quantity and temperature. Despite this, 
the loss in solid would of course be compensated for by the selective 
crystallisation that would result upon cooling and reestablishment of a driving 
force. For isothermal cooling programmes however, whereby the system 
temperature remains constant after addition of seed, the quantity of desired 
solute that could be recovered and hence the success of CIAT (for a single 
stage process), is determined by how far below Tsat the system can be seeded 
without inducing crystallisation of the antipode.  
Several different temperature programmes and seeding regimes were trialled 
during the CIAT study, due to the anticipated effects described above and as a 
result of experiences during the investigation, aiming to provide conditions that 
favoured growth of the seeded enantiomer and racemisation kinetics whilst also 
minimising the possibility of spontaneous crystallisation of the antipode. Figure 
7.2 shows a qualitative representation of the different temperature programmes 
used consisting of isothermal (a) and polythermal (b, c and d) temperature 
profiles.  
Considering Figure 7.2a, initially the pre-prepared racemisation mixture and 
base required for catalyst activation were dissolved in toluene and held at Tmax 
for a minimum of 1 h to ensure complete dissolution. Tmax was selected to be at 
least 15°C above the saturation temperature of the racemisation mixture to 
ensure that upon dissolution no liquid phase order remained which could have 
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resulted in the crystallisation kinetics being affected due to the MSZW 
potentially being reduced. At the end of Tmax, the racemisation catalyst was 
added to the system and the solution cooled to Tseed, where the enantiopure 
seed crystals were introduced into the system, either under a prescribed cooling 
rate or by crash cooling. The latter condition was chosen as it was postulated 
that the likelihood of spontaneous crystallisation of the antipode is partly a 
function of the time that the system is metastable. Hence, it may be favourable 
to achieve the desired level of supersaturation, i.e. Tseed, at the fastest rate 
possible in order to maximise the period of time that the seed crystal spend 
suspended in solution. After allowing crystallisation of the seed to proceed for a 
period of time by both growth and secondary nucleation, the solution was 
filtered at Tfilt (where for the isothermal program Tcryst = Tfilt) to yield the product 
crystals which were washed and dried using the procedure described in section 
7.2.1. 
The polythermal temperature programme depicted in Figure 7.2b is an 
extension of a where instead of filtering the crystals at the end of the isothermal 
section of the profile, the solution temperature is reduced under a controlled 
cooling rate. Assuming the rate of racemisation is sufficiently fast, enough time 
has elapsed, and the antipode has not reached its metastable limit and 
crystallised, at the end of the isotherm the system should consist of a racemic 
solution in equilibrium with enantiopure solid. By subsequently cooling the 
resulting slurry, a driving force for crystallisation will be induced therefore a 
greater quantity of solute can theoretically be obtained as the solubility is 
reduced as the temperature is lowered. To allow for the solution phase to 
remain as close to racemic as possible during the process, a slow cooling rate 
would be most favourable as the rate at which solute is removed would be 
minimised. Temperature programme b was applied using a range of different 
cooling rates and different seed temperatures, Tseed, with the slurry being 
filtered as soon as Tfilt was achieved.  
For the scenario where the rate of racemisation was thought to become too 
slow to maintain an observably racemic solution during cooling, the temperature 
program illustrated in Figure 7.2c was utilised. Instead of continuously reducing 
the temperature to Tfilt, the programme consisted of alternating between cooling 
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and constant temperature stages. After addition of the seed crystals, the system 
temperature was reduced by a small amount and subsequently held constant 
for a period of time. The hypothesis was that lowering the temperature would 
generate supersaturation inducing crystallisation of the desired form; however, 
not to the degree that the antipode would reach its metastable limit as a result 
of the difference in relative concentrations of the two enantiomers in solution 
becoming significant. Subsequently maintaining the temperature would inhibit 
the system becoming increasingly supersaturated, allowing time for 
crystallisation to reach equilibrium and for racemisation to proceed to re-
establish a racemic composition in solution. 
The final cooling programme investigated, shown in Figure 7.2d, was proposed 
for the event where the relative rates of racemisation and seeded crystallisation 
were unfavourable and resulted in spontaneous crystallisation of the undesired 
enantiomer. This consisted of crash cooling the seeded system followed by a 
period of heating to just below Tsat, at which point a constant temperature was 
maintained. The cycle of crash cooling, heating and constant temperature was 
then repeated with the minimum and maximum temperatures in each cycle 
being gradually reduced until Tfilt was achieved which corresponded to the end 
of the maximum constant temperature stage of the last cycle. Considering the 
first cycle, initially a driving force is created when the system is crash cooled 
resulting in crystallisation of the seeded enantiomer; however, as a result of the 
slow relative racemisation rate, crystallisation of the antipode is also eventually 
observed. By increasing the temperature as soon as the minimum is achieved, 
the magnitude of supersaturation is reduced and hence the rate of 
crystallisation of the undesired enantiomer (and that of the desired) decreases. 
The system is heated to and held at a point in close proximity but below Tsat 
resulting dissolution of the predominately racemic portion leaving only the pure 
enantiomer as the solid phase, and racemisation of any excess, with the 
quantity of desired solute yielded from solution corresponding to the difference 
between Tsat and the constant temperature stage of the current cycle.  Thus, in 
theory repeating this cycle until Tfilt, should yield enantiopure crystals where the 
racemisation rate is too slow to allow utilisation of a constant cooling rate. 
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Figure 7.2 Graphical representation of the cooling profiles used for the CIAT experiments. 
 
7.2.2.2 Solution Concentration 
Since the MSZW is reduced with an increase in temperature, the concentration 
of the racemisation mixture used will influence the period of time the solution 
can remain metastable during enantio-selective crystallisation. Ideally a 
relatively low concentration would be used as this would result in a large 
MSZW; however, this would compromise the rate of racemisation increasing the 
likelihood of the antipode spontaneously crystallising due to a build-up of its 
concentration, and hence its supersaturation, relative to the desired enantiomer. 
Conversely, a high concentration would enhance the probability of spontaneous 
nucleation occurring, despite the faster racemisation kinetics, as the frequency 
of the molecular collisions required for crystal formation would increase. 
Therefore the choice of racemisation mixture concentration used is a 
compromise between these conflicting conditions and, consequently, the results 
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for runs using two different concentrations are presented to investigate these 
effects. 
 
7.2.2.3 Seed Mass 
As with the seeding regime, the quantity of seed used during the proposed 
CIAT process could have a significant influence over its success. It is postulated 
that the quantity of seed required is primarily influenced by a combination of the 
racemisation kinetics and the temperature programme used. For a seeded 
crystallisation, remaining within the MSZW will always result in spontaneous 
crystallisation after the induction time period has elapsed. Therefore for CIAT, to 
prevent antipode crystallisation in the case of a slow racemisation rate, it is 
favourable that the process is operated in the shortest time possible or as close 
to solid-liquid equilibrium as allowable whilst still maintaining a crystallisation 
driving force and maximising product yield.  
In this scenario, use of a small quantity of seed would supply a comparatively 
small area for enantio-selective crystallisation hence reducing the rate at which 
solute is removed from solution; therefore the system would remain close to 
equilibrium and the relative difference in concentration between the 
enantiomers in solution as the process progresses would be low and effectively 
compensated for by the action of the racemisation catalyst. It is thus also 
necessary in this case to use a temperature profile which keeps the system 
close to equilibrium and prevent excessive build-up of supersaturation. If large 
volumes of seed were to be used, solute would be removed at a much faster 
rate due to the larger surface area provided, and as the racemisation rate would 
not be sufficient to minimise the excessive build-up of the antipodes relative 
concentration, it would reach its metastable limit much sooner.  
For the case of relatively fast racemisation kinetics, it is possible to remove the 
desired enantiomer from solution at a much faster rate since it is efficiently 
replaced by the catalyst; therefore much larger volumes of seed could be used. 
This could be particularly useful when applying an isothermal temperature 
programme since, under these conditions, for the same Tsat the rate of 
crystallisation would be dictated by the surface area provided hence larger 
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quantities of seed should result in shorter process runs for a given solid yield 
which in turn would reduce the chance of the antipodes induction time being 
achieved. As a result of the different conditions investigated, several different 
quantities of seed crystals were used during the study. 
 
7.2.2.4 Catalyst Load 
The rate of racemisation is perhaps the most significant parameter influencing 
the success of the proposed CIAT process since it has a direct impact on each 
of the process parameters described. For the reasons already discussed, it is 
essential that that the racemisation kinetics are sufficiently fast to allow for 
efficient in-situ conversion of the waste enantiomer whilst the antipode remains 
dissolved. Not considering the effect of temperature on racemisation kinetics 
(which was previously discussed), it would therefore seem logical to use large 
quantities of catalyst to maximise the rate; however, there are several issues 
concerning this approach.  
It is vital that the catalyst remains dissolved for the duration of the process 
since, if it were to crystallise, it could potentially act as a crystallisation centre 
for the enantiomers as a result of the presence of a solid surface lowering the 
nucleation energy barrier. In preliminary investigations however, it was shown 
that each of the catalysts used were sufficiently soluble in the earmarked 
process solvent toluene with approximately 0.2 g being dissolved in 1 ml of 
solvent at room temperature. Despite this, each of the catalysts required 
activation by excess base in the form of KOH which is considerably less soluble 
(< 1 mg ml-1) which was thus a limiting factor in the quantity of catalysts that 
could be employed to prevent any solid being present during the process 
(several alternative bases were investigated for use with the catalysts, for which 
the results are not presented; however, complete racemisation was only 
possibly with KOH and tBuOK, with essentially all of the bases showing no 
activity). 
Addition of any foreign body to a crystallising solution will affect the kinetics of 
the process typically reducing the MSZW promoting spontaneous nucleation or 
alternatively acting as a nucleation inhibitor. Foreign bodies can also affect 
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crystal growth kinetics by becoming incorporated within the crystal lattice which 
can also lead to the formation of different crystal habits. The effect of the 
catalyst being present in solution during CIAT on the crystallisation behaviour 
was hence investigated (seed section 7.3.4)  
For the CIAT experiments presented, 4 mol% of catalyst was selected as the 
quantity used with the exception of several runs where 8 mol% was utilised. 
This choice ensured that both the catalyst and base remained dissolved for the 
duration of the process under the varying temperatures experienced. It was also 
sufficient to allow for efficient racemisation of the undesired enantiomer as was 
shown in chapter 5, whilst also remaining economically viable considering the 
high value of the complexes used and the number of runs performed. 
 
7.2.2.5 Stirring Rate 
Stirring rate has been shown to have a considerable influence in preferential 
crystallisations being a factor that determines the resolution time i.e. the 
duration under which the seed crystals can remain entrained in solution before 
filtration [9]. At low stirring rates crystal growth is limited by the diffusion rate of 
solute from the bulk solution to the crystal surface. Increasing the stirring rate is 
therefore beneficial in this respect. However, the diffusional resistance becomes 
less of an influence as stirring speed is increased until a plateau occurs and it 
has no further effect. For preferential crystallisation and CIAT, since the 
antipode is metastable throughout the process, high stirring rates are 
detrimental as the mechanical system-shock can reduce the nucleation 
induction time therefore the possible entrainment time will be reduced. 
Furthermore, high stirring rates could increase the likelihood of crystal breakage 
which can lead to exposure of high energy surface sites which may promote 
nucleation of the antipode. Consequently, an optimum exists whereby sufficient 
mass transfer is achieved whilst minimising the mechanical influence that the 
system experiences. Furthermore, considering the experimental rig used for the 
CIAT runs, the level of stirring had to allow for efficient heat transfer to eliminate 
any temperature gradients between the vessel wall and the bulk of the process 
slurry. A stirring rate of approximately 100 rpm was used for the majority of the 
CIAT runs performed and for all of the data presented as this was sufficient to 
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allow the solids to remain suspended and visibly well mixed, and was also 
shown in preliminary investigations to give an even distribution of temperature 
within the process solvent. 
7.2.3 Presentation of Experimental Conditions and Results 
Due to the number of experimental conditions investigated, and to maintain 
clarity, the precise conditions varied in each CIAT run are presented with the 
corresponding results in the following sections for a selection of experimental 
runs of interest. For each catalyst the data is grouped according to the 
temperature programme used for comparison and presented in four-part tables 
being divided into: 
 Part 1: CIAT process conditions 
 Part 2: Theoretical and obtained crystal yields 
 Part 3: Product composition 
 Part 4: System composition 
Part 1 list the conditions used for each CIAT run consisting of the seed 
temperature, Tseed, temperature programme, which is referenced to the 
graphical representations shown in Figure 7.2, filtration temperature, Tfilt, 
quantity of seed used (wt% of 4 or 5-racmix-2), and total quantity of the desired 
enantiomer ((S,S)-2 for the results presented with one exception where (R,R)-2 
is used) initially present in the system (%) which incorporates the contribution 
from both the racemisation mixture in solution, 4 or 5-racmix-2, and the 
enantiopure seed crystals.  
Part 2 gives the theoretical product mass (g), which is deduced from the 
solubility curves for the racemisation mixtures determined in section 6.4, the 
prescribed temperature programme i.e. the difference between Tsat and Tfilt, and 
the seed/initial excess contributions. The theoretical mass of (S,S)-2 in the 
product (g) is given which incorporates both the recovered solid mass and 
seed/initial excess used, and assumes no racemisation i.e. the theoretical 
quantity of (S,S)-2 that would be received upon seeding it into a solution of 4 or 
5-racmix-2 with no catalyst present and allowing the solid and liquid phases to 
reach equilibrium. The product mass (g) for each run is presented both with and 
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without seed/initial excess. Finally the crystal yield (%) is given which does not 
include seed/initial excess. 
Part 3 gives the product composition which was determined by HPLC using the 
method described in section 11.1.5.  
Part 4 presents the mass of (S,S)-2 (g) that is present in the product (using the 
HPLC analysis from Part 3), the quantity of (S,S)-2 remaining in the equilibrated 
solution and the total quantity of (S,S)-2 present in the system in both the solid 
and solution phases (g, %). This is used to determine the change in total (S,S)-
2 composition in the system based on the initial composition (solid and 
solution), and is used as a measure to determine whether the action of the 
catalyst has increased the fraction of (S,S)-2 present through CIAT i.e. through 
conversion of the antipode in the solution phase by seeding the solution with 
enantiopure crystals. Changes > 0 % indicate that (S,S)-2 has been generated 
from it stereoisomers, (R,R)- and meso-2, by the CIAT process. 
 
7.3 CIAT of Hydrobenzoin (2) using Chloro(indenyl)-bis-
(triphenylphosphine)-ruthenium(II) (4) 
7.3.1 Isothermal and Cyclic Polythermal Temperature Programmes 
Table 7.1a lists the conditions used for a selection of CIAT runs using 2 and 
catalyst 4 under the temperature programmes that correspond to a and d in 
Figure 7.2, with the total quantity of (S,S)-2 initially present in the system as 
solid and solution also given.  
Considering entry 1, the solution was crash cooled from 75°C to 49°C upon 
which 1 wt% of pure (S,S)-2 seed was added to the solution. This was then held 
at 49°C for 60 min after which the solution was immediately filtered. Despite the 
operating temperature being considerably lower than the metastable equilibrium 
temperature, Tcryst, for 4-racmix-2 (section 6), preliminary experiments showed 
that the solution could remain metastable well below Tcryst for a period of time 
when crash cooled without spontaneous nucleation. This is due to the rate of 
supersaturation generation not allowing sufficient time for the molecular addition 
process that is required to form a 3-D crystal which can be observed by the 
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increasing and decreasing gradients of the dissolution and crystallisation 
temperatures respectively verses the rate of cooling (see section 5).  
Based on the solubility curve for 4-racmix-2 and the quantity of seed used, 
theoretically 0.94 g of product could be obtained if the solid and liquid phases 
were in equilibrium at the end of the process (0.91 g from solution, 0.03 g from 
seed), and of this 0.35 g would consist of (S,S)-2 if no racemisation had 
occurred (35% of 0.91 g from 4-racmix-2 solution, 0.03 g of seed) (Table 7.1b). 
At the end of the experimental run, 0.23 g of solid was obtained for entry 1, with 
the quantity of solute being removed from solution being 0.2 g if the seed used 
is not considered, leading to a crystal yield of 21.94% (see Figure 7.4a for a 
microscope image of product crystals). 
Table 7.1c shows the composition of the crystalline product determined by 
chiral HPLC. For entry 1, 99.59% of the solid obtained was comprised of (S,S)-2 
with the remainder consisting of small quantities of benzaldehyde, whilst no 
(R,R)- or meso-2 were found to be present. Figure 7.3, the chiral HPLC 
chromatograms for the product and solution phases at the end the process for 
entry 1, show that the product is comprised almost solely of (S,S)-2 whereas the 
solution phase exhibits the catalytically equilibrated composition of 4-racmix-2. 
Using this data and a simple mass balance, the solution phase composition of 
(S,S)-2 was calculated as 0.98 g, whilst the total quantity within the system 
equated to 1.21 g or 39.90%. Comparing the initial and final state of the system, 
the total composition of (S,S)-2 present, both in solution and as solid, increased 
by 11.95% over the duration of the CIAT run. This finding confirms that through 
the action of seeding enantiopure crystals into a supersaturated solution of 
stereoisomers equilibrated by way of an organometallic racemisation catalyst, it 
is possible to transform the antipode in-situ in solution (and in this particular 
case the corresponding meso-2 stereoisomer) into the desired crystalline form 
and obtain a pure chiral product.  
Similar results were seen for entry 2 which was performed under identical 
conditions to entry 1. Based on the chiral HPLC analysis, in the solid product 
recovered at the end of the process, 99.71% consisted of (S,S)-2 with the 
remainder being composed of benzaldehyde, giving a higher purity product than 
that obtained in entry 1. However, a lower crystal yield resulted with 0.15 g of 
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solute being removed from solution through crystallisation (16.46% crystal yield) 
which translates to 1.18 g or 38.84% of the system being composed of (S,S)-2 
considering both solid and solution phase. Comparing this with the initial state 
of the system, a 8.98% change in the total composition of (S,S)-2 was observed 
at the end of the process also confirming that the undesired stereoisomers were 
converted in solution through the action of seeding and subsequent catalytic 
equilibration.  
Despite the successes seen in entries 1 and 2, a relatively low crystal yield was 
obtained in both cases indicating that at the end of the process the solid and 
solution phases were far from achieving equilibrium. In entry 3, an attempt was 
made to improve on this by performing a CIAT run under the same conditions 
but instead holding the system at the operating temperature for a longer 
duration of time (90 min).  
As anticipated, a greater mass of product was obtained as a result with 0.31 g 
being recovered (34.01% crystal yield); however, considering the chiral HPLC 
analysis, at the end of the process the crystalline product had a lower 
enantiomeric purity with 78.16% being comprised of (S,S)-2 whilst  the 
undesired antipode (R,R)-2 and small quantities of meso-2 were seen to be 
present (21.49% and 0.35% respectively). Based on this 0.27 g of (S,S)-2 was 
present in the product obtained whereas 0.89 g remained in solution which 
translates to 1.21 g or 39.90% of the system being comprised of (S,S)-2. 
Comparing this with the initial state of the system, a total increase of 11.78% of 
(S,S)-2 present in both the solid and solution phases was observed. In spite of 
the latter finding and the greater yield obtained, the presence of the antipode 
and meso- form in the resulting product indicates that both species reached 
their metastable limits over the duration of the CIAT run as their induction times 
had been achieved. Therefore, under the conditions used, increasing the run is 
not sufficient to increase the productivity of the process due to the limitation of 
the crystallisation kinetics. 
Continuing the quest to obtain a high purity product and increased crystal yield, 
an alternative approach was attempted whereby the system was cooled to a 
lower temperature to establish a greater magnitude of supersaturation. 
However, based on the previous findings and the understanding of 
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crystallisation behaviour, it was anticipated that the induction would be reduced 
as a result of the lower operating temperature hence the run time was 
shortened to 30 min. Furthermore, to attempt to maximise the crystal yield, 
enantiopure (S,S)-2 was added to the system as its equilibrium saturation 
temperature was achieved to initiate crystallisation as soon as the system 
became supersaturated. Lastly, a greater quantity of seed crystals was 
introduced into the system with the aim of providing a larger surface area for 
crystallisation which in turn was anticipated to increase the quantity of solute 
that was recovered. 
Entries 4-6 give the data for the runs where the conditions described above 
were utilised. In each run 10 wt% (S,S)-2 seed was added to the system at the 
approximate saturation temperature (54°C – 53.5°C) whilst crash cooling to 
40°C, 35°C and 25°C for entries 4, 5 and 6 respectively, at which point the 
system was held for 30 min before filtration. In entry 4 0.32 g of solute was 
recovered from solution giving a high purity product with 99.21% (S,S)-2 being 
present; however (R,R)-2 was also seen to crystallise (0.56%) with a small 
quantity of benzaldehyde being present (0.24%). Moreover, a crystal yield of 
16.95% was achieved which is comparable with those seen in the previous 
entries; therefore, despite obtaining a greater overall mass of crystalline 
product, the crystal yield was not improved, and in spite of the high purity, 
crystallisation of the antipode through it achieving its metastable limit occurred 
which was not seen when the process was operated at a higher temperature. 
In entries 5 and 6, as a result of the increasingly lower operating temperatures, 
a greater proportion of the resulting product consisted of the antipode with 
meso-2 also being present due to the higher levels of supersaturation. In entry 
5, 76.03%, 23.13% and 0.3% of the resulting solid were comprised of (S,S)-2, 
(R,R)-2 and meso-2 respectively. The higher levels of (R,R)-2 in addition to the 
presence of meso-2, indicates that the system was well beyond the metastable 
limit of the undesired species. This is also evident in the yield of product 
obtained where 0.97 g of solute was recovered from solution which equates to a 
crystal yield of 43.54%. As (R,R)-2 and meso-2 crystallised, additional solute 
was transferred from solution to the crystalline phase thus increasing the mass 
of the solid and the resulting yield. Since the magnitude of supersaturation was 
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greater than in previous entries, at the end of the process the system was 
closer to equilibrium and hence a greater quantity of (S,S)-2 was also deposited 
from solution resulting in an increase in its total final composition since the 
solution phase remained catalytically equilibrated which translates to a 24.16% 
enhancement compared with the initial state of the system.  
Entry 6 shows the same trend but to a greater extent due to the lower operating 
temperature used. A greater proportion of the product consisted of (R,R)-2 and 
meso-2 with 18.17% of the latter being present in the sold phase and, as a 
result, the crystal yield increased to 66.01%. However, due to the higher rates 
of (R,R)-2 and meso-2 crystallisation, there was insufficient time for the catalyst 
to convert their excesses in solution that occurred as a result of (S,S)-2 being 
deposited; hence, the change in total (S,S)-2 composition considering the initial 
and final state of the system reduced to 8.15%. 
Due to the limitations seen using the conditions applied in the entries discussed, 
where a low magnitude of supersaturation gave a high purity product but low 
crystal yields, whist on the other hand increasing the level of supersaturation 
enhance yields but at the expense of product purity, an alternative temperature 
programme was used to attempt to incorporate the benefits of both 
methodologies. In entries 7-9, the system was crash cooled to 25°C whilst 
seeding at the approximate equilibrium saturation temperature (54°C/53°C). As 
soon as 25°C was achieved the slurry temperature was increased to 51°C i.e. 
just below the saturation temperature, and held for 30 min. In entries 8 and 9, 
the crash cool–heating cycle was repeated whilst gradually lowering the 
isothermal temperature. It was postulate that crash cooling to a low temperature 
would generate a high magnitude of supersaturation which in turn would result 
in relatively high quantities of the desired enantiomer being deposited from 
solution. Similarly, eventual crystallisation of the undesired species after some 
time had elapsed was also anticipated; however, by heating the solution and 
maintaining at a temperature below that of the equilibrium solubility, dissolution 
of the unwanted stereoisomers was expected yielding a slurry consisting of pure 
(S,S)-2 in the solid phase and an equilibrated solution. Hence, repeating the 
cycle whilst gradually lowing the isothermal temperature with each stage would 
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result in an increase in the quantity of (S,S)-2 crystals present corresponding to 
the 4-racmix-2 phase equilibria. 
Entry 7 shows that for a single cooling-heating cycle the approach described 
above successfully gave high purity crystals at the end of the CIAT run 
consisting of 98.54% (S,S)-2  with benzaldehyde constituting the remainder. 
However, since the temperature of the isothermal stage was only slightly below 
the saturation temperature, only a small enhancement in the total quantity of 
(S,S)-2 present in the system was observed (3.44%). For entry 8, the cycle was 
repeated to the final temperature of 48°C, yet, unlike entry 7, a significant 
amount of (R,R)-2 (22.31%) was found to present in the resulting product 
indicating that it had achieved its induction time, which explains the increased 
crystal yield of 39.99% (see Figure 7.4b for a microscope image of product 
crystals). Repeating the cycle for a third time (entry 9) acted only to enhance 
the levels of undesired stereoisomers seen (36.26% (R,R)-2, 0.81% meso-2) 
whilst, due to the greater time of exposure to the solution that the solid 
experienced, a higher change in total (S,S)-2 composition occurred (20.17%). 
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Table 7.1a Conditions used and results for CIAT experiments using catalyst 4 (4 mol%) and 
seeding 4-racmix-2 with (S,S)-2, 0.467 mol l
-1
, 30 ml scale, temperature programmes a and d 
(Figure 7.2)
a
. 
 
Part 1: CIAT process conditions 
Entry 
TSeed 
(°C) 
Temperature Programme
a
 
Tfilt 
(°C) 
Seed 
quantity 
(wt%) 
(S,S)-2 in 
system 
(%)
b
 
1 49 [a] Crash cool to 49°C,maintain 49°C for 
60 min. 
49 1 35.64 
2 49 49 1 35.64 
3 49 [a] As above, maintain 49°C for 90 min. 49 1 35.64 
4 54 
[a] Crash cool to 40°C, maintain for 30 
min. 
40 10 40.91 
5 53.5 
[a] Crash cool to 35°C, maintain for 30 
min. 
35 10 40.91 
6 54 
[a] Crash cool to 25°C, maintain for 30 
min. 
25 10 40.91 
7 54 
[d] Crash cool to 25°C, maintain for 30 
min, increase to 51°C, maintain for 30 min. 
51 10 40.91 
8 53 
[d] As entry 7, crash cool to 25°C, increase 
to 48°C, maintain for 30 min. 
48 10 40.91 
9 54 
[d] As entry 8, crash cool to 25°C, increase 
to 44°C, maintain for 30 min, crash cool to 
25°C, increase to 40°C, maintain for 30 
min. 
40 10 40.91 
a
See Figure 7.2 for a graphical presentation of the temperature programmes used 
corresponding to the value in square brackets. 
b
Initial (S,S)-2 in system (%) based on 4-racmix-2 
composition in solution (35% (S,S)-2) and seed fraction. 
 
 
Table 7.1b Conditions used and results for CIAT experiments using catalyst 4 (4 mol%) and 
seeding 4-racmix-2 with (S,S)-2, 0.467 mol l
-1
, 30 ml scale, temperature programmes a and d. 
 
Part 2: Theoretical and obtained crystal yields 
Entry 
Theoretical yields Product Yields 
Product mass 
including seed 
(g)
c
 
Mass of (S,S)-2 
in product (g)
d
 
Product mass 
including seed 
(g) 
Product 
Mass (g)
e
 
Crystal 
Yield 
(%)
e
 
1 0.94 0.35 0.23 0.2 21.94 
2 0.94 0.35 0.18 0.15 16.46 
3 0.94 0.35 0.34 0.31 34.01 
4 2.19 0.96 0.62 0.32 16.95 
5 2.53 1.08 1.27 0.97 43.54 
6 2.95 1.23 2.05 1.75 66.01 
7 0.91 0.51 0.38 0.08 13.22 
8 1.35 0.67 0.72 0.42 39.99 
9 2.19 0.96 1.7 1.4 74.16 
c
Theoretical mass from 4-racmix-2 solubility curve (Figure 6.5). 
d
Theoretical mass of (S,S)-2 in 
product with no racemisation, based on 4-racmix-2 composition (35% (S,S)-2) and seed fraction. 
e
Not including seed. 
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Table 7.1c Conditions used and results for CIAT experiments using catalyst 4 (4 mol%) and 
seeding 4-racmix-2 with (S,S)-2, 0.467 mol l
-1
, 30 ml scale, temperature programmes a and d. 
 
Part 3: Product Composition (%)
f
 
Entry (S,S)-2 (R,R)-2 meso-2 Benzil Stilbene 
Benz-
aldehyde 
1 99.59 0.00 0.00 0.00 0.00 0.41 
2 99.71 0.00 0.00 0.00 0.00 0.29 
3 78.16 21.49 0.35 0.00 0.00 0.00 
4 99.21 0.56 0.00 0.00 0.00 0.24 
5 76.03 23.13 0.30 0.00 0.00 0.54 
6 49.88 30.27 18.17 0.00 0.00 1.68 
7 98.54 0.00 0.00 0.00 0.00 1.46 
8 77.30 22.31 0.00 0.00 0.00 0.39 
9 62.49 36.29 0.81 0.00 0.00 0.40 
f
Determined by chiral HPLC (see section 11.1.5 for method details). 
 
 
 
Table 7.1d Conditions used and results for CIAT experiments using catalyst 4 (4 mol%) and 
seeding 4-racmix-2 with (S,S)-2, 0.467 mol l
-1
, 30 ml scale, temperature programmes a and d. 
 
Part 4: System Composition 
Entry 
Mass of 
(S,S)-2 in  
product (g)
g
 
Remaining 
(S,S)-2 in 
solution (g)
h
 
(S,S)-2 in system
i
  Change in total 
(S,S)-2 
composition (%)
j
 (g) (%) 
1 0.23 0.98 1.21 39.90 11.95 
2 0.18 1.00 1.18 38.84 8.98 
3 0.27 0.94 1.21 39.84 11.78 
4 0.62 0.94 1.55 47.06 15.04 
5 0.97 0.71 1.68 50.79 24.16 
6 1.02 0.44 1.46 44.24 8.15 
7 0.37 1.02 1.40 42.32 3.44 
8 0.56 0.90 1.46 44.23 8.11 
9 1.06 0.56 1.62 49.16 20.17 
g
From chiral HPLC data and product mass. 
h
(S,S)-2 in solution based on solubility curve, 
product mass and 4-racmix-2 composition (35% (S,S)-2). 
i
Both solid and solution phase 
contributions. 
j
Percent change in (S,S)-2 composition considering initial and final solid and 
solution phases. 
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a b 
  
Figure 7.3 Entry 1 chiral HPLC chromatograms for a) the product obtained and b) the solution 
phase at the end of the run. (approximate component positions: 3 min benzaldehyde; 13 min 
stilbene; 21 min benzil; 33 min (S,S)-2; 40 min (S,S)-2; 51 min meso-2 )  
 
 
a b 
  
Figure 7.4 CIAT product crystal from Table 7.1 entries a) 1 and b) 8. 
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7.3.2 Polythermal Temperature Programmes 
Table 7.2 lists the conditions used for a selection of CIAT runs using 2 and 
catalyst 4 under the temperature programmes that correspond to b and c in 
Figure 7.2, with the total quantity of (S,S)-2 initially present in the system as 
solid and solution also given. 
The polythermal temperature programmes used are an extension of findings 
presented as entries 1, 2 and 3 in the previous section (Table 7.1). Enantiopure 
crystals were obtained, and the total quantity of (S,S)-2 present in the system 
increased, when pure (S,S)-2 seed was introduced to the equilibrated solutions 
and held isothermally below the saturation temperature (49°C/40°C). However, 
as a result of maintaining the latter condition (with further reductions in 
temperature resulting in crystallisation of the undesired stereoisomers), low 
yields were obtained as the thermodynamic driving force was insufficient to 
maximise solute recovery and hence the productivity of the CIAT process. In the 
results presented in Table 7.2, the temperature programme began by replicating 
the entries that resulted in high chiral purity products, yet, to maintain 
supersaturation and hence increase the quantity of solute recovered, controlled 
cooling was subsequently applied to the system. 
In entries 1 and 2 in (Table 7.2), the solution was seeded at 54°C which was 
maintained for a further 30 min. Unlike the lower temperature conditions used in 
the entries in the previous section discussed above, the seed temperature was 
selected to be approximately the saturation temperature to minimise the 
possibility of antipode and meso- form crystallisation due to them being close to 
their metastable limits. The solution was then cooled at a controlled rate of -
0.1°C min-1 to 42°C at which point the solution was immediately filtered.   
Considering entry 1 (Table 7.2), the solution was seeded with 5 wt% (S,S)-2 
which after cooling resulted in 1.24 g of solid being obtained. This equates to 
1.09 g of solute being deposited from solution giving a crystal yield of 63.47%. 
Of this, chiral HPLC showed that 64.07% consisted of (S,S)-2 with the 
remainder being comprised predominantly of (R,R)-2 (35.25%) leading to a 
21.91% change in total (S,S)-2 present in the system. Similar results were seen 
when the quantity of seed was increased to 10 wt% (entry 2); however, as a 
result of the greater crystallisation surface area provided, the crystal yield was 
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improved (68.13%) since, for a given time and set of process conditions, a 
larger quantity of solute would be expected to be deposited. Despite this, the 
presence of more surface area was observed to have a detrimental effect on 
the fraction of (S,S)-2 in the product crystal obtained, with a considerable 
amount of meso-2 also being present. Crystallisation of the antipode and meso- 
form indicates that either its nucleation induction time was achieved, the 
enantiopure crystals added to the system were acting as non-selective 
nucleation centres, or that the controlled cooling programme applied was not 
sufficiently slow enough to allow the system to remain close to equilibrium 
between the solid and liquid phases leading to the undesired stereoisomers 
reaching their metastable limits through a progressive increase in 
supersaturation. 
In entries 3-6 the process cooling rate was reduced to -0.23°C min-1 in an 
attempt to allow the system to remain closer to the equilibrium solubility curve 
under cooling without excessive build-up of supersaturation. Furthermore, the 
time spent at the initial isothermal stage was increased to 60 min in order to 
provide more time for the system to approach equilibrium between the solid and 
solution phases. With the exception of entry 5, as anticipated the crystal yield 
was seen to increase as a result of the reduced cooling rate allowing greater 
time for crystallisation. Despite this, little change was seen in the composition of 
(S,S)-2 in the product obtained; however, unlike entries 1 and 2, a greater 
proportion benzaldehyde was present in the crystal phase at the end of the run 
(with entries 3 and 5 containing 9.02% and 8.99% respectively compared with 
0.38% and 0.84% for entries 1 and 2). Interestingly, entry 4, where 10 wt% seed 
was introduced in to the system, yielded the greatest quantity of (S,S)-2 from 
solution with no benzaldehyde being observed in the final product.  
These findings suggest that for a slow cooling rate, which results in the crystals 
being suspended in solution for a longer period of time, and a low crystallisation 
surface area provided by the seed, which reduces the rate of (S,S)-2 deposition 
and hence minimises the quantity of material being converted by way of the 
catalyst since the solution phase is closer to catalytic equilibrium, sufficient time 
is given for benzaldehyde to become increasingly more supersaturated 
eventually leading to its spontaneous nucleation. However, it is known that 
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benzaldehyde is far more soluble in toluene than 2, and coupled with the low 
levels seen in the racemisation mixture, it is unlikely that it would independently 
reach its metastable limit and nucleate. A more plausible explanation for its 
presence in the product crystals is that, due to similarities in their molecular 
structures, the (S,S)-2 seed acts as a crystallisation centre for benzaldehyde 
thus lowering the energy barrier for crystal formation resulting in it being 
deposited from solution.  
Based on this assumption, it is reasonable to expect the quantity of 
benzaldehyde present in the product to increase with the amount of seed 
introduced to the system due to the larger surface area yet the results 
presented in Table 7.2 (and the vast majority of the results presented in the 
report) suggest the opposite is true i.e. generally for the same given process 
conditions, and if sufficient time is available, an increase in the quantity of seed 
results in less benzaldehyde being deposited. For a conventional seeded 
crystallisation this would appear to be counterintuitive; however, it is likely that 
this is a result of the catalyst being present in solution. When large quantities of 
seed are introduced into the system, comparatively higher rates of (S,S)-2 
removal are observed as a result of the greater surface area. Consequently, the 
other catalytically equilibrated species in solution are transformed a faster rate 
which lowers their concentration and therefore reduces their tendency to 
crystallise, even in the presence of a crystal surface. On the other hand, if small 
volumes of seed are used, the rate of solute removal, and hence the rate of 
undesired species transformation by the catalyst is comparatively slower, 
therefore their concentrations remain higher and they are more likely to 
crystallise given the opportunity either through achievement of the metastable 
solubility limit or by non-selective molecular addition onto the seed crystal 
surface. Examination of the data presented for CIAT of 2 using catalyst 4 shows 
that this trend occurs in the majority of cases but is not always observed which 
is most likely due to the statistical dependency of this phenomena occurring 
Considering entries 5 and 6, for which the difference in process conditions was 
the seed temperature, Tseed (53.5°C and 52°C respectively), a similar effect is 
observed to that described previously for differing seed quantities. When the 
seed is introduced at a lower temperature, a greater quantity of solute is 
 
208 
 
deposited due to the greater magnitude of supersaturation. Consequently, a 
greater crystal yield is obtained, and the levels of benzaldehyde seen are 
significantly lower since the faster rate of solute removal gives correspondingly 
faster catalytic transformation hence its concentration is comparatively lower 
and its less likely to crystallise. Conversely, despite the superior yield, the 
fraction of (S,S)-2 present in the product is lower for entry 6 since the relative 
difference in the concentration of its antipode, which unlike benzaldehyde is 
supersaturated, is higher therefore it is more likely to reach its metastable limit. 
In entries 7-11 a similar temperature programme was applied whereby the 
system was held isothermally for 60 min at Tseed and subsequently cooled at a 
rate of 0.025°C min-1; however, unlike the previous entries this was continued to 
the lower temperature of 25°C.  
Considering entry 7, relatively high crystal yield of 81.85% was obtained which 
is a result of the crystals remaining in solution for a longer duration of time 
allowing for equilibrium between the solid and solution phases to be 
approached. Despite this, a low chiral purity product was obtained as similarly 
the antipode was also given a longer process time for it to both achieve its 
nucleation induction time and for it to be subsequently deposited through growth 
and secondary nuclei formation. Comparing entry 7 with 8, in which the amount 
of seed introduced was increased from 1 to 10 wt%, similar results were 
obtained, yet, for the reasons described previously, benzaldehyde was only 
found to be present when 1 wt% of seed was used and was absent for the 10 
wt% case. 
Entries 9 and 10 were performed using the same controlled cooling rate; 
however, in 9 the seed was introduced at the lower temperature of 49°C. 
Despite being introduced at a greater magnitude of supersaturation, and with 
entry 9 having a shorter process time, little difference was seen between the 
results of the two runs. However, in each case a significant change in the total 
(S,S)-2 composition present in the system in both the solid and solution phase 
was observed being 42.19% and 37.79% respectively for the two entries 9 and 
10. Similar results were seen in entry 11, which was simply a repeat of entry 10 
for comparison. Interestingly, identical yields of crystalline product were 
received in both cases (83.74%), yet, the resulting compositions did differ. The 
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difficulty in reproducing data for identical conditions was a common theme 
throughout the investigation which was of course a result of the many different 
process and experimental parameters that influenced the CIAT process. 
For entries 12-14 the cooling rate was further reduced to 7 x 10-4°C min-1 with 
each entry being performed under the same process conditions. However, in 
entry 12 enantiopure (R,R)-2 seed was used instead of (S,S)-2 whereas entry 
14 used 8 mol% of catalyst 4 (with (S,S)-2 seed). Comparing entries 12 and 13, 
as expected very similar results are obtained when either (R,R)-2 or (S,S)-2 
seeds are used since there should be no difference in phase equilibria between 
the two. A slightly higher yield was observed when (S,S)-2 was used however 
which is likely due to unavoidable experimental variations between the two runs. 
Despite this, as a result of the higher purity product obtained when (R,R)-2 was 
used, near identical changes in the total composition of the desired enantiopure 
present in the system as solid and solution were seen (15.54% and 16.19% 
respectively when (R,R)-2 and (S,S)-2 seed was used).  
Comparing entries 13 and 14, it can be seen that a higher catalyst loading 
resulted in similar performance albeit giving a slightly lower yield and a lower 
change in total (S,S)-2 system composition at the end of the run (which could 
be due to unavoidable experimental variations between the two runs). It would 
be expected that by increasing the solution phase transformation rate, a higher 
quantity of catalyst would improve the productivity of the process since the 
stereoisomers will be closer to equilibrium in solutions whilst the desired 
enantiomer is being deposited on the enantiopure seeds. However, as 
mentioned previously, presence of foreign species can have a considerable 
influence on crystallisation kinetics by reducing the MSZW, altering crystal 
growth, or by supressing nucleation. In the data presented, it appears that 
increasing the catalyst load does not have a considerable effect on the outcome 
of the process warranting the acceptable use of lower quantities.  
Entries15 and 16 give the data for the CIAT runs that were performed under the 
temperature programme that corresponds to c in Figure 7.2. For each of the 
entries, the solution was seeded at Tseed and held isothermally for 16 min, after 
which a controlled cooling rate of -0.25°C min-1 was applied for a 1°C 
temperature change i.e. 4 min of cooling. The solution was again held 
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isothermally for an addition 16 min with cooling/isothermal temperature 
programme being repeated unit Tfilt was achieved, at which point the slurry was 
immediately filtered. By inducing a low magnitude of supersaturation with a 
small temperature change, then allowing the system to sit isothermally, it was 
postulated that the latter condition would allow the system to approach 
equilibrium between the solid and solution phases. Generation of a small driving 
force would minimise the chance of the undesired species crystallising since 
their concentrations would be reduced by the catalyst during the isothermally 
stages. Through repetition of the cycle, the system would therefore remain 
close to the equilibrium solubility.  
Considering entry 15, the solution was seeded at 52°C with the temperature 
programme described above being repeated to 42°C. By attempting to stay 
close to the equilibrium solubility, a considerable crystal yield of (S,S)-2 was 
achieved (71.04%). Furthermore, a relatively high enantiomeric purity was 
obtained with 78.72% of the product being comprised of (S,S)-2 which lead to 
its total composition in the system as both solid and solution being increased by 
43.40%. As anticipated, by staying close to equilibrium, the relative 
supersaturation of the undesired species was reduced which was further 
enhanced due to conversion by the catalyst. 
Entry 16 was performed under the same conditions; however, the quantity of 
seed crystals used was twice that of entry 15 (8 wt%). As a result of the larger 
crystallisation area, leading to a greater quantity of solute being deposited, a 
slight increase in the crystal yield was observed. However, the composition of 
(S,S)-2 in the final product was approximate 7% lower than what was seen in 
entry 15. With a larger quantity of seed resulting in correspondingly faster rates 
of crystal growth and secondary nucleation, and with the rate of catalytic 
transformation being unchanged, it is likely that the concentrations of the 
antipode and meso- form was not reduced at a sufficient rate by the catalyst to 
compensate for the increased rate of removal by the seed hence they 
experienced a greater magnitude of supersaturation leading to larger quantities 
of them being deposited. 
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Table 7.2a Conditions used and results for CIAT experiments using catalyst 4 (4 mol%) and 
seeding 4-racmix-2 with (S,S)-2, 0.467 mol l
-1
, 30 ml scales temperature programmes b ad c
a
. 
 
Part 1: CIAT process conditions 
Entry
b
 
TSeed 
(°C) 
Temperature Programme 
Tfilt 
(°C) 
Seed 
quantity 
(wt%) 
(S,S)-2 in 
system 
(%)
c
 
1 54 [b] Isothermal at TSeed for 30 min,  
-0.1°C min
-1
 
42 5 38.10 
2 54 42 10 40.91 
3 53.5 
[b] Isothermal at TSeed for 60 min  
-0.023°C min
-1
 
43.5 5 41.44 
4 53.5 43.5 10 43.97 
5 53.5 43.5 2 39.81 
6 52 43.5 2 39.81 
7 53.5 
[b] Isothermal at TSeed for 60 min 
 -0.025°C min
-1
 
25 1 39.25 
8 53.5 25 10 43.97 
9 49 25 1 39.25 
10 53 25 1 39.25 
11 53 25 1 39.25 
 12
d
 54 
[b] Isothermal at TSeed for 30 min,  
-7x10
-4
°C min
-1
 
40 10 40.91 
13 54 40 10 40.91 
 14
e
 54 40 10 40.91 
15 52 [c] Isothermal at TSeed for 16 min, -0.25°C 
min
-1
 for 1°C, isothermal for 16 min, repeat 
to TFilt 
42 4 36.5 
16 52 42 8 38.9 
a
See Figure 7.2 for a graphical presentation of the temperature programmes used 
corresponding to the value in square brackets.
b
6% initial excess of (S,S)-2. 
c
Initial (S,S)-2 in 
system (%) based on 4-racmix-2 composition in solution (35% (S,S)-2) and seed fraction. 
d
Seeding with (R,R)-2. 
e
8 mol% 4. 
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Table 7.2b Conditions used and results for CIAT experiments using catalyst 4 (4 mol%) and 
seeding 4-racmix-2 with (S,S)-2, 0.467 mol l
-1
, 30 ml scale temperature programme b. 
 
Part 2: Theoretical and obtained crystal yields 
Entry 
Theoretical yields Product Yields 
Product mass 
including 
seed/initial 
excess (g)
f
 
Mass of (S,S)-2 in 
product (g)
g
 
Product mass 
including 
seed/initial 
excess (g) 
Product 
Mass (g)
h
 
Crystal 
Yield (%) 
1 1.87 0.75 1.24 1.09 63.47 
2 2.02 0.90 1.47 1.17 68.13 
3 1.90 0.88 1.50 1.17 74.32 
4 2.05 1.03 1.63 1.15 73.05 
5 1.81 0.79 1.11 0.87 55.27 
6 1.81 0.79 1.32 1.08 68.61 
7 2.86 1.14 2.38 2.17 81.85 
8 3.13 1.41 2.51 2.03 76.57 
9 2.86 1.14 2.38 2.17 81.85 
10 2.86 1.14 2.43 2.22 83.74 
11 2.86 1.14 2.43 2.22 83.74 
12
c
 2.19 0.96 0.88 0.58 30.70 
13 2.19 0.96 1.10 0.80 42.38 
14
d
 2.19 0.96 0.96 0.66 34.96 
    15 1.84    0.72    1.34 1.22 71.04 
    16 1.96    0.84    1.51 1.27 73.95 
f
Theoretical mass from 4-racmix-2 solubility curve (Figure 6.5). 
g
Theoretical mass of (S,S)-2 in 
product with no racemisation, based on 4-racmix-2 composition (35% (S,S)-2) and seed fraction. 
h
Not including seed/initial excess. 
 
Table 7.2c Conditions used and results for CIAT experiments using catalyst 4 (4 mol%) and 
seeding 4-racmix-2 with (S,S)-2, 0.467 mol l
-1
, 30 ml scale temperature programme b. 
 
Part 3: Product Composition (%)
i
 
Entry (S,S)-2 (R,R)-2 meso-2 Benzil Stilbene 
Benz-
aldehyde 
1 64.07 35.25 0.30 0.00 0.00 0.38 
2 61.73 31.97 5.46 0.00 0.00 0.84 
3 62.47 28.23 0.29 0.00 0.00 9.02 
4 71.60 28.10 0.30 0.00 0.00 0.00 
5 65.16 25.57 0.28 0.00 0.00 8.99 
6 54.12 44.47 0.78 0.00 0.00 0.63 
7 54.83 39.83 0.46 0.00 0.00 4.88 
8 57.02 42.72 0.25 0.00 0.00 0.00 
9 63.07 34.67 1.35 0.00 0.00 0.90 
10 60.21 34.00 3.94 0.00 0.00 1.84 
11 53.86 41.24 3.17 0.00 0.00 1.73 
 12
c
 8.72 80.93 0.74 0.00 0.00 9.61 
13 72.59 24.91 0.31 0.18 0.06 1.94 
 14
d
 68.16 31.32 0.00 0.00 0.00 0.52 
15 78.72 19.79 0.34 0.00 0.00 1.15 
16 71.69 26.10 0.16 0.00 0.00 2.05 
i
Determined by chiral HPLC (see section 11.1.5 for method details). 
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Table 7.2d Conditions used and results for CIAT experiments using catalyst 4 (4 mol%) and 
seeding 4-racmix-2 with (S,S)-2, 0.467 mol l
-1
, 30 ml scale temperature programme b. 
 
Part 4: System Composition 
Entry 
Mass of 
(S,S)-2 in  
product (g)
j
 
Remaining 
(S,S)-2 in 
solution (g)
k
 
(S,S)-2 in system
l
  Change in total 
(S,S)-2 
composition (%)
m
 (g) (%) 
1 0.79 0.67 1.46 46.44 21.91 
2 0.91 0.64 1.55 46.91 14.66 
3 0.94 0.64 1.58 47.37 14.31 
4 1.17 0.65 1.81 52.14 18.60 
5 0.72 0.75 1.47 45.33 13.86 
6 0.71 0.67 1.39 42.79 7.47 
7 1.30 0.29 1.60 49.70 26.63 
8 1.43 0.34 1.77 50.89 15.74 
9 1.50 0.29 1.79 55.81 42.19 
10 1.46 0.27 1.74 54.09 37.79 
11 1.31 0.27 1.58 49.27 25.53 
 12
c
 0.71 0.85 1.56 47.25 15.49 
13 0.80 0.77 1.57 47.53 16.19 
 14
d
 0.65 0.82 1.47 44.65 9.14 
15 1.05 0.62 1.68 53.78 43.40 
16 1.08 0.61 1.69 52.10 30.85 
j
From chiral HPLC data and product mass. 
k
(S,S)-2 in solution based on solubility curve, 
product mass and 4-racmix-2 composition (35% (S,S)-2). 
l
Both solid and solution phase 
contributions. 
m
Percent change in (S,S)-2 composition considering initial and final solid and 
solution phases. 
 
 
a b 
  
Figure 7.5 CIAT product crystals from Table 7.2 entries a) 7 and b) 12 
 
7.3.3 Reduced Concentration 
Table 7.3 lists the conditions used for a selection of CIAT runs using 2 and 
catalyst 4 under the  temperature programme that corresponds to b in Figure 
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7.2, with the total quantity of (S,S)-2 initially present in the system as solid and 
solution also given. In all of the entries presented, a reduced 4-racmix-2 
concentration of 0.233 mol l-1 was used (compared with the data presented 
previously). Since the MSZW for a solid-solution system generally increases 
with decreasing temperature, CIAT was performed at a lower concentration to 
investigated whether the productivity of the process could be improved as a 
result of potentially more time being available for the seed crystals to be 
entrained, and hence the reduced possibility of undesired species reaching 
there metastable solubility limit. In all of the entries presented, the solution was 
seeded at 43.5°C, held isothermally for 75 min, and cooled under a controlled 
rate to 20°C at which point the solution was immediately filtered.  
Entries 1 and 2 were performed under identical conditions; however, in the 
former 8 mol% of catalyst 4 was used since, at these comparatively lower 
process temperatures, the racemisation rate is reduced therefore is was 
essential to know whether the productivity of the process could be enhanced by 
using larger catalyst loadings. Considering the resulting data, little difference 
was seen between the crystal yields of entries 1 and 2; however, for the case 
where the lower 4 mol% of catalyst was used, a higher chiral purity product was 
obtained and significantly less benzaldehyde was present in the resulting 
crystalline product. This may have been due to the presence of additional 
foreign material in solution (entry 1) influencing the crystallisation kinetics of 
benzaldehyde by acting as centres for nucleation as discussed previously. In 
both cases however, considerably more benzaldehyde was observed in the final 
product compared with the subsequent entries (3-5) which were performed 
under the same conditions but with slower cooling rates. This suggest that 
benzaldehyde may have approached or exceeded its metastable limit under the 
comparatively faster cooling rate which, in conjunction with the reduced rate of 
its catalytic conversion upon removal of the seeded enantiomer (S,S)-2 (due to 
the low relative operating temperatures), may have resulted in its concentration 
being higher than what it would be if a slower cooling rate was used and hence 
more time provided for the solution to catalytically equilibrate.  
Examination of entries 3-5, for which the cooling rates were reduced to 0.01°C 
min-1, 0.0075°C min-1 and 0.001°C min-1 respectively, provides further evidence 
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for this hypothesis; low levels of benzaldehyde were found to be present in the 
product crystals in each case. Crystal yields were comparable to entries 1 and 
2; however, the chiral purity of the product obtained was considerably higher. 
Furthermore the change in the quantity of (S,S)-2 present in the system at the 
end of the process in both the solid and solution phases was significantly 
improved with entry 5 giving a 61.57% increase. Of the three entries, 5 used the 
median cooling rate of 0.0075°C min-1 which implies that an optimum exists. For 
faster rates of cooling, it is more likely that the undesired species will reach their 
metastable solubility limits since the rate of catalytic conversion is not sufficient 
to minimise their concentrations in solution. On the other hand, for very slow 
cooling rates, and hence longer process times, it is possible that crystallisation 
of the undesirables may occur through them achieving their induction times. 
Comparing the entries in Table 7.3 with those given in the previous sections 
using a higher 4-racmix-2 concentration, it is evident that there has been an 
improvement in the change in total quantity of (S,S)-2 present in the system i.e. 
more of the undesired species were converted compared with the previous high 
relative-concentration runs. Similarly, increased chiral-purity products were also 
obtained under these conditions. As anticipated, the improvement in CIAT 
productivity seen when lower concentrations were used is likely due to the wider 
MSZW allowing the process to operate further from the metastable solubility 
points for each of the system components hence allowing more time for seeded 
enantiomer to crystallise. However, despite this slight improvement, it must be 
noted that in all of the polythermic CIAT experiments conducted it was not 
possible to recover an enantiopure product. 
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Table 7.3a Conditions used and results for CIAT experiments using catalyst 4 (4 mol%) and 
seeding 4-racmix-2 with (S,S)-2, 0.233 mol l
-1
, 30 ml scale, temperature programme b
a
. 
 
Part 1: CIAT process conditions 
Entry 
TSeed 
(°C) 
Temperature Programme 
TFilt 
(°C) 
Seed 
quantity 
(wt%) 
(S,S)-2 in 
system 
(%)
b
 
 1
c
 43.5 [b] Isothermal at TSeed for 75 min, 
-0.05°C min
-1
 
20 10 1.28 
2 43.5 20 10 1.28 
3 43.5 [b] As above -0.01°C min
-1
 20 10 1.28 
4 43.5 [b] As above -0.0075°C min
-1
 20 10 1.28 
5 43.5 [b] As above -0.001°C min
-1
 20 10 1.28 
a
See Figure 7.2 for a graphical presentation of the temperature programmes used 
corresponding to the value in square brackets. 
b
Initial (S,S)-2 in system (%) based on 4-racmix-2 
composition in solution (35% (S,S)-2) and seed fraction. 
c
8 mol% 4 
 
Table 7.3b Conditions used and results for CIAT experiments using catalyst 4 (4 mol%) and 
seeding 4-racmix-2 with (S,S)-2, 0.467 mol l
-1
, 30 ml scale, temperature programme b. 
 
Part 2: Theoretical and obtained crystal yields 
Entry 
Theoretical yields Product Yields 
Product mass 
including 
seed (g)
d
 
Mass of (S,S)-2 in 
product (g)
e
 
Product mass 
including seed 
(g) 
Crystal 
Yield  
(g)
f
 
Crystal 
Yield (%) 
1
c
 1.43 0.60 1.17 1.02 79.74 
2 1.43 0.60 1.26 1.11 86.78 
3 1.43 0.60 1.03 0.88 68.80 
4 1.43 0.60 1.19 1.04 81.31 
5 1.43 0.60 1.03 0.88 68.80 
d
Theoretical mass from 4-racmix-2 solubility curve (Figure 6.5). 
e
Theoretical mass of (S,S)-2 in 
product with no racemisation, based on 4-racmix-2 composition (35% (S,S)-2) and seed fraction. 
f
Not including seed. 
 
Table 7.3c Conditions used and results for CIAT experiments using catalyst 4 (4 mol%) and 
seeding 4-racmix-2 with (S,S)-2, 0.467 mol l
-1
, 30 ml scale, temperature programme b. 
 
Part 3: Product Composition (%)
g
 
Entry (S,S)-2 (R,R)-2 meso-2 Benzil Stilbene 
Benz-
aldehyde 
 1
c
 46.07 6.73 2.55 0.00 0.00 44.65 
2 55.11 31.12 0.27 0.93 0.00 12.57 
3 63.47 35.24 0.16 0.00 0.00 1.12 
4 78.12 21.31 0.34 0.00 0.00 0.23 
5 69.20 28.68 0.86 0.00 0.00 1.26 
g
Determined by chiral HPLC (see section 11.1.5 for method details). 
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Table 7.3d Conditions used and results for CIAT experiments using catalyst 4 (4 mol%) and 
seeding 4-racmix-2 with (S,S)-2, 0.467 mol l
-1
, 30 ml scale, temperature programme b. 
 
Part 4: System Composition 
Entry 
Mass of 
(S,S)-2 in  
product (g)
h
 
Remaining 
(S,S)-2 in 
solution (g)
i
 
(S,S)-2 in system
j
  Change in (S,S)-2 
composition (%)
k
 (g) (%) 
1 0.54 0.17 0.71 42.85 4.75 
3 0.69 0.14 0.83 50.36 23.10 
4 0.65 0.22 0.87 52.77 29.00 
5 0.93 0.16 1.09 66.10 61.57 
6 0.71 0.22 0.93 56.35 37.74 
h
From chiral HPLC data and product mass. 
i
(S,S)-2 in solution based on solubility curve, 
product mass and 4-racmix-2 composition (35% (S,S)-2).
 j
Both solid and solution phase 
contributions. 
k
Percent change in (S,S)-2 composition considering initial and final solid and 
solution phases. 
 
 
 
a b 
  
C d 
Figure 7.6 Product crystals from Table 7.3 Entries a) 1 and b) 4. 
 
 
7.3.4 Effect of Catalyst 4 on Crystallisation 
As a result of the mixed success seen in the CIAT experiments using catalyst 4 
presented in the previous sections, in which it was possible to obtain 
enantiopure product under an isothermal temperature programme but with low 
yields, whereas under a polythermal temperature program a comparatively 
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higher yield could be obtained but crystallisation of the antipode and the other 
species present in racemisation mixture could not be avoided, the effect on 
crystallisation due to the catalyst being in solution was investigated. PXRD was 
used to identify whether the catalyst was being incorporated to the crystalline 
product by comparing the diffraction patterns of the enantiopure (S,S)-2 seed 
crystals with that of the enantiopure product obtained using the isothermal 
temperature programme. Although single crystal XRD would have allowed for a 
more thorough examination, it was not possible to obtain crystals large enough 
from the CIAT experiment.  
Figure 7.7 shows the XRD diffraction patterns for the (S,S)-2seed used 
throughout the investigation and the enantiopure product crystals from entry 1 in 
Table 7.1. It is evident from close examination of the figure that the two 
diffraction patterns are a very close match despite the relative peak intensities 
differing for the two sets of data as a result of the differing crystal morphologies 
seen between the crystal samples due to them being obtained under different 
conditions. Each of the characteristic peaks occur at the same location with no 
additional peaks being present the pattern for entry 1 which would indicate a 
change in crystal structure or the presence of another species. This strongly 
indicates that it is not being incorporated into the crystal lattice although it is 
very likely that the catalyst has an effect on the crystallisation kinetics of 2 which 
is suggested by the strong exhibition of vicinal faces in the CIAT product 
crystals (Figure 7.4-7.6). Ideally single crystal XRD analysis would have been 
used to provide conclusive evidence for the lack of catalyst incorporation into 
the crystal lattice; however, under the conditions of CIAT it was not possible to 
grow a single crystal off sufficient size.  
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Figure 7.7 X-ray powder diffraction spectra for (S,S)-2 and entry 1 from Table 7.1. 
 
7.3.5 Catalyst 4 Activity 
For the reasons mentioned in the previous section, the activity of catalyst 4 was 
investigated to identify whether it was the cause for the mixed success seen in 
the CIAT runs in which it was used. The length of time that 4 remained active in 
solution was determined by performing a simple experiment (results not 
presented) in which a fixed quantity of stock solution consisting of catalytically 
equilibrated 2 was added to solutions of enantiopure (S,S)-2 in toluene at 
different time intervals, giving a catalyst load of 4 mol%, and left for a period of 
time to observe if any change in composition occurred due to the activity of the 
catalyst. Since the time that the stock solution spent racemising was known, it 
was possible to identify how long it took for catalyst 4 to become inactive since 
addition of the stock solution to the enantiopure solution at a given time would 
not result in the latter being equilibrated (the composition being determined by 
chiral HPLC).  
Despite the findings in chapter 5, where the rate of racemisation was shown to 
be exceptionally fast, the experiment showed that catalyst 4 became 
deactivated after approximately 1 to 2 hours of operation, since the resulting 
composition after combing to two solutions exhibited an excess in (S,S)-2 
corresponding to what was present in the enantiopure solution.  
 
220 
 
This was investigated further by monitoring the catalytic transformation of (S,S)-
2 by catalyst 4 using online  temperature controlled 31P NMR analysis. Known 
quantities of (S,S)-2, 4 and KOH were added to an air tight NMR tube, 
evacuated and purged with argon, after which dry toluene was added using a 
syringe to give a prescribed concentration and a catalyst load of 4 mol%. The 
sample was immediately submitted for analysis where it was heated to 50°C 
with a spectra being recorded every 10 min for a period of 3 hours. 
Figure 7.8 shows a selection of the resulting 31P NMR spectra for the 
racemisation of (S,S)-2 by 4 over time. Catalyst 4 gives rise to the peak 
positioned at δ = 47.6 whilst those occurring at δ = 64.9-63.8 and δ = 57.8 are 
attributed to the catalyst-substrate complexes that are formed during the 
catalytic transformation (note: at t = 0 there was approximately a 1-2 min delay 
between initiation of the reaction and recording the first spectra due to the time 
taken for the instrument to load the sample, hence the t = 0 spectra represents 
a racemising composition, not catalyst 4 alone). At δ = 28.9 triphenylphosphine 
oxide (PPh3=O) can be seen to be formed in increasing quantities over the 
duration of the reaction. Conversely, the peak corresponding to catalyst 4 is 
gradually reduced, becoming absent from the spectra after around 80 to 90 min 
of reaction time has elapsed, with those representing the catalyst-substrate 
intermediates also becoming comparatively less intense.  This shows that over 
the course of the reaction, and hence also during the CIAT runs, catalyst 4 was 
gradually converted predominantly to PPh3=O, either through reaction with the 
oxygen in 2 or with that present in the air in the case that it was not sufficiently 
removed from the system (although the mechanism is not known). This 
occurred until 4 was completely void from solution at approximately 80 to 90 
min at which point catalytic conversion ceased. 
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Figure 7.8 
31
P NMR (500 MHz, toluene) racemisation of (S,S)-2 with catalyst 4 at 50°C: δ = 
64.9-63.8 / δ = 57.8 unknown catalyst-substrate intermediates; δ = 47.6 catalyst 4 (s, 2P, PPh3), 
δ = 28.9 triphenylphosphine oxide (PPh3=O) (s, 1P, PPh3). 
The findings from the 31P NMR experiment discussed above can be used to 
explain the mixed success seen in the data presented in the previous sections 
for CIAT of 2 with catalyst 4. For the shorter isothermal runs, for which the 
process operation time did not exceed 90 min, high enantiomeric purities and in 
some cases enantiopure product was obtained. However, for those runs 
operated for greater that 90 min, the antipode was always seen to be present in 
the resulting crystalline product, with meso-2 and other reaction intermediates 
also being frequently deposited. The fact that catalytic transformation was 
shown to cease after 80 to 90 min can be used to interpret the findings of the 
CIAT experiments.  
Upon seeding the catalytically equilibrated solution with enantiopure (S,S)-2 at 
the beginning of the process run, the desired enantiomer was deposited 
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exclusively without crystallisation of the undesired species since their 
concentrations were subsequently reduced by the action of the catalyst as soon 
as the solution phase composition deviated from that observed at equilibrium as 
a result of growth and secondary nucleation of (S,S)-2. For runs that exceeded 
90 min, transformation of the undesired species to (S,S)-2 had ceased due to 
catalyst 4  being absent from solution since it had been converted to PPh3=O. 
Consequently, despite the magnitude of supersaturation experienced by the 
undesired components in solution remaining constant for the isothermal runs, 
the increased process times lead to their nucleation induction time periods 
being achieved hence they were deposited from the solution. For the 
polythermal runs, their magnitude of supersaturation increased with the 
reduction in temperature since they were not being converted leading to them 
reaching the metastable solubility limits and crystallising from solution. Thus, for 
runs in excess of approximately 90 min of operation, the solution phase 
components were no longer in dynamic catalytic equilibrium and, due to the 
solid phase equilibria, crystallisation of the undesired species was always 
observed.  
 
 
7.4 CIAT of Hydrobenzoin (2) using 
Chloromonocarbonyltriphenylphosphine-(1,2,3,4,5-
pentaphenylcyclopentadienyl)-ruthenium(II) (5) 
Complex 5 was investigated for use as a CIAT catalyst due to the findings 
shown in the previous sections where CIAT of (S,S)-2 was attempted using 
catalyst 4. During these runs catalytic transformation of the undesired species in 
solution ceased after approximately 90 min due to the catalyst being converted 
to PPh3=O leading to low chiral purity products being obtained since 
crystallisation of the other system components could not be avoided. Using the 
same methodology described in the opening paragraph of section 7.3.5, where 
a fixed quantity of a racemising stock solution was added to enantiopure 
solutions at prescribed time intervals, catalyst 5 was shown to remain active for 
up to 5 days of operation. Furthermore, it was shown in section 5.5.2 that 5 is 
air stable, and can in fact be operated under a pure O2 atmosphere according to 
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a literature investigation [126], therefore it was anticipated that the issue seen 
with 4 disappearing from the reaction mixture due to being converted to PPh3=O 
would not occur for 5.  
 
7.4.1 Isothermal and Cyclic Polythermal Temperature Programmes 
Table 7.4 lists the conditions used for a selection of the CIAT runs using 2 and 
catalyst 5 under the temperature programmes that correspond to b and d in 
Figure 7.2, with the total quantity of (S,S)-2 initially present in the system as 
solid and solution also given. The conditions selected were based on the 
findings of the CIAT experiment using catalyst 4. A relatively low process 
temperature was used as this was shown to be favourable since it resulted in 
the MSZW being wider therefore the seed crystals could remain entrained in the 
solution for a longer duration of time leading to greater crystal yields. 
Furthermore, for the majority of the entries present in Table 7.4, comparatively 
large quantities of seed were used since it was observed that the undesired 
species in solution were less likely to crystallise during the process since fast 
removal of solute from solution by seeding resulted in their concentrations being 
subsequently reduced due to the action of the catalyst. 
In entry 1, the solution was seeded with 10 wt% of (S,S)-2 at 38°C at which it 
was held for 1 h before being immediately filtered. A crystal yield of 13.79% was 
achieved of which 44.54% and 44.28% were shown by chiral HPLC to be 
composed of (S,S)-2 and (R,R)-2 respectively. Considering the initial and final 
state of the system, this gave a negative change of -5.18% for the total quantity 
of (S,S)-2 present in the system at the end of the process. Initially it was thought 
that this may have been due to an experimental or measurement error; 
however, a similar result was seen when repeated, and in entries 2-4, where the 
largest reduction in the quantity of (S,S)-2 present was -9.24%.  
This finding suggests that the solution was undersaturated in 5-racmix-2 when 
the enantiopure crystals were added to the system which would have resulted in 
(S,S)-2 being partially dissolved upon introduction, the extent of which being 
determined by how far the solution was above the saturation temperature. This 
would have led to the solution becoming non-equimolar which, in turn, would 
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have initiated catalytic conversion of the excess enantiomer to re-establish 
equilibrium. However, from the solubility curve for 5-racmix-2 (identified in 
section 6), it is known that the equilibrium solubility temperature at this 
concentration is 43.2°C; therefore, the system was well within the MSZW which 
happens to be relatively large at 16.6°C. Furthermore, if the sequence of events 
described above were to have occurred, it would be expected that only (S,S)-2 
would be left in the solid phase (assuming it hadn’t completely dissolve) since 
once equilibrated in solution, there would be no driving force for crystallisation. 
Analysis of the data given for entries 1-4 shows that this is not the case, and in 
fact, for each entry the quantities of (S,S)-2 and (R,R)-2 present in the product 
crystals were almost identical, with considerable amounts of meso-2 also being 
present.  
Perhaps even more unexpected were the findings presented in entries 5-7. For 
each run, the solution was held isothermally for 2 h at 38°C with between 10-50 
wt% of seed present. A temperature programme was applied which consisted of 
initially heating the system by 2°C to 40°C for 30 min, followed by crash cooling 
by 4°C to 36°C, at which point the system was held for 2 h. This cycle of heating 
by 2°C and crash cooling by 4°C was repeated to 26°C upon which the solution 
was immediately filtered. It was though that by initially heating the system above 
the seed temperature whilst remaining within the MSZW, any undesired species 
that may have been deposited would be re-dissolved. Subsequent crash cooling 
would increase the thermodynamic driving force thus resulting in crystallisation 
of the desired enantiomer onto the seed and inducing catalytic transformation in 
solution. Repeating the heating stage of the temperature programme would 
again result in any unwanted solid phase components of the system that may 
have formed being dissolved; therefore, the process would potentially operate 
close to equilibrium between the solid and solution phases leading to 
enantiopure product. 
Examination of the data given for entries 5-7 shows that, even when 50 wt% of 
seed crystals were introduced into the system, and in spite of the reduction in 
process temperature to 26°C, no solids were received at the end of each run i.e. 
complete dissolution of the seed crystals occurred. Comparing this with entries 
1-4, it would be expected that sufficiently more product would be obtained due 
 
225 
 
to the reduction in temperature changing the position of equilibrium. 
Furthermore, considering the possibility that the initial heating stage of the 
temperature programme resulted in the solution becoming unsaturated, with the 
solubility of the pure enantiomer being double that of its racemate, and again 
with the comparatively low final process temperature, it would be impossible 
that the seed would have completed dissolved particularly when 50 wt% was 
used. Therefore the only conclusion that can be drawn from the findings in 
entries 1-7 is that the phase equilibria is being altered as a result of the catalyst 
being present in solution. 
 
Table 7.4a Conditions used and results for CIAT experiments using catalyst 5 (4 mol%) and 
seeding 5-racmix-2 with (S,S)-2, 0.156 mol l
-1
, 30 ml scale, temperature programmes a and d 
(Figure 7.2)
a
. 
 
Part 1: CIAT process conditions 
Entry 
TSeed 
(°C) 
Temperature Programme 
Tfilt 
(°C) 
Seed 
quantity 
(wt%) 
(S,S)-2 in 
system 
(%)
b
 
1 38 [a] Isothermal for 1 h 38 10 38.18 
2 38 [a] Isothermal for 2 h 38 10 38.18 
3 35.5 
[a] Isothermal for 1 h 
35.5 10 38.18 
4 35.5 35.5 20 38.18 
5 38 [d] Isothermal for 2 h, 40°C for 30 min, 
crash cool to 36°C, isothermal for 2 h, 
38°C for 30 min, crash cool to 36°C, 
isothermal for 2 h, repeat to Tfilt 
26 10 38.18 
6 38 26 20 38.18 
7 38 26 50 38.18 
a
See Figure 7.2 for a graphical presentation of the temperature programmes used 
corresponding to the value in square brackets. 
b
Initial (S,S)-2 in system (%) based on 5-racmix-2 
composition in solution (33% (S,S)-2) and seed fraction.  
 
 
 
 
 
 
 
 
226 
 
Table 7.4b Conditions used and results for CIAT experiments using catalyst 5 (4 mol%) and 
seeding 5-racmix-2 with (S,S)-2, 0.156 mol l
-1
, 30 ml scale, temperature programmes a and d 
(Figure 7.2)
a
. 
 
Part 2: Theoretical and obtained crystal yields 
Entry 
Theoretical yields Product Yields 
Product mass 
including seed 
(g)
c
 
Mass of (S,S)-2 
in product (g)
d
 
Product mass 
including seed 
(g) 
Product 
Mass (g)
e
 
Crystal 
Yield 
(%)
e
 
1 0.39 0.19 0.14 0.04 13.79 
2 0.39 0.19 0.18 0.08 27.57 
3 0.50 0.23 0.21 0.11 27.61 
4 0.60 0.33 0.47 0.27 67.02 
5 0.72 0.30 
Seed dissolved 6 0.82 0.40 
7 1.12 0.70 
c
Theoretical mass from 5-racmix-2 solubility curve (Figure 6.5). 
d
Theoretical mass of (S,S)-2 in 
product with no racemisation, based on 5-racmix-2 composition (33% (S,S)-2) and seed fraction. 
e
Not including seed. 
 
Table 7.4c Conditions used and results for CIAT experiments using catalyst 5 (4 mol%) and 
seeding 5-racmix-2 with (S,S)-2, 0.156 mol l
-1
, 30 ml scale, temperature programmes a and d 
(Figure 7.2)
a
. 
 
Part 3: Product Composition (%)
f
 
Entry (S,S)-2 (R,R)-2 meso-2 Benzil Stilbene 
Benz-
aldehyde 
1 44.45 44.28 10.57 0.00 0.00 0.70 
2 44.22 43.99 11.04 0.00 0.00 0.75 
3 43.06 37.97 18.97 0.00 0.00 0.00 
4 46.12 40.38 13.18 0.00 0.00 0.32 
5 
Seed dissolved 6 
7 
f
Determined by chiral HPLC (see section 11.1.5 for method details). 
 
Table 7.4d Conditions used and results for CIAT experiments using catalyst 5 (4 mol%) and 
seeding 5-racmix-2 with (S,S)-2, 0.156 mol l
-1
, 30 ml scale, temperature programmes a and d 
(Figure 7.2)
a
. 
 
Part 4: System Composition 
Entry 
Mass of 
(S,S)-2 in  
product (g)
g
 
Remaining 
(S,S)-2 in 
solution (g)
h
 
(S,S)-2 in system
i
  Change in total 
(S,S)-2 
composition (%)
j
 
(g) (%) 
1 0.06 0.34 0.40 36.20 -5.18 
2 0.08 0.32 0.40 36.51 -4.38 
3 0.09 0.31 0.40 36.54 -4.30 
4 0.22 0.26 0.47 39.33 -9.24 
5 
Seed dissolved 6 
7 
g
From chiral HPLC data and product mass. 
h
(S,S)-2 in solution based on solubility curve, 
product mass and 5-racmix-2 composition (33% (S,S)-2). 
i
Both solid and solution phase 
contributions. 
j
Percent change in (S,S)-2 composition considering initial and final solid and 
solution phases. 
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7.4.2 Catalyst 5 Activity  
The activity of the complex 5 during catalytic transformation of 2 was 
investigated as a result of the unexpected events described in the previous 
section whereby attempts of 2 CIAT using catalyst 5 led to either a reduction in 
the total quantity of (S,S)-2 present in the system for short relative process 
times, or complete dissolution of the seed when longer times were utilised 
despite large quantities of seed being introduced into the system. To determine 
what was occurring in solution, a mixture of 5-racmix-2 and KOH was dissolved 
in toluene-d8 at 50°C. 4 mol% of catalyst 4 was then added and known solution 
volumes samples at regular intervals to be analysed by chiral HPLC.  
Figure 7.9 shows the chiral HPLC data for the solution phase over time. 
Unexpectedly, it evident that there is a significant change in composition over 
time with (S,S)-2, (R,R)-2 and meso-2 eventually disappearing from solution. At 
15 h the solution was free of the enantiomers and the meso form being 
composed predominantly of benzaldehyde, with some stilbene and benzil 
present in small quantities, indicating that C-C bond cleavage had occurred. 
This finding can be used to give a possible explanation for the observations 
seen when CIAT of 2 was attempted with 5.  
For short process times of 1 to 2 h where crystals were recovered with roughly 
equimolar quantities of each enantiomer (entries 1-4 in Table 7.4), addition of 
the seed to the supersaturated solution would have resulted in (S,S)-2 initially 
being deposited from solution followed by catalytic transformation of the other 
species. Simultaneously, (S,S)-2 and (R,R)-2 were being converted to the 
considerably more soluble benzaldehyde in solution reducing their 
concentrations which, in turn, would have led to a portion of the (S,S)-2 seeds 
dissolving to compensate, whilst it is likely that, despite the drop in 
concentration, (R,R)-2 eventually crystallised since it was still supersaturated 
with its loss being compensated for through catalytic conversion of (S,S)-2. 
Hence, at the end of the process, when the mass balance was calculated, the 
total composition of (S,S)-2  was shown to reduce since it was converted to 
benzaldehyde, and was likely also transformed to (R,R)-2. For the runs in 
 
228 
 
excess of 2 h (entries 5-7 in Table 7.4), as they were gradually transformed to 
benzaldehyde, the concentration of the enantiomers and meso form in solution 
would have subsequently reduced leading to dissolution of the seeds and any 
additional solids that may have formed due to crystallisation of the undesired 
species. Therefore, despite the high activity of the catalyst, the tendency of 5 to 
convert the desired enantiomer and its stereoisomers into by-products over time 
rendered it unsuitable for CIAT thus the experimental runs in which it was used 
were unsuccessful. 
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Figure 7.9 Drop in 5-racmix-2 concentration with time under catalytic conditions using complex 5 
(S,S)-2, (R,R)-2, meso-2, benzaldehyde, benzil, stilbene. (  (S,S)-2,  ▼  (R,R)-2,  meso-2, ● 
benzil, ■ benzaldehyde,  ▲ stilbene). 
 
7.5 CIAT Using Other Catalysts Investigated 
CIAT of 2 was also attempted using chlorodicarbonyl-(1,2,3,4,5-
pentaphenylcyclopentadienyl)-ruthenium(II) as a racemisation catalyst (results 
not presented). Comparable results to 4 were seen using this catalyst which is 
likely due to their structural similarities, differing only by a single ligand. This 
complex was also observed to become inactive after period of time and was 
also significantly more expensive therefore its use through the CIAT 
investigation was limited relative to catalyst 4.  
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7.6 Attrition-Enhance De-racemisation (Viedma Ripening)   
In addition to the CIAT process, the attrition-enhanced de-racemisation system 
was also investigated using 2 as a substrate and catalysts 4 and 5 (results not 
presented). In a round bottom flask, 4- or 5-racmix-2 were added with a known 
excess of (S,S)-2 (10-50%) followed by 4 or 5 and KOH. 3 mm glass beads 
were then introduced to the vessel which was subsequently sealed. A known 
quantity of toluene was then syringed into the system giving a slurry which had 
a fixed excess of the desired enantiomer (note: for runs using 4, the system was 
purged with argon, with degassed dry toluene being used as the process 
solvent). The slurry was heated to the desired temperature and stirred 
vigorously for time periods of several days to weeks, at which point the reactor 
contents were filtered, washed with cold toluene, and the product analysed by 
chiral HPLC. 
Due to the problems seen with catalysts 4 and 5 when used in CIAT, none of 
the Viedma ripening runs resulted in successful de-racemisation of the system. 
The product obtained using 4 exhibited a composition corresponding to that at 
the start of the process which would be expected knowing that the complex 
becomes in active after approximately 90 min, whilst the experimental runs 
lasted up to several weeks. When 5 was used as the catalyst, no solids were 
obtained at the end of the process due to conversion of the enantiomers and 
meso form to benzaldehyde as discussed in the previous sections. 
 
7.7 CIAT Modelling 
In addition to the experimental work performed during the investigation, a model 
for the CIAT system was proposed to simulate the process of selective crystal 
growth by preferential crystallisation of a single enantiomer from solution using 
a population balance model, with simultaneous replacement of the crystallised 
solute through the racemisation reaction. However, due to the mixed successes 
seen during the experimental investigations, particularly the difficulty in 
obtaining enantiopure crystal using CIAT, implementation of the model was not 
 
230 
 
taken forward. The discussion below gives a general outline of the proposed 
model and the associated assumptions. 
For a batch crystallisation, assuming perfect mixing and no particle breakage or 
agglomeration, the crystal number density distribution,        (# crystals m-3), as 
a function of time, t (s), and of a one-dimensional characteristic length, L (m), 
can be obtained using the population balance equation which can be written 
as[163]: 
       
  
 
             
  
   Equation 7.1 
 
 
where      is the crystal linear growth rate (m s-1) in the direction of the 
characteristic length, L, i.e. 
  
  
  
 Equation 7.2 
 
 
Equation 7.1 can be solved in discretised form to yield        by applying a 
backward finite difference approximation with a time step ∆t and characteristic 
length step ∆L. For CIAT, under ideal conditions, crystallisation of the desired 
enantiomer occurs solely through growth on the crystal seeds whilst the 
undesired enantiomer remains dissolved in solution therefore it can be assumed 
that no nucleation occurs during the process or: 
  
  
  
   Equation 7.3 
 
 
where B is the nucleation rate (# crystals m-3 s-1) and N is the number of 
crystals. Since CIAT involves introducing seed crystals to the solution, at the 
beginning of the process 
         
Equation 7.4 
 
 
i.e. the number of crystals initially present is determined by the quantity and 
characteristic length, L, of the seeds. Using the population balance equation, 
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the rate of mass deposition of the desired enantiomer (e.g. the (S)-enantiomer) 
from solution, JS-crys (kg m
-3 s-1) can be determined by numerically solving the 
expression: 
         
        
  
             ∫       
    
    
     
Equation 7.5 
 
 
 where MS-crys is the mass of desired solute (in this case the (S)-enantiomer) 
crystallised (kg), kv is the geometric shape factor (kv = 1 for a cubic particle) and 
 crys is the crystal density (kg m
-3). 
During the CIAT process, as the desired enantiomer is deposited onto the seed 
crystals, it is simultaneously replaced in solution due to the action of the 
catalysts by converting the excess antipode thus re-establishing an equimolar 
enantiomeric composition. In Chapter 5 it was shown that the rate of 
racemisation can be fitted to the form 
      
     
  
      
  Equation 7.6 
 
 
where      is the rate of mass conversion of the undesired enantiomer (in this 
case (R)-) to the desired (S)-enantiomer (kg m-3 s-1), Mw is the molecular weight 
(kg kmol-1), CR is the concentration of (R)-enantiomer which is in excess as a 
result of crystallisation of (S)- (kmol m-3), n is the reaction order, and k is the 
reaction rate constant (m(n-1) mol-(n-1) s-1).  Hence combining the expressions for 
crystallisation given above with the kinetic equation for the racemisation 
reaction leads to a description for the rate of solution (and solid) phase change 
in mass of the desired (S)-enantiomer, dMS-sol/dt (kg m
-3 s-1), which assumes 
that crystallisation proceeds via crystal growth only and that crystallisation of the 
undesired enantiomer does not occur: 
       
  
               Equation 7.7 
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7.8 Chapter Summary 
Crystallisation-induced asymmetric transformation (CIAT) of the conglomerate 
alcohol hydrobenzoin (2) was attempted using the organometallic catalysts 
chloro(indenyl)-bis-(triphenylphosphine)-ruthenium(II) (4) and 
chloromonocarbonyltriphenylphosphine-(1,2,3,4,5-
pentaphenylcyclopentadienyl)-ruthenium(II) (5) for solution phase racemisation.   
Based on the racemisation kinetics (chapter 5) and the solubility of the 
stereoisomeric mixtures that resulted upon catalytic transformation of 2 with 4 
and 5, 4-racmix-2 and 5-racmix-2 respectively (chapter 6), conditions were 
selected for CIAT to allow the enantiopure crystals (prepared using 
methodology outlined in chapter 6) to be introduced into the system whilst the 
solution was within the metastable zone so that a sufficient driving force for 
crystallisation existed. Taking the rates of racemisation and crystallisation into 
consideration, the parameters suspected to be influential to the success of the 
process were highlighted to attempt to identify a suitable methodology for 
operation of the CIAT system which were the cooling programme, seeding 
temperature i.e. degree of supersaturation, seed quantity, solution 
concentration and catalyst load, which were all varied to attempt to identify 
conditions that would yield optically pure product. 
Using catalyst 4, it was possible to obtain enantiopure (99.71% chemical purity) 
product crystals of the desired enantiomer (S,S)-2, albeit with a relatively low 
crystal yield (16.46%), using an isothermal temperature programme which 
consisted of crash cooling a slurry of the seed to well below the saturation 
temperature of 4-racmix-2 and holding for a period of up to 90 min. This 
translated into an increase of 8.98% in the total quantity of (S,S)-2 present in 
the system in both the solid and solution phases, indicating that, through the 
action of seeding the equilibrated solution, the undesired stereoisomers had 
been converted to (S,S)-2. For a slight reduction in purity (99.59%), the 
maximum crystal yield obtained for the runs in which enantiopure products were 
recovered was 21.94% which consequently gave the largest change in the 
quantity of (S,S)-2 present in the system (11.95%). Despite the operating 
temperature being considerably lower than the metastable equilibrium 
temperature, Tcryst, for 4-racmix-2, the solution was seen to remain metastable 
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well beyond the metastable solubility due to the rate of supersaturation 
generation not allowing sufficient time for the molecular addition process that is 
required to form a 3-D crystal. 
For CIAT runs using 4 in excess of 90 min, for both isothermal and polythermal 
temperature programmes, enantiopure crystals were never obtained. 
Investigation into the activity of the catalyst showed that, in addition to 
converting the undesired species, 4 itself was gradually converted to 
triphenylphosphine oxide in solution leading to racemisation ceasing. As a 
result, the antipode and meso form were found to be present in the product 
crystals obtained at the end of the process due to them reaching their 
metastable limits and crystallising. Despite this, changes in total (S,S)-2 system 
compositions of up to 61.57% (81.31% crystal yield) were seen when the 
polythermal temperature program was applied indicating that a substantial 
quantity of the undesired species had be transformed into (S,S)-2. 
Issues related to the catalyst during CIAT were also observed for complex 5. In 
contrast to 4, 5 remained active for the duration of the process; however, 
instead of maintaining an equilibrated solution, the stereoisomers (S,S)-2, 
(R,R)-2 and meso-2 were all consumed being converted almost entirely to 
benzaldehyde. Consequently, despite large quantities of seed being introduced 
well below the saturation temperature of 5-racmix-2, complete dissolution of the 
solid was observed in all of the runs that exceeded 2 h. Furthermore, for the 
shorter runs in which product was recovered, as a result of the solution 
concentration being reduced to the by-product formation, negative changes in 
the (S,S)-2 total system composition were observed which was due to the seed 
crystals partially dissolving 
In addition to CIAT, the attrition-enhanced de-racemisation process (Viedma 
Ripening) was also attempted using the conglomerate 2 and the racemisation 
catalysts 4 and 5.  Due to the issues with the catalysts described above, de-
racemisation was not observed in any of the runs attempted. For 4, the resulting 
composition was equivalent to that at the start of the process since it was 
consumed after a short period of time hence no solution phase transformation 
was occurring. On the other hand, use of 5 led to complete dissolution of the 
slurry since the stereoisomers in solution were converted to benzaldehyde 
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which as a result reduced their concentration in solution leading to it become 
undersaturated in solute. 
Finally, a model for CIAT was proposed based on combining a population 
balance model for batch cooling crystallisation with the kinetics for in-situ 
solution phase racemisation of the excess undesired enantiomer. 
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8 Conclusions 
 
 
A novel approach to the CIAT process was investigated by using organometallic 
catalysts 4 and 5 for solution phase racemisation to obtain a single enantiomer 
of 2 from an initially racemic mixture of a conglomerate forming system. Use of 
these complexes to establish dynamic equilibrium between solution phase 
enantiomers does not necessitate the presence of low pKa chiral protons, which 
has been the prerequisite for previously demonstrated CIAT examples limiting 
its use as an industrial scale method of producing pure enantiomers. Therefore 
the application of organometallics as racemisation catalysts in CIAT could 
potentially increase the number of conglomerates that can be resolved by this 
process. 
To attempt CIAT with racemisation catalysts it was first necessary to identify a 
suitable model chiral compound which meets the requirements of the process, 
the most essential of which being that it crystallises as a stable racemic 
conglomerate (see chapter 4.3 for a discussion of the model chiral system 
selection criteria). It was also necessary that the chosen compound had the 
potential to undergo racemisation using available organometallic complexes 
which resulted in chiral alcohols and amines being earmarked for selection as 
extensive examples of their racemisation have been demonstrated. In chapter 4 
several compounds listed as conglomerates in the literature were screened to 
identify a model system for use in the CIAT process. Of these hydrobenzoin 
(1,2-diphenylethane-1,2-diol), 2, a chiral system containing two identical 2° 
alcohol stereogenic centres, was selected to be taken forward in the study as it 
was shown to form a stable conglomerate when crystallised. 
In chapter 5, racemisation of (S,S)-2 was attempted using a number of known 
iridium and ruthenium-based racemisation catalysts. The iridium-based 
complexes were found to be unsuccessful at racemising the chiral alcohol; 
however, as anticipated due to their success in DKR, those based on ruthenium 
were shown to be highly active with complete racemisation being possible 
within ~2 min under some of the conditions investigated. Three organometallic 
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complexes were selected for use as CIAT racemisation catalysts; 
Chloro(indenyl)-bis-(triphenylphosphine)-ruthenium(II) (4), chlorodicarbonyl-
(1,2,3,4,5-pentaphenylcyclopentadienyl)-ruthenium(II) (5) and chlorocarbonyl-
triphenylphosphene(1,2,3,4,5-pentaphenylcyclopentadienyl)-ruthenium(II) (6). 
With the model chiral system and potential racemisation catalysts selected, the 
conditions required for CIAT were identified in chapter 6. Racemisation of (S,S)-
2 resulted in the formation of its antipode but also led to equivalent amounts of 
meso-2 being formed in addition to small quantities of other related by-products 
including benzaldehyde. As a consequence, it was necessary to identify the 
equilibrium and metastable solubilities of the mixtures that resulted upon 
racemisation (S,S)-2 with catalysts 4 and 5 (4-racmix-2 and 5-racmix-2) using 
each of the chosen complexes (as opposed to that of the true racemate which 
would be required for non-catalytic preferential crystallisation) since addition of 
the catalyst to any mixture of 2 stereoisomers would eventually lead to the 
corresponding equilibrated composition. The metastable zone width was 
determined for each of the racemisation mixtures 4-racmix-2 and 5-racmix-2 to be 
used as a basis to select conditions for CIAT. Finally enantiopure crystals of 2 
enantiomers were prepared to be used for seeding. 
The results of the CIAT experiments performed using the model conglomerate 2 
and the racemisation catalysts 3 and 4 were presented in chapter 7.  
Enantiopure product crystals with up to 99.71% purity were obtained with 
catalysts 4 using an isothermal temperature programme in which the 
undersaturated solution was crash cooled to well below the saturation 
temperature of 4-racmix-2 where it was held for periods of up to 90 min. 
However; for each of the optically active products recovered at the end of the 
CIAT process, low crystals yields were observed with the maximum being 
21.94% which consequently gave the largest change in the quantity of (S,S)-2 
present in the system (11.95%) for the enantiopure products obtained. The 
latter finding confirmed that by introducing enantiopure seed to the solution of 
catalytically equilibrated enantiomers, it was possible to convert the undesired 
species including the antipode and meso form into (S,S)-2 by the action of the 
CIAT process. 
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Crystal yield was improved, with up to 86.78% being achieved, by increasing 
the process time, using a reduced concentration, and applying a polythermal 
temperature programme which allowed the system to operate closer to 
equilibrium between the solid and solution phases. Similarly, increases of up to 
61.57% where observed in the total quantity of (S,S)-2 present in both the solid 
and solution phases at the end of the process due to the longer process times 
and wider MSZW at lower concentrations. However, in each of these CIAT runs, 
and in fact all those operated beyond 90 min, crystallisation of (S,S)-2 and 
meso-2 could not be avoided.  
It was shown that this was a result of issues with the catalyst. After 
approximately 1-2 h, 4 had been completely converted to triphenylphosphine 
oxide in solution which led to catalytic conversion of the 2 stereoisomers 
ceasing. Consequently, when the saturated solution was initially seeded, the 
excess antipode and meso form were converted to (S,S)-2 which lowered their 
concentrations hence they remained within their respective metastable zones 
and did not spontaneously nucleate which resulted in the ability to obtain 
enantiopure products for short operation times. At the point where the catalysts 
had been completely converted to benzaldehyde, the lack of catalytic 
conversion led to the undesired species becoming increasingly more 
supersaturated which eventually led to them reaching their metastable limits 
and thus crystallisation was observed.  
Issues were also seen when catalyst 5 was employed in CIAT. In the runs 
performed for a duration of time in excess of 2 h, the seed crystals that were 
initially introduced to the system were found to have dissolved with no product 
being obtained under these conditions, even when the amount of seed was 
increased to 50 wt% of 5-racmix-2. Conversely, for process times less than 2 h, 
solids were recovered; however, the total quantity of (S,S)-2 in the system in 
both the solid and solution phases was seen to decrease. Investigation into the 
activity of catalyst 5 revealed that, in addition to converting the undesired 
enantiomers into (S,S)-2 which was being removed by crystallisation, each of 
the stereoisomers was also reacting to form benzaldehyde which led to them 
eventually being completely consumed. As a result, their solution 
concentrations were reduced leading to them becoming undersaturated 
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therefore dissolution of the seed occurred. For the shorter duration runs, this 
was interrupted before complete dissolution had occurred; however, that which 
had transferred into solution was converted to the undesired species resulting in 
a reduction in the (S,S)-2 composition being observed.  
The attrition-enhanced de-racemisation process (Viedma Ripening) was also 
attempted using the conglomerate 2 and the racemisation catalysts 4 and 5. For 
the reasons discussed above with regards to the performance of the catalysts, 
no enhancements in optical activity were achieved with no change in the system 
composition being observed with 4, and complete dissolution of the solids 
occurring when 5 was utilised. 
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9 Future Work 
 
 
Despite the mixed successes seen during the investigation, CIAT using general 
purpose racemisation catalysts is sure to become a more utilised method of 
obtaining single enantiomers from a racemate as the understanding in the 
respective areas of conglomerate formation and homogeneous racemisation 
catalysis are progressed. Throughout the course of the study, two factors were 
found to be a hindrance in achieving a successfully operating CIAT system 
which are recommended to be the focus of future works:   
 The ability to identify suitable candidates for CIAT that form a 
conglomerate but also have the functionality that allows for racemisation 
 The availability of organometallic complexes that:  
o do not require the substrate to have a chiral proton 
o are air stable 
o are capable of efficiently racemising without the need for additives 
to induce activity which could affect crystallisation 
o have long lasting activity 
o are not consumed during racemisation 
o are selective in that they only induce racemisation and do not 
catalyse by-product formation 
o are inert to the effects of solvents 
During the investigation, the requirement of the conglomerate to possess a 
chiral proton was perhaps the most significant limitation of the proposed CIAT 
process. Many examples of racemates that crystallise as conglomerates have 
been demonstrated in the literature; however, organometallic racemisation is 
currently constrained to chiral alcohols and amines, with the latter being far less 
established. This severely restricted the number of conglomerates that could 
have potentially been used since a wide variety of functionality exists for those 
that are known. Future work should focus on developing complexes that are 
functionally more widely applicable to broaden the number of chiral systems 
that could be potential candidates for CIAT. 
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For established catalysts that have been shown to be capable of racemising 
chiral alcohols and amines, efforts should be focussed of increasing 
performance to give longer activity times, lower by-product formation and 
solvent tolerance. Furthermore, the vast majority of available organometallics 
are air sensitive which increases the complexity of operating CIAT since inert 
atmospheres and degassed solvent must be used. A possible approach to 
resolving these issues is to take known complexes and trial many different 
ligands to observe the resultant effects on racemisation performance and 
applicability.  
In addition to the requirement of more robust catalysts, a better understanding 
of conglomerate formation is required. If conditions could be prescribed that 
influence conglomerate formation it may be possible to increase the number of 
racemates that could be used in CIAT. A more realistic short term approach 
would be to conduct a thorough screening of existing chiral compounds as there 
are few recent examples. This could also be expanded to altering the molecular 
functionality of known racemates similarly followed by a structural screening of 
the configurations that result.  
It is known that the formation of salts using achiral agents can significantly 
increase the probability of conglomerate formation; however, this limits the 
number of complexes that can be used for racemisation since the acidic or 
basic process conditions that result from salt dissolution are unsuitable for most 
racemisation catalysts. Despite this, it is likely that development of this 
methodology presents the most promising advancement; however, suitably 
robust catalysts would need to be identified through experimentation. 
As of current, development of a successful CIAT system using organometallics 
is likely due to be determined by the chance of identifying a compatible system 
of conglomerate and catalyst. In the event that this does occur, the influential 
conditions discussed in section 7.2.2 in conjunction with the knowledge 
acquired from existing literature examples of CIAT should be used as a basis 
for development of a successful process. 
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11  Appendix 
11.1 Equipment and Analytical Techniques 
11.1.1 Equipment 
Unless stated otherwise, all procedures were carried out in multi-neck heat-
resistant glass round bottom flasks equipped, where necessary, with a 
thermometer, reflux condenser and Argon/N2 gas supply. Heating and agitation 
were provided by a digital magnetic stirrer hotplate, with an overhead motor-
driven agitator being used for larger scale syntheses.  
 
11.1.2 1H Nuclear Magnetic Resonance (NMR) Spectroscopy 
Structural analysis was performed using proton nuclear magnetic resonance (1H 
NMR) with a Brucker Avance 500 MHz NMR spectrometer. Samples (~ 1-3 mg) 
were added to 5 mm diameter borosilicate glass NMR tubes, dissolved in 
deuterated chloroform (CDCl3), and sealed with a polyethylene cap prior to 
analysis. 
 
11.1.3 Polarimetry 
Optical rotations were determined under ambient conditions (20°C) using a 
Schmidt + Haensch H532 polarimeter (0.0001° resolution) with an 
electromagnetic wavelength of 589.44 nm. Samples were prepared by 
dissolving a known quantity of solid in a prescribed solvent (1-indanol – 
chloroform c = 2; methylephedrine - methanol c = 5; hydrobenzoin – ethanol c = 
2.5) with the resulting solution being added to a 100 mm path length micro tube 
cell and sealed. The loaded cell was placed in the polarimeter and the absolute 
rotation recorded after sufficient time had elapsed for the signal to remain 
stable. 
 
11.1.4 Differential Scanning Calorimetry (DSC) 
Melting points and enthalpies of fusion were determined by differential scanning 
calorimetry (DSC) using a Mettler Toledo DSC820 calorimeter equipped with a 
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Mettler Toledo TS0801R0 sample robot. Samples of approximately 5 mg were 
loaded into 40 μl aluminium pans and weighed before and after analysis to 
ensure decomposition did not occur. The applied heating programme for 1-
indanol, methylephedrine and hydrobenzoin consisted of holding the pan 
temperature for 25 min at 25°C, 40°C and 80°C, and heating at a rate of 2°C 
min-1 to 90°C, 110°C and 170°C respectively.  
 
11.1.5 High Performance Liquid Chromatography (HPLC) 
The enantiomeric composition hydrobenzoin was determined by chiral high 
performance liquid chromatography (HPLC) using an Agilent 1290 Infinity 
UHPLC. To identity a suitable resolution method a range of different normal 
phase chiral HPLC columns were trialled with different solvents at ambient 
temperature using racemic and enantiopure samples. Hydrobenzoin was 
analysed using a Daicel CHIRALCEL® OD-H chiral column (length = 150 mm, 
internal diameter = 4.6 mm, particle size = 5 μm), also using a 5 v/v% binary 
solvent of propan-2-ol in hexane as a mobile phase at a rate of 1 ml min-1, with 
a DAD wavelength of 210 nm. Peak areas were calibrated using external 
standards (see section 11.4.1 for HPLC calibration data) 
 
11.1.6 X-ray Diffraction 
Powder XRD was performed using a Phillips X’Pert-Pro diffractometer, under 
ambient conditions, using Cu-Kα radiation without a monochromator, and a 
generator current and tube current of 40 mA and 40 kV respectively. Samples 
were ground to a fine powder, paced in an aluminium holder and scanned with 
a diffraction angle 2θ range of 5-80˚. 
Single crystal XRD was performed using a Bruker-Nonius Apex X8 
diffractometer equipped with an Apex II CCD detector and using graphite 
monochromated Mo-Kα radiation from a FR591 rotating anode generator at -
123°C. Single crystals of each enantiomer were grown from toluene by firstly 
dissolving the solid and allowing the solvent to evaporate.  
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11.1.7 FT-Infra-Red Spectroscopy 
FT Infra-red analysis was performed using a Bruker ALPHA spectrometer using 
powdered samples.  
 
11.2 Materials Preparation 
11.2.1 (R)- and (S)-1-indanol (1) Synthesis  
The pure enantiomers of 1-indanol were synthesised individually according to 
the procedure given by Li et al [144], with the intention of obtaining the racemate 
for analysis by combining equal amounts of the two stereoisomers and 
recrystallising them from the melt. The reaction proceeds by asymmetric 
transfer hydrogenation of 1-indanone (C9H8O) in neat water using 
pentamethylcyclopentadienyl iridium dichloride dimer ([Cp*IrCl2]2) as a pre-
catalyst, and excess sodium formate (HCOONa) as a hydrogen source. To 
direct the handedness of the resulting enantiomer, the chiral ligand N-
camphorsulphonyl-1,2-diphenylethylenediamine (CsDPEN) was used with 
[Cp*IrCl2]2 to form the active chiral catalytic species Ir-CsDPEN (0.1 mol%), with 
the (R,R,R)- and (S,S,S)- forms of Ir-CsDPEN leading to the synthesis of (R)-1-
indanol and (S)-1-indanol respectively, giving yields in excess of 85% (Scheme 
11.1). Table 11.1list the materials and quantities used during the procedure for 
a 10 mmol scale synthesis with the methodology given below. 
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Table 11.1 Materials used in the synthesis of (R)-1-indanol and (S)-1-indanol (10 mmol scale) 
 
Material 
Molecular 
weight (g/mol) 
Quantity 
(mmol) 
Quantity 
1-indanone (C9H8O) 132.16 10 1322 mg 
Pentamethylcyclopentadienyl iridium 
dichloride dimer ([Cp*IrCl2]2) 
796.71 0.005 4 mg 
(R,R,R) and (S,S,S)-N-
camphorsulphonyl-1,2-
diphenylethylenediamine (CsDPEN) 
426.20 0.012 5.1 mg 
Sodium formate (HCOONa) 68.01 50 3400 mg 
Diethyl ether  74.12 76.99 8 ml 
Distilled water  18.02 443.27 8 ml 
Anhydrous sodium sulphate 142.04 
As required Petrol (40-60°C) - 
Hexane 86.18 
 
 
Scheme 11.1 Formation of (R)- and (S)-1-indanol by asymmetric transfer hydrogenation of 1-
indanone in water using [Cp*IrCl2]2 and (R,R,R)- / (S,S,S)-CsDPEN as a catalyst (0.1 mol%), 
and excess HCOONa as a hydrogen source. 
Procedure for (S)-1-indanol (1a) synthesis (10 mmol scale): To prepare the 
catalyst, 0.005 mmol (4 mg) of [Cp*IrCl2]2 and 0.012 mmol (5.1 mg) of (S,S,S)-
CsDPEN were added to 8 ml of distilled water in a 25 ml round bottom flask and 
stirred for 1 hour at 40˚C forming the active chiral species Ir-(S,S,S)-CsDPEN. 
50 mmol (3.4 g) of HCOONa and 10 mmol (1.322 g) of 1-indanone were then 
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added to the suspension and left to stir for 20 hours at 40˚C. After allowing the 
reaction mixture to cool to room temperature the organic phase was extracted 
three times using 8 ml of diethyl ether and dried using anhydrous sodium 
sulphate.  The solution was then filtered, concentrated and passed through a 
short silica gel column using a 2:3 mix of petrol and diethyl ether as the eluent. 
Finally, after evaporating the solvent and drying under vacuum, the crude 
product was recrystallized from hexane resulting in the formation of very fine 
white needles (9.2 mmol, 1230 mg).  
 
Procedure for (R)-1-indanol synthesis (1b) (10 mmol scale): 1b was obtained 
following the same procedure as 1a using (R,R,R)-CsDPEN instead as a ligand. 
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Table 11.2 Specific rotation,     
    , of the synthesised enantiomers of 1-indanol (c = 2 in 
chloroform) 
(R)-1-indanol (S)-1-indanol 
-31.2 30.4 
10 8 6 4 2 0
(S)-1-indanol
ppm)
1-indanone
(R)-1-indanol
 
Figure 11.1 
1
H NMR (500 MHz, CDCl3): 1-indanone δ 7.76 (d, 1H, J = 7.8 Hz, aryl H), 7.59 (t, 
1H, J =7.3 Hz, aryl H), 7.48 (d, 1H, J = 7.8 Hz, aryl H), 7.37 (t, 1H, J =7.3 Hz, aryl H), 3.15 (t, 
2H, J = 6.4 Hz, cyclopentyl H), 2.70 (t, 2H, J = 6.4 Hz, cyclopentyl H); (R)-1-indanol δ 7.41 (d, 
1H, J = 6.4 Hz, aryl H) 7.32-7.22 (m, 3H, aryl H), 5.29-5.21 (m, 1H, OH), 3.17-3.01 (m, 1H, 
cyclopentyl H), 2.91-2.77 (m, 1H, cyclopentyl H), 2.56-2.43 (m, 1H, cyclopentyl H), 2.03-1.89 
(m, 1H, cyclopentyl H), 1.86-1.76 (m, 1H, cyclopentyl H); (S)-1-indanol δ 7.42 (d, 1H, J = 6.4 Hz, 
aryl H) 7.36-7.20 (m, 3H, aryl H), 5.29-5.21 (m, 1H, OH), 3.17-3.01 (m, 1H, cyclopentyl H), 2.91-
2.77 (m, 1H, cyclopentyl H), 2.56-2.43 (m, 1H, cyclopentyl H), 2.03-1.89 (m, 1H, cyclopentyl H), 
1.86-1.76 (m, 1H, cyclopentyl H). 
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11.2.2 (S,S)- and (R,R)-hydrobenzoin (2)Synthesis  
The pure enantiomers of hydrobenzoin were synthesised according to the 
procedure given by Ikariya et al [146], with the intention of obtaining the racemate 
for analysis by combining equal amounts of the two stereoisomers and 
recrystallising them from the melt. The reaction proceeds by asymmetric 
transfer hydrogenation of benzil (diphenylethanedione) without solvent using a 
molar 1.69:1 mixture of formic acid and triethylamine as a hydrogen source, and  
the chiral organometallic catalysts RuCl[(1S,2S)-N-p-toluenesulfonyl-1,2-
diphenylethanediamine](η6-p-cymene) (RuCl[(S,S)-TsDPEN(η6-p-cymene)]) and 
its corresponding enantiomer RuCl[(R,R)-TsDPEN(η6-p-cymene)] (0.1 mol%) to 
give (R,R)- and (S,S)-hydrobenzoin respectively (Scheme 11.2). Table 11.3 lists 
the materials used during the synthesis with the procedure for a 10 mmol scale 
synthesis given below. 
 
Table 11.3 Materials used in the synthesis of (S,S)- and (R,R)-hydrobenzoin ((S,S)-2 and (R,R)-
2) (10 mmol scale). 
Material 
Molecular 
weight (g/mol) 
Quantity 
(mmol) 
Quantity 
Benzil 210.23 10 2100 mg 
Formic acid  46.03 48.3 1.83 ml 
Triethylamine 101.19 28.6 4 ml 
Rucl[(R,R)-TsDEPN(p-cymene)] 
Rucl[(S,S)-TsDEPN(p-cymene)] 
636.21 0.01 6.36 mg 
Distilled water  18.02 1163 21 ml 
Methanol 32.04 259.5 10.5 ml  
Propan-2-ol 60.1 27.5 2.1 ml 
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Scheme 11.2 Synthesis of (S,S)- and (R,R)-hydrobenzoin ((S,S)-2 and (R,R)-2) by asymmetric 
transfer hydrogenation using RuCl[(S,S)-TsDPEN(p-cymene)] and RuCl[(R,R)-TsDPEN(p-
cymene)] as catalysts respectively (0.1 mol%), and a formic acid/triethylamine mixture (1.69:1) 
as a hydrogen source
[146]
. 
Procedure for (S,S)-hydrobenzoin ((S,S)-2) synthesis (10 mmol scale): A four-
neck round bottom flask equipped with a reflux condenser, thermometer and 
nitrogen gas supply, was charged with 4 ml of triethylamine (28.6 mmol) and 
cooled to 4°C in an ice bath. 1.83 ml of formic acid (48.3 mmol) was then added 
slowly using a dropping funnel ensuring the exothermic process was sufficiently 
cooled. After allowing the mixture to return to room temperature, 2100 mg benzil 
(10 mmol) and 6.36 mg RuCl[(S,S)-TsDPEN[p-cymene)] (0.01 mmol) were 
added and the vessel heated to 40°C. After stirring the reaction for 24 h, the 
mixture was cooled to 4°C in an ice bath, and 10.5 ml of distilled water added 
resulting in precipitation of a pale pink solid.  This was filtered and washed with 
a further 10.5 ml of water and dried under vacuum giving a white solid. The 
crude product was dissolved in 10.5 ml of methanol at 60°C, after which being 
cooled to -40°C in a propan-2-ol/dry ice bath resulting in the formation of the 
final crystalline product. This was filtered and washed with 2.1 ml of cold 
propan-2-ol giving 1.69 g of (S,S)-2 as white crystals (78.8% yield). 
Procedure for (R,R)-hydrobenzoin ((R,R)-2) synthesis (10 mmol scale): (R,R)-2 
was obtained following the same procedure as (S,S)-hydrobenzoin using 
instead RuCl[(R,R)-TsDPEN(p-cymene)] as a catalyst. 
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Table 11.4 Specific rotation,     
     (°), of the synthesised enantiomers of hydrobenzoin (c = 2.5 
in ethanol). 
(R,R)-hydrobenzoin (S,S)-hydrobenzoin 
92.1 -92.7 
 
10 8 6 4 2 0
(S,S)-hydrobenzoin
ppm)
(R,R)-hydrobenzoin
meso-hydrobenzoin
Benzil
 
Figure 11.2 
1
H NMR (500 MHz, CDCl3): Benzil δ 8.15-7.17 (m, 10H, aryl H); meso-hydrobenzoin 
δ 7.34-7.22 (m, 10H, aryl H), 4.83 (s, 2H, OH), 2.16 (s, 2H, CH); (R,R)-hydrobenzoin δ 7.32-
7.12 (m, 10H, aryl H), 4.76 (s, 2H, OH), 2.83 (s, 2H, CH); (S,S)-hydrobenzoin δ 7.32-7.12 (m, 
10H, aryl H). 4.75 (s, 2H, OH), 2.86 (s, 2H, CH) ((S,S)-2 spectra was obtained using the seed 
crystals synthesised using the recipe described above and prepared for CIAT using the 
methodology given in 6.3.5. 
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11.2.3 N-Methylephedrine (3) Preparation 
(R,S)- and (S,R)-N-methylephedrine ((R,S)-3 and (S,R)-3 respectively) were 
purchased from Sigma Aldrich (ee > 99%) and used directly without further 
purification.  
 
Table 11.5 Specific rotation,     
     (°), of the commercial enantiomers of methylephedrine (c = 
5 in methanol). 
 
(R,S)-N-methylephedrine (S,R)-N-methylephedrine 
-30.1 29.7 
 
10 8 6 4 2 0
(S,R)-N-methylephedrine
 (ppm)
(R,S)-N-methylephedrine
 
Figure 11.3 
1
H NMR (500 MHz, CDCl3): (1R,2S)-N-methylephedrine δ 7.36-7.19 (m, 5H, aryl H), 
4.93 (d, 1H, J = 3.7 Hz, OH), 2.56-2.47 (m, 1H, CH(CH3)), 2.35 (s, 6H, (CH3)2), 2.17 (s, 1H, 
CH(OH)), 0.81 (d, 3H, J = 6.42, CH(CH3)); (1S,2R)-N-methylephedrine  δ 7.35-7.19 (m, 5H, aryl 
H), 4.94 (d, 1H, J = 3.7 Hz, OH), 2.54-2.47 (m, 1H, CH(CH3)), 2.35 (s, 6H, (CH3)2), 2.17 (s, 1H, 
CH(OH)), 0.81 (d, 3H, J = 6.4, CH(CH3)). 
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11.2.4 Chloro(indenyl)-bis-(triphenylphosphine)ruthenium(II) (4) Synthesis  
Chloro(indenyl)-bis-(triphenylphosphine)ruthenium(II) ([RuCl(PPh3)2(η
5-C9H7)]) 
(4) was synthesised according to the procedure given by Oro et al [155]. The 
route involves refluxing [RuCl2(PPh3)3] with indene (C9H8) and potassium 
hydroxide, in dry ethanol under a N2 gas atmosphere (Scheme 11.3). Table 
11.6 gives the materials and quantities used during the reaction for a 1.04 mmol 
scale synthesis with the methodology given below. 
 Table 11.6 Materials used in the synthesis of [RuCl(PPh3)2(η
5
-C9H7)] (4) (1.04 mmol scale) 
 
Material 
Molecular 
weight (g/mol) 
Quantity 
(mmol) 
Quantity 
[RuCl2(PPh3)3] 958.83 1.04 1000 mg 
Indene (C9H8) 116.16 17.17 2 ml 
KOH 56.11 1.04 58.4 mg 
Ethanol - - 19.3 ml 
Dichloromethane - - 8 ml 
Methanol - - 30 ml 
Diethyl ether - As required 
 
 
Scheme 11.3 Synthesis of catalyst 4 ([RuCl(PPh3)2(η
5
-C9H7)]) by the reaction between indene, 
[RuCl2(PPh3)3] and potassium hydroxide in ethanol. 
Procedure for catalyst 4 synthesis (1.04 mmol scale): 1.04 mmol (58.4 mg) of 
KOH was added to a 50 ml Schlenk flask, evacuated and filled with N2, after 
which 9.3 ml of dry ethanol was added to make a 0.11 M solution. This was 
then rapidly added to a refluxing suspension of RuCl2(PPh3)3 (1.04 mmol, 1000 
mg) and indene (17.17 mmol, 2 ml)  in 10 ml of ethanol, and under N2, giving a 
red-brown suspension after 20 min of stirring. After allowing the reaction to 
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procedure for 4 h, the vessel was left to cool to room temperature and filtered, 
with the crude product then being extracted with 8 ml of dichloromethane. The 
extract was filtered leaving a solution to which 30 ml of methanol was added 
leading to precipitation of a red solid. This was filtered and washed with cold 
methanol, then diethyl ether, and dried under vacuum to give 614 mg of the final 
crystalline product (76% yield). 
 
11.2.5 Chlorocarbonyl-triphenylphosphene(1,2,3,4,5-
pentaphenylcyclopentadienyl)-ruthenium(II)  (5) Synthesis 
Chlorocarbonyl-triphenylphosphene(1,2,3,4,5-pentaphenylcyclopentadienyl)-
ruthenium(II) ([RuCl(PPh3)(CO)(η
5-Ph5C5)]) (5) was synthesised according to 
the procedure given by Ko et al [126]. The reaction involves substituting a 
carbonyl ligand on the chlorodicarbonyl-(1,2,3,4,5-pentaphenylcyclopentadienyl-
ruthenium(II) complex (catalyst 5) with a triphenylphosphine group, at 25°C 
under an argon atmosphere (Scheme 11.4). Table 11.7 list the materials and 
quantities used during the synthesis with the procedure for a 0.5 mmol scale 
given below. 
 
Table 11.7 Materials used in the synthesis of [RuCl(PPh3)(CO)(η
5
-Ph5C5)] (5) (0.5 mmol scale) 
 
Material 
Molecular 
weight (g/mol) 
Quantity 
(mmol) 
Quantity 
[RuCl(CO)2(η
5
-Ph5C5)] 638.12 0.50 319 mg 
Triphenylphosphine  262.29 0.55 144 mg 
Trimethylamine N-oxide 75.11 1.00 75.1 mg 
Dichloromethane - - 5.3 ml 
Acetonitrile - - 2.1 ml 
Methanol - As required 
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Scheme 11.4 Synthesis of [RuCl(PPh3)(CO)(η
5
-Ph5C5)] (5) by the substitution of a CO ligand on 
([RuCl(CO)2(η
5
-Ph5C5)]) (6) with triphenylphosphine. 
Procedure for catalyst 5 synthesis (1.04 mmol scale): 0.5 mmol [RuCl(CO)2(η
5-
Ph5C5)] (319 mg) and 0.55 mmol triphenylphosphine (144 mg) was added to a 
25 ml Schlenk flask which was evacuated and filled with argon gas. The solids 
were dissolved in 5.3 ml of dry dichloromethane, then a solution of 
trimethylamine N-oxide (1.00 mmol, 75.1 mg) in 2 ml of dry acetonitrile was 
added slowly whilst stirring at room temperature. After 15 min the solution was 
concentrated and chromatographed on silica using a two stage elution of 
methanol followed by dichloromethane. The resulting solution was again 
concentrated giving 362 mg of the final solid product (83% yield). 
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11.3 Appendix C – Single Crystal X-Ray Diffraction and Refinement 
Data for 1-indanol (1) 
 
 
Figure 11.4 (S)-(-)-1-indanol 
 
(±)-1-indanol 
The structure was solved by direct methods and refined using SHELXL-97. The 
racemate crystallises in the body-centred tetragonal space group I41/a with 16 
molecules in the unit cell. All non-hydrogen atoms were refined anisotropically. All 
hydrogen atoms could be located in a difference Fourier map but, in the final stages of 
the refinement, they were placed in calculated positions and refined using a riding 
model. All Uiso(H) values were constrained to be 1.2 times (1.5 for hydroxyl) Ueq of the 
parent atom. 
(±)-1-indanol Crystallographic Data 
Formula C9H10O 
Formula weight 134.17 
Size 0.26 x 0.14 x 0.12 mm 
Crystal morphology Colourless prism 
Temperature 150(2) K 
Wavelength 0.71073 Å  [Mo-Ka] 
Crystal system Tetragonal 
Space group I41/a 
Unit cell dimensions a = 20.1935(16) Å α = 90° 
 b = 20.1935(16) Å β = 90° 
 c = 7.6039(7) Å γ = 90° 
Volume 3100.7(4) Å3 
Z 16 
Density (calculated) 1.15 Mg/m3 
Absorption coefficient 0.073 mm-1 
F(000) 1152 
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Data collection range 2.02  q  29.22° 
Index ranges -27  h 27,  -27  k  27,  -10  l  10 
Reflections collected 29038 
Independent reflections 2087 [R(int) = 0.0542] 
Observed reflections 1657 [I >2s(I)] 
Absorption correction multi-scan 
Max. and min. transmission 0.9912 and 0.7861 
Refinement method Full 
Data / restraints / parameters 2087 / 0 / 92 
Goodness of fit 1.046 
Final R indices  [I >2s(I)] R1 = 0.0435, wR2 = 0.1121 
R indices (all data) R1 = 0.0568, wR2 = 0.1225 
Largest diff. peak and hole 0.213 and -0.150e.Å-3 
 
Table 11.8 Interatomic distances (Å) rac-1-indanol with s.u.s in parentheses. 
 
O(1)-C(1) 1.4514(14) C(9)-C(4) 1.4137(15) 
 C(9)-C(8) 1.4162(15) C(9)-C(1) 1.5360(15) 
 C(1)-C(2) 1.5609(16) C(3)-C(4) 1.5327(16) 
 C(3)-C(2) 1.551(2) C(7)-C(8) 1.4098(18) 
 C(7)-C(6) 1.411(2) C(4)-C(5) 1.4112(17) 
 C(5)-C(6) 1.410(2) 
 
Table 11.9 Angles between interatomic vectors (°) with s.u.s in parentheses 
 C(4)-C(9)-C(8) 120.91(10) C(4)-C(9)-C(1) 110.46(9) 
 C(8)-C(9)-C(1) 128.59(10) O(1)-C(1)-C(9) 114.92(9) 
 O(1)-C(1)-C(2) 109.58(10) C(9)-C(1)-C(2) 103.35(9) 
 C(4)-C(3)-C(2) 103.88(9) C(8)-C(7)-C(6) 120.33(11) 
 C(5)-C(4)-C(9) 120.19(11) C(5)-C(4)-C(3) 129.13(11) 
 C(9)-C(4)-C(3) 110.67(10) C(7)-C(8)-C(9) 118.68(11) 
 C(6)-C(5)-C(4) 118.84(12) C(5)-C(6)-C(7) 121.05(12) 
 C(3)-C(2)-C(1) 106.42(10) 
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(R)-1-indanol 
The structure was solved by direct methods and refined using SHELXL-97. The 
enantiomer crystallises in the chiral monoclinic space group P21 with one 
molecule of C9 H10 O in the asymmetric unit. In the absence of significant 
anomalous scattering effects, the absolute configuration could not be confirmed 
from the diffraction data and Friedel pairs were merged. The model was 
assigned on the basis of the known stereochemistry of the starting material, (R) 
at C1 therefore the absolute configuration was established by the structure 
determination of a compound containing a chiral reference molecule of known 
absolute configuration. All non-hydrogen atoms were refined anisotropically. All 
hydrogen atoms could be located in a difference Fourier map but, in the final 
stages of the refinement, they were placed in calculated positions and refined 
using a riding model. All Uiso(H) values were constrained to be 1.2 times (1.5 
for hydroxyl) Ueq of the parent atom.  
 
(R)-1-indanol Crystallographic Data 
Formula C9H10O 
Formula weight 134.17 
Size 0.36 x 0.14 x 0.08 mm 
Crystal morphology Colourless fragment 
Temperature 150(2) K 
Wavelength 0.71073 Å  [Mo-Ka] 
Crystal system Monoclinic 
Space group P21 
Unit cell dimensions a = 7.0645(8) Å α = 90° 
 b = 4.8427(5) Å β = 95.749(6)° 
 c = 11.0135(12) Å γ = 90° 
Volume 374.89(7) Å3 
Z 2 
Density (calculated) 1.189 Mg/m3 
Absorption coefficient 0.076 mm-1 
F(000) 144 
Data collection range 1.86  q  29.35° 
Index ranges -9  h 9,  -6  k  5,  -15  l  15 
Reflections collected 8184 
Independent reflections 1142 [R(int) = 0.0494] 
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Observed reflections 1085 [I >2s(I)] 
Absorption correction multi-scan 
Max. and min. transmission 0.9940 and 0.7373 
Refinement method Full 
Data / restraints / parameters 1142 / 1 / 92 
Goodness of fit 1.046 
Final R indices  [I >2s(I)] R1 = 0.0347, wR2 = 0.0924 
R indices (all data) R1 = 0.0369, wR2 = 0.0946 
Largest diff. peak and hole 0.316 and -0.148e.Å-3 
 
 
Table 11.10 Interatomic distances (Å) for (R)-1-indanol with s.u.s in parentheses. 
 O(1)-C(1) 1.4529(16) C(1)-C(9) 1.522(2) 
 C(1)-C(2) 1.565(2) C(2)-C(3) 1.561(2) 
 C(3)-C(4) 1.527(2) C(4)-C(5) 1.407(2) 
 C(4)-C(9) 1.4164(18) C(5)-C(6) 1.408(2) 
 C(6)-C(7) 1.415(2) C(7)-C(8) 1.409(2) 
 C(8)-C(9) 1.411(2) 
 
Table 11.11 Angles between interatomic vectors (°) with s.u.s in parentheses 
 O(1)-C(1)-C(9) 110.86(12) O(1)-C(1)-C(2) 113.53(12) 
 C(9)-C(1)-C(2) 103.60(12) C(3)-C(2)-C(1) 106.41(12) 
 C(4)-C(3)-C(2) 103.73(11) C(5)-C(4)-C(9) 120.16(13) 
 C(5)-C(4)-C(3) 129.17(12) C(9)-C(4)-C(3) 110.65(13) 
 C(4)-C(5)-C(6) 119.14(13) C(5)-C(6)-C(7) 120.73(15) 
 C(8)-C(7)-C(6) 120.30(14) C(7)-C(8)-C(9) 118.92(12) 
 C(8)-C(9)-C(4) 120.76(13) C(8)-C(9)-C(1) 128.10(12) 
 C(4)-C(9)-C(1) 111.11(12) 
 
(S)-1-indanol 
The structure was solved by direct methods and refined using SHELXL-97. The 
enantiomer crystallises in the chiral monoclinic space group P21 with one molecule of 
C9 H10 O in the asymmetric unit. In the absence of significant anomalous scattering 
effects, the absolute configuration could not be confirmed from the diffraction data and 
Friedel pairs were merged. The model was assigned on the basis of the known 
stereochemistry of the starting material, (S) at C1 therefore the absolute configuration 
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was established by the structure determination of a compound containing a chiral 
reference molecule of known absolute configuration. All non-hydrogen atoms were 
refined anisotropically. All hydrogen atoms could be located in a difference Fourier map 
but, in the final stages of the refinement, they were placed in calculated positions and 
refined using a riding model. All Uiso(H) values were constrained to be 1.2 times (1.5 
for hydroxyl) Ueq of the parent atom.  
 
(S)-1-indanol Crystallographic Data 
Formula C9H10O 
Formula weight 134.17 
Size 0.37 x 0.34 x 0.29 mm 
Crystal morphology Colourless fragment 
Temperature 150(2) K 
Wavelength 0.71073 Å  [Mo-Ka] 
Crystal system Monoclinic 
Space group P21 
Unit cell dimensions a = 7.0460(9) Å α = 90° 
 b = 4.8230(6) Å β = 95.763(8)° 
 c = 10.9731(14) Å γ = 90° 
Volume 371.01(8) Å3 
Z 2 
Density (calculated) 1.201 Mg/m3 
Absorption coefficient 0.077 mm-1 
F(000) 144 
Data collection range 2.91  q  30.32° 
Index ranges -9  h 9,  -6  k  6,  -15  l  15 
Reflections collected 6919 
Independent reflections 1217 [R(int) = 0.0656] 
Observed reflections 1158 [I >2s(I)] 
Absorption correction multi-scan 
Max. and min. transmission 0.9781 and 0.7333 
Refinement method Full 
Data / restraints / parameters 1217 / 1 / 92 
Goodness of fit 1.086 
Final R indices  [I >2s(I)] R1 = 0.0399, wR2 = 0.1023 
R indices (all data) R1 = 0.0417, wR2 = 0.1039 
Largest diff. peak and hole 0.371 and -0.181e.Å-3 
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Table 11.12 Interatomic distances (Å) for (S)-1-indanol with s.u.s in parentheses. 
 O(1)-C(1) 1.4464(16) C(1)-C(9) 1.517(2) 
 C(1)-C(2) 1.561(2) C(2)-C(3) 1.554(2) 
 C(3)-C(4) 1.523(2) C(4)-C(5) 1.406(2) 
 C(4)-C(9) 1.4091(17) C(5)-C(6) 1.404(2) 
 C(6)-C(7) 1.408(2) C(7)-C(8) 1.406(2) 
 C(8)-C(9) 1.4068(19) 
 
 
Table 11.13 Angles between interatomic vectors (°) for (S)-1-indanol with s.u.s in parentheses. 
 O(1)-C(1)-C(9) 110.88(12) O(1)-C(1)-C(2) 113.66(11) 
 C(9)-C(1)-C(2) 103.53(12) C(3)-C(2)-C(1) 106.51(12) 
 C(4)-C(3)-C(2) 103.68(11) C(5)-C(4)-C(9) 120.17(12) 
 C(5)-C(4)-C(3) 129.03(12) C(9)-C(4)-C(3) 110.79(12) 
 C(6)-C(5)-C(4) 119.02(13) C(5)-C(6)-C(7) 120.82(15) 
 C(8)-C(7)-C(6) 120.33(13) C(7)-C(8)-C(9) 118.81(12) 
 C(8)-C(9)-C(4) 120.86(13) C(8)-C(9)-C(1) 128.01(12) 
 C(4)-C(9)-C(1) 111.11(12) 
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11.4 (S,S)-hydrobenzoin ((S,S)-2) Racemisation Raw High 
Performance Liquid Chromatography (HPLC) Data for 
Hydrobenzoin 
 
11.4.1 High Performance Liquid Chromatography (HPLC) External 
Standard Calibration  
 
Benzaldehyde 
Retention Time 
(min) 
Concentration 
(mg ml-1) 
Height 
(mAU) 
Area 
(mAU*min) 
Relative Area 
(%) 
9.41 0.5 190.26 76.93 100.00 
9.36 1 355.84 189.48 100.00 
9.49 1.5 524.75 294.03 100.00 
9.50 2 688.68 418.21 100.00 
 
Stilbene 
Retention Time 
(min) 
Concentration 
(mg ml-1) 
Height 
(mAU) 
Area 
(mAU*min) 
Relative Area 
(%) 
22.56 0.5 341.30 393.60 100.00 
22.44 1 677.04 814.47 100.00 
22.48 1.5 969.54 1195.00 100.00 
22.44 2 1259.02 1611.95 100.00 
 
Benzil 
Retention Time 
(min) 
Concentration 
(mg ml-1) 
Height 
(mAU) 
Area 
(mAU*min) 
Relative Area 
(%) 
23.76 0.5 232.30 274.69 100.00 
23.57 1 412.54 482.95 100.00 
23.33 1.5 617.58 750.37 100.00 
23.28 2 790.14 1024.23 100.00 
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(S,S)-hydrobenzoin 
Retention Time 
(min) 
Concentration 
(mg ml-1) 
Height 
(mAU) 
Area 
(mAU*min) 
Relative Area 
(%) 
41.42 0.5 78.80 191.17 100.00 
41.09 1 139.95 352.60 100.00 
40.55 1.5 216.82 564.91 100.00 
40.32 2 279.10 743.95 100.00 
 
(R,R)-hydrobenzoin 
Retention Time 
(min) 
Concentration 
(mg ml-1) 
Height 
(mAU) 
Area 
(mAU*min) 
Relative Area 
(%) 
49.36 0.5 69.60 189.69 100.00 
48.93 1 136.02 383.79 100.00 
48.36 1.5 198.01 567.47 100.00 
46.84 2 233.03 670.80 100.00 
 
meso-hydrobenzoin 
Retention Time 
(min) 
Concentration 
(mg ml-1) 
Height 
(mAU) 
Area 
(mAU*min) 
Relative Area 
(%) 
63.38 0.5 65.95 236.38 100.00 
63.18 1 132.38 478.07 100.00 
63.05 1.5 189.00 695.21 100.00 
62.93 2 242.98 918.74 100.00 
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Figure 11.5 High performance liquid chromatography (HPLC) calibration plots of hydrobenzoin 
and the known components that are formed upon racemisation. 
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11.4.2 Racemisation by chloro(indenyl)-bis-
(triphenylphosphine)ruthenium(II) (4) 
 
Table 11.14 Raw data obtained by HPLC for the racemisation of (S,S)-2 in toluene (mol 
fractions) by complex 4. 
0.117 mol l-1 (S,S)-2, 2 mol% 4, 60°C 
Component 
Time (min) 
0 2 5 9 15 25 
Benzaldehyde 
0 0.0053 0.0115 0.0101 0.0131 0.0093 
Stilbene 
0 0.0050 0.0055 0.0060 0.0055 0.0063 
Benzil 
0 
     
(S,S)-hydrobenzoin 
0.117 0.0420 0.0371 0.0372 0.0355 0.0376 
(R,R)-hydrobenzoin 
0 0.0368 0.0373 0.0382 0.0366 0.0386 
meso-hydrobenzoin 
0 0.0276 0.0254 0.0252 0.0259 0.0248 
 0.117 mol l-1 (S,S)-2, 1 mol% 4, 60°C 
Component 
Time (min) 
0 2 5 9 15 25 
Benzaldehyde 
0 0.0013 0.0227 0.0145 0.0139 0.0148 
Stilbene 
0 0.0036 0.0033 0.0039 0.0036 0.0037 
Benzil 
0 
     
(S,S)-hydrobenzoin 
0.117 0.0538 0.0363 0.0391 0.0385 0.0383 
(R,R)-hydrobenzoin 
0 0.0329 0.0324 0.0361 0.0361 0.0362 
meso-hydrobenzoin 
0 0.0250 0.0220 0.0231 0.0246 0.0236 
 
 
0.117 mol l-1 (S,S)-2, 4 mol% 4, 60°C 
Component 
Time (min) 
0 2 5 9 15 25 
Benzaldehyde 
0 0.0373 0.0557 0.0338 0.0559 0.0169 
Stilbene 
0 0.0110 0.0082 0.0119 0.0030 0.0092 
Benzil 
0 
     
(S,S)-hydrobenzoin 
0.117 0.0260 0.0196 0.0260 0.0213 0.0338 
(R,R)-hydrobenzoin 
0 0.0266 0.0207 0.0274 0.0223 0.0359 
meso-hydrobenzoin 
0 0.0158 0.0125 0.0176 0.0142 0.0209 
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0.117 mol l-1 (S,S)-2, 2 mol% 4, 50°C 
Component 
Time (min) 
0 2 5 9 15 25 
Benzaldehyde 
0 0.0140 0.0204 0.0097 0.0083 0.0069 
Stilbene 
0 0.0054 0.0059 0.0068 0.0057 0.0069 
Benzil 
0 
     
(S,S)-hydrobenzoin 
0.117 0.0503 0.0335 0.0367 0.0375 0.0368 
(R,R)-hydrobenzoin 
0 0.0231 0.0331 0.0383 0.0397 0.0387 
meso-hydrobenzoin 
0 0.0239 0.0238 0.0252 0.0256 0.0274 
 0.117 mol l-1 (S,S)-2, 2 mol% 4, 70°C 
Component 
Time (min) 
0 2 5 9 15 25 
Benzaldehyde 
0 0.0156 0.0353 0.0170 0.0059 0.0178 
Stilbene 
0 0.0065 0.0052 0.0068 0.0064 0.0061 
Benzil 
0 
     
(S,S)-hydrobenzoin 
0.117 0.0360 0.0279 0.0337 0.0378 0.0334 
(R,R)-hydrobenzoin 
0 0.0351 0.0289 0.0348 0.0399 0.0353 
meso-hydrobenzoin 
0 0.0234 0.0194 0.0244 0.0266 0.0242 
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11.4.3 Racemisation by chloro(indenyl)-bis-
(triphenylphosphine)ruthenium(II) (5) 
 
Table 11.15 Raw data obtained by HPLC for the racemisation of (S,S)-2 in toluene (mol 
fractions) by complex 5. 
0.117 mol l-1 (S,S)-2, 2 mol% 5 60°C 
Component 
Time (min) 
0 2 5 9 15 25 60 
Benzaldehyde 
0 0.0096 0.0209 0.0184 0.0217 0.0240 0.0295 
Stilbene 
0 0.0004 0.0013 0.0020 0.0052 0.0064 0.0091 
Benzil 
0 0.0002 0.0006 0.0009 0.0027 0.0030 0.0046 
(S,S)-
hydrobenzoin 
0.117 0.0982 0.0701 0.0562 0.0391 0.0365 0.0299 
(R,R)-
hydrobenzoin 
0 0.0026 0.0103 0.0236 0.0316 0.0304 0.0262 
meso-
hydrobenzoin 
0 0.0059 0.0134 0.0156 0.0163 0.0164 0.0173 
 
0.117 mol l-1 (S,S)-2, 1 mol% 5, 60°C 
Component 
Time (min) 
0 2 5 9 15 25 60 
Benzaldehyde 
0.0000 0.0175 0.0168 0.0173 0.0140 0.0110 0.0113 
Stilbene 
0.0000 0.0002 0.0006 0.0005 0.0009 0.0012 0.0015 
Benzil 
0.0000 0.0001 0.0004 0.0004 0.0005 0.0007 0.0010 
(S,S)-
hydrobenzoin 
0.1170 0.0960 0.0884 0.0771 0.0705 0.0608 0.0520 
(R,R)-
hydrobenzoin 
0.0000 0.0015 0.0041 0.0078 0.0148 0.0264 0.0339 
meso-
hydrobenzoin 
0.0000 0.0013 0.0064 0.0135 0.0160 0.0166 0.0170 
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0.117 mol l-1 (S,S)-2, 4 mol% 5, 60°C 
Component 
Time (min) 
0 2 5 9 15 25 60 
Benzaldehyde 
0.0000 0.0511 0.0633 0.0630 0.0679 0.0653 0.0516 
Stilbene 
0.0000 0.0004 0.0004 0.0010 0.0013 0.0021 0.0031 
Benzil 
0.0000 0.0003 0.0003 0.0010 0.0013 0.0021 0.0047 
(S,S)-
hydrobenzoin 
0.1170 0.0566 0.0366 0.0249 0.0199 0.0191 0.0230 
(R,R)-
hydrobenzoin 
0.0000 0.0027 0.0064 0.0148 0.0159 0.0179 0.0220 
meso-
hydrobenzoin 
0.0000 0.0056 0.0096 0.0120 0.0104 0.0102 0.0123 
 0.117 mol l-1 (S,S)-2, 2 mol% 5, 50°C 
Component 
Time (min) 
0 2 5 9 15 25 60 
Benzaldehyde 
0.0000 0.0129 0.0133 0.0183 0.0167 0.0118 0.0528 
Stilbene 
0.0000 0.0002 0.0005 0.0008 0.0011 0.0023 0.0036 
Benzil 
0.0000 0.0001 0.0002 0.0004 0.0007 0.0010 0.0022 
(S,S)-
hydrobenzoin 
0.1170 0.1014 0.0921 0.0753 0.0658 0.0507 0.0241 
(R,R)-
hydrobenzoin 
0.0000 0.0007 0.0031 0.0070 0.0170 0.0329 0.0210 
meso-
hydrobenzoin 
0.0000 0.0014 0.0074 0.0148 0.0153 0.0179 0.0131 
 0.117 mol l-1 (S,S)-2, 2 mol% 5, 70°C 
Component 
Time (min) 
0 2 5 9 15 25 60 
Benzaldehyde 
0.0000 0.0174 0.0120 0.0179 0.0154 0.0165 0.0351 
Stilbene 
0.0000 0.0010 0.0033 0.0055 0.0077 0.0088 0.0097 
Benzil 
0.0000 0.0006 0.0021 0.0033 0.0052 0.0042 0.0042 
(S,S)-
hydrobenzoin 
0.1170 0.0592 0.0420 0.0345 0.0329 0.0314 0.0232 
(R,R)-
hydrobenzoin 
0.0000 0.0173 0.0363 0.0356 0.0348 0.0337 0.0248 
meso-
hydrobenzoin 
0.0000 0.0212 0.0210 0.0199 0.0206 0.0221 0.0197 
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11.5 HEL Automate Solubility Raw Data for Chloro(indenyl)-bis-
(triphenylphosphine)ruthenium(II) racemisation mixture (4-
racmix-2) in Toluene  
 
Table 11.16 Crystallisation, TCryst, and dissolution, TDiss, temperatures for a range of 
concentrations of 4-racmix-2 in toluene under a cooling rate of 0.25°C min
-1
. 
0.25°C/min 
Run 
Measured Temperature (°C) 
Concentration (mol l
-1
) 
0.0014
a
 0.0035 0.0070 0.0105 0.0140 
TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss 
1 7.6 24.9 18.6 36.9 35.3 43.9 46.9 - 49.7 55.0 
2 7.7 25.3 21.4 35.2 36.3 44.6 45.0 51.1 52.4 56.0 
3 7.8 25.3 22.0 - 36.8 44.5 42.0 53.4 46.9 56.7 
4 8.1 25.5 27.5 36.1 36.6 45.1 48.1 52.8 - - 
5 7.6 22.1 - - - - 45.7 52.0 - - 
6 7.7 22.1 - - - - 42.9 52.9 - - 
7 7.8 23.7 - - - - - - - - 
8 8.1 25.1 - - - - - - - - 
Av. (°C) 7.8 24.2 22.4 36.1 36.2 44.5 45.1 52.5 49.7 55.9 
St. Dev. 
(°C) 
0.2 1.3 3.2 0.7 0.6 0.4 2.1 0.8 2.3 0.7 
St. Error 
(%) 
0.92 1.95 7.18 1.06 0.80 0.45 1.93 0.67 2.63 0.71 
a
Data obtained using the Crystal16 system. 
 
 
 
 
 
 
 
 
 
 
 
284 
 
Table 11.17 Crystallisation, TCryst, and dissolution, TDiss, temperatures for a range of 
concentrations of 4-racmix-2 in toluene under a cooling rate of 0.5°C min
-1
. 
0. 5°C/min 
Run 
Measured Temperature (°C) 
Concentration (mol l
-1
) 
0.0014
a
 0.0035 0.0070 0.0105 0.0140 
TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss 
TCrys
t 
TDiss 
1 5.4 24.4 18.5 39.4 31.6 49.5 38.5 54.6 45.7 56.9 
2 5.5 24.6 19.4 36.7 30.5 48.8 36.5 54.3 49.3 58.9 
3 5.7 24.7 21.8 - 35.5 50.9 39.4 55.3 46.0 - 
4 6.0 24.8 25.3 38.1 - 48.4 39.6 55.5 47.6 59.4 
5 4.5 24.4 -  - - - - - - 
6 5.4 24.6 - - - - - - - - 
7 5.5 24.7 - - - - - - - - 
8 5.7 24.8 - - - - - - - - 
Av. (°C) 5.4 24.6 21.3 38.0 32.5 49.4 38.5 54.9 47.2 58.4 
St. Dev. 
(°C) 
0.4 0.1 2.6 1.1 2.1 1.0 1.2 0.5 1.5 1.1 
St. Error 
(%) 
0.15 0.05 1.32 0.64 1.23 0.48 0.62 0.24 0.73 0.62 
a
Data obtained using the Crystal16 system. 
 
 
Table 11.18 Crystallisation, TCryst, and dissolution, TDiss, temperatures for a range of 
concentrations of 4-racmix-2 in toluene under a cooling rate of 0.75°C min
-1
. 
0. 75°C/min 
Run 
Measured Temperature (°C) 
Concentration (mol l
-1
) 
0.0014
a
 0.0035 0.0070 0.0105 0.0140 
TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss 
TCrys
t 
TDiss 
1 3.2 24.9 18.6 40.5 29.4 - 35.9 56.3 41.0 57.7 
2 4.6 25.1 22.7 40.9 29.1 49.8 33.6 56.6 46.0 58.1 
3 7.5 25.1 - 40.9 33.3 49.3 36.8 - 42.4 57.8 
4 8.1 25.2 20.6 41.3 31.3 51.5 39.4 53.5 - - 
5 1.9 24.9 - - 30.7 49.7 35.5 54.6 - - 
6 2.8 25.1 - - 30.3 - 35.5 53.3 - - 
7 1.3 25.1 - - - - - - - - 
8 1.3 25.2 - - - - - - - - 
Av. (°C) 3.8 25.1 20.6 40.9 30.7 50.1 36.1 54.8 43.1 57.9 
St. Dev. 
(°C) 
2.5 0.1 1.7 0.3 1.4 0.9 1.8 1.4 2.1 0.2 
St. Error 
(%) 
0.89 0.04 0.96 0.13 0.56 0.43 0.72 0.62 1.20 0.09 
a
Data obtained using the Crystal16 system. 
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Table 11.19 Crystallisation, TCryst, and dissolution, TDiss, temperatures for a range of 
concentrations of 4-racmix-2 in toluene under a cooling rate of 1°C min
-1
. 
1°C/min 
Run 
Measured Temperature (°C) 
Concentration (mol l
-1
) 
0.0014
a
 0.0035 0.0070 0.0105 0.0140 
TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss 
TCrys
t 
TDiss 
1 1.6 25.4 14.5 40.7 - 52.6 33.4 58.4 40.5 61.4 
2 2.1 25.4 19.3 40.9 29.9 50.8 33.0 - 41.8 - 
3 2.8 25.4 - 41.2 - 49.0 35.7 58.5 41.0 62.0 
4 4.5 25.5 16.9 41.4 26.2 50.8 35.3 57.7 39.8 63.2 
5 1.6 25.4 - - 25.4 51.0 - - - - 
6 1.6 25.4 - - 27.5 53.5 - - - - 
7 2.1 25.4 - - 27.1 - - - - - 
8 2.8 25.5 - - - - - - - - 
Av. (°C) 2.4 25.4 16.9 41.0 27.2 51.3 34.4 58.2 40.8 62.2 
St. Dev. 
(°C) 
0.9 0.1 2.0 0.3 1.5 1.4 1.1 0.4 0.7 0.7 
St. Error 
(%) 
0.33 0.02 1.13 0.14 0.69 0.58 0.57 0.22 0.37 0.43 
a
Data obtained using the Crystal16 system. 
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11.6 Crystal16 Calibration 
 
Table 11.20 Crystal16 calibration: Measured vessel temperatures for given set temperatures  
Block 
Set Point 
20°C 40°C 
Vessel Number 
1 2 3 4 1 2 3 4 
Measured Temperature (°C) 
A 
19.9 19.9 20 20.1 38.2 38.4 38.2 38.4 
19.9 19.9 20 20.1 38.4 38.5 38.4 38.3 
19.9 19.9 20 20 38.3 38.4 38.3 38.3 
B 
20 20 20.2 20.1 38.5 38.7 38.4 38.7 
19.9 20 20.2 20.1 38.8 38.9 38.7 38.6 
20 19.9 20.1 20.1 38.7 38.8 38.5 38.6 
C 
19.9 20 20.2 20 38.5 38.6 38.4 38.4 
20 20 20 20.1 38.6 38.6 38.4 38.4 
19.9 20 20.1 20 38.5 38.6 38.4 38.4 
D 
20 20 20.3 20.3 38.7 38.9 38.7 38.4 
20.2 20.2 20.4 20.3 38.7 38.9 38.7 38.6 
20.2 20.2 20.3 20.3 38.7 38.9 38.7 38.5 
 
Block 
Set Point 
60°C 80°C 
Vessel Number 
1 2 3 4 1 2 3 4 
Measured Temperature (°C) 
A 
57.8 58 57.7 57.5 76.3 77.1 77 75.7 
57.8 58 57.8 57.4 76.4 77.1 76.9 75.8 
57.8 58 57.8 57.5 76.4 77.2 76.9 75.7 
B 
58.5 58.5 58.4 58.2 76.5 77.1 77.4 76.7 
58.3 58.5 58 58.5 76.5 77.2 77.2 76.7 
58.4 58.5 58.2 58.3 76.6 77.3 77.4 76.8 
C 
58.1 58.2 57.9 58 76.2 76.4 75.9 75.1 
57.8 58.2 57.7 58.3 76.1 76.7 76.1 75.2 
58 58.2 57.8 58.1 76.2 76.5 76 75.1 
 
D 
 
58.5 58.7 57.4 58.2 75.8 77 77.2 76.2 
58.2 58.4 57.8 58.1 75.6 77.1 77.4 76 
58 58.4 58 58.3 75.8 77.2 77.2 76.3 
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Table 11.21 Crystal16 calibration: Average measured temperatures for a given set temperature 
Block A Block B 
Set 
Point 
Measured 
Temperature (°C) 
Standard 
Deviation 
Set 
Point 
Measured 
Temperature (°C) 
Standard 
Deviation 
20 19.97 0.07 20 20.05 0.10 
40 38.34 0.09 40 38.66 0.14 
60 57.76 0.19 60 58.36 0.16 
80 76.54 0.55 80 76.95 0.34 
 
Block C Block D 
Set 
Point 
Measured 
Temperature (°C) 
Standard 
Deviation 
Set 
Point 
Measured 
Temperature (°C) 
Standard 
Deviation 
20 20.02 0.08 20 20.23 0.12 
40 38.48 0.09 40 38.70 0.15 
60 58.03 0.18 60 58.17 0.33 
80 75.96 0.52 80 76.57 0.65 
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Figure 11.6 Crystal16 calibration: Measured temperature vs. set temperature for each Crystal16 
block. 
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Table 11.22 Calibration equations for Crystal16 
blocks 
Block Equation R
2
 
A y=0.94571x+0.86667 0.999 
B y=0.952x+0.90417 0.999 
C y=0.93683x+1.27917 0.999 
D y=0.94246x+1.29167 0.999 
 
 
 
11.7 Calibrated Crystal16 Raw Solubility Data 
11.7.1 Chlorocarbonyl-triphenylphosphene(1,2,3,4,5-
pentaphenylcyclopentadienyl)-ruthenium(II) (5-racmix-2) in Toluene  
 
Table 11.23 Measured and calibrated crystallisation, TCryst, and dissolution, TDiss, temperatures 
for 5-racmix-2 in Toluene under a cooling rate of 0.25°C min
-1
. 
0.25°C/min 
Run 
Block A: 0.311 mol l
-1
 Block B: 0.233 mol l
-1
 
Measured T (°C) Calibrated T (°C) Measured T (°C) Calibrated T (°C) 
TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss 
1 35.6 52.6 34.5 50.6 32.1 48.9 31.5 47.5 
2 35.7 52.7 34.6 50.7 32.6 49.1 31.9 47.6 
3 36.1 52.9 35.0 50.9 33.2 49.2 32.5 47.7 
4 36.7 53.2 35.6 51.2 35.1 49.7 34.3 48.2 
5 31.2 52.6 30.4 50.6 24.3 42.4 24.0 41.3 
6 35.8 52.7 34.7 50.7 24.5 49.2 24.2 47.7 
7 35.9 52.7 34.8 50.7 24.8 49.5 24.5 48.0 
8 37.3 53.1 36.1 51.1 32.0 49.7 31.4 48.2 
Average (°C) 34.5 50.8 
 
29.3 47.0 
Standard Deviation (°C) 1.6 0.2 
 
4.0 2.2 
Standard Error (%) 0.58 0.07  1.41 0.78 
 
Run 
Block C: 0.155 mol l
-1
 Block D: 0.078 mol l
-1
 
Measured T (°C) Calibrated T (°C) Measured T (°C) Calibrated T (°C) 
TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss 
1 26.4 44.7 26.0 43.2 11.0 32.1 11.7 31.5 
2 27.2 45 26.8 43.4 13.0 32.6 13.5 32.0 
3 27.3 45.5 26.9 43.9 13.8 33.0 14.3 32.4 
4 27.5 45.6 27.0 44.0 13.9 33.1 14.4 32.5 
5 18.7 44.7 18.8 43.2 7.0 32.8 7.9 32.2 
6 19.4 45.2 19.5 43.6 8.3 32.9 9.1 32.3 
7 22.0 45.7 21.9 44.1 8.6 33.1 9.4 32.5 
8 25.9 45.8 25.5 44.2 8.7 33.2 9.5 32.6 
Average (°C) 24.0 43.7 
 
11.2 32.3 
Standard Deviation (°C) 3.2 0.4 
 
2.4 0.3 
Standard Error (%) 4.75 0.31  7.63 0.35 
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Table 11.24 Measured and calibrated crystallisation, TCryst, and dissolution, TDiss, temperatures 
for 5-racmix-2 in Toluene under a cooling rate of 0.5°C min
-1
. 
0.5°C/min 
Run 
Block A: 0.311 mol l
-1
 Block B: 0.233 mol l
-1
 
Measured T (°C) Calibrated T (°C) Measured T (°C) Calibrated T (°C) 
TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss 
1 26.8 52.7 26.2 50.7 24.7 49.3 24.4 47.8 
2 28.1 52.79 27.4 50.8 24.9 49.5 24.6 48.0 
3 31.9 52.96 31.0 51.0 26.3 49.6 25.9 48.1 
4 36.7 53 35.6 51.0 30.3 49.6 29.7 48.1 
5 28.6 52.7 27.9 50.7 27.4 49.6 27.0 48.1 
6 31.7 52.9 30.8 50.9 28.5 49.6 28.0 48.1 
7 32.7 52.9 31.8 50.9 29.2 49.7 28.7 48.2 
8 33.07 53.1 32.1 51.1 30.2 49.9 29.7 48.4 
Average (°C) 30.4 50.9 
 
27.3 48.1 
Standard Deviation (°C) 2.8 0.1 
 
2.0 0.2 
Standard Error (%) 1.01 0.04  0.70 0.05 
 
Run 
Block C: 0.155 mol l
-1
 Block D: 0.078 mol l
-1
 
Measured T (°C) Calibrated T (°C) Measured T (°C) Calibrated T (°C) 
TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss 
1 19.8 45.4 19.8 43.8 8.3 32.3 9.1 31.7 
2 21.3 45.5 21.2 43.9 8.6 32.6 9.4 32.0 
3 21.6 45.5 21.5 43.9 15 33 15.4 32.4 
4 21.6 45.8 21.5 44.2 20 33.1 20.1 32.5 
5 19.2 45.2 19.3 43.6 8 32.9 8.8 32.3 
6 20.1 45.4 20.1 43.8 10.8 32.9 11.5 32.3 
7 20.4 45.7 20.4 44.1 10.8 33.2 11.5 32.6 
8 23.7 45.7 23.5 44.1 17.4 33.2 17.7 32.6 
Average (°C) 20.9 43.9 
 
12.9 32.3 
Standard Deviation (°C) 1.2 0.2 
 
4.0 0.3 
Standard Error (%) 2.09 0.14  10.79 0.3 
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Table 11.25 Measured and calibrated crystallisation, TCryst, and dissolution, TDiss, temperatures 
for 5-racmix-2 in Toluene under a cooling rate of 0.75°C min
-1
. 
0.75°C/min 
Run 
Block A: 0.311 mol l
-1
 Block B: 0.233 mol l
-1
 
Measured T (°C) Calibrated T (°C) Measured T (°C) Calibrated T (°C) 
TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss 
1 24.1 53 23.7 51.0 23.4 50 23.2 48.5 
2 24.4 53.13 23.9 51.1 23.4 50.1 23.2 48.6 
3 24.6 53.2 24.1 51.2 24.9 50.1 24.6 48.6 
4 24.7 53.3 24.2 51.3 25.4 50.2 25.1 48.7 
5 25 53.1 24.5 51.1 22.9 49.7 22.7 48.2 
6 25 53.3 24.5 51.3 23.1 49.9 22.9 48.4 
7 25.5 53.5 25.0 51.5 23.4 50 23.2 48.5 
8 25.5 53.6 25.0 51.6 23.4 50 23.2 48.5 
Average (°C) 24.4 51.2 
 
23.5 48.5 
Standard Deviation (°C) 0.4 0.2 
 
0.8 0.1 
Standard Error (%) 0.64 0.12  1.21 0.10 
 
Run 
Block C: 0.155 mol l
-1
 Block D: 0.078 mol l
-1
 
Measured T (°C) Calibrated T (°C) Measured T (°C) Calibrated T (°C) 
TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss 
1 17.9 45.9 18.0 44.3 6.5 33.2 7.4 32.6 
2 18.4 45.9 18.5 44.3 7.1 33.4 8.0 32.8 
3 18.4 46 18.5 44.4 7.1 33.4 8.0 32.8 
4 18.8 46 18.9 44.4 7.2 33.5 8.1 32.9 
5 17.6 46 17.8 44.4 4.2 33.3 5.3 32.7 
6 17.7 46 17.9 44.4 4.4 33.4 5.4 32.8 
7 18.3 46 18.4 44.4 4.8 33.5 5.8 32.9 
8 18.5 46.1 18.6 44.5 5.9 33.5 6.9 32.9 
Average (°C) 18.3 44.4 
 
6.9 32.8 
Standard Deviation (°C) 0.4 0.1 
 
1.1 0.1 
Standard Error (%) 0.71 0.04  5.77 0.10 
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Table 11.26 Measured and calibrated crystallisation, TCryst, and dissolution, TDiss, temperatures 
for 5-racmix-2 in Toluene under a cooling rate of 1°C min
-1
. 
1°C/min 
Run 
Block A: 0.311 mol l
-1
 Block B: 0.233 mol l
-1
 
Measured T (°C) Calibrated T (°C) Measured T (°C) Calibrated T (°C) 
TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss 
1 22.72 53.7 22.4 51.7 21.3 50 21.2 48.5 
2 23.6 53.7 23.2 51.7 21.7 50.2 21.6 48.7 
3 23.6 54 23.2 51.9 22.1 50.4 21.9 48.9 
4 23.89 54.1 23.5 52.0 22.1 50.6 21.9 49.1 
5 22.6 53.4 22.2 51.4 18.9 50.2 18.9 48.7 
6 23.1 53.5 22.7 51.5 19.8 50.2 19.8 48.7 
7 24 53.9 23.6 51.8 20.3 50.6 20.2 49.1 
8 24.5 54 24.0 51.9 21 50.8 20.9 49.3 
Average (°C) 23.1 51.7 
 
20.8 48.9 
Standard Deviation (°C) 0.6 0.2 
 
1.0 0.2 
Standard Error (%) 0.89 0.15  1.74 0.17 
 
Run 
Block C: 0.155 mol l
-1
 Block D: 0.078 mol l
-1
 
Measured T (°C) Calibrated T (°C) Measured T (°C) Calibrated T (°C) 
TCryst TDiss TCryst TDiss TCryst TDiss TCryst TDiss 
1 13.2 46.2 13.6 44.6 4.2 33.6 5.3 33.0 
2 16.1 46.5 16.4 44.8 4.5 33.8 5.5 33.1 
3 16.5 46.8 16.7 45.1 6 33.9 6.9 33.2 
4 16.6 46.9 16.8 45.2 1.2 33.6 2.4 33.0 
5 15.2 46.3 15.5 44.7 2.9 33.7 4.0 33.1 
6 15.9 46.5 16.2 44.8 3.5 33.7 4.6 33.1 
7 16.4 46.6 16.6 44.9 4.1 33.9 5.2 33.2 
8 17 46.8 17.2 45.1 3.7 33.7 4.8 33.1 
Average (°C) 16.1 44.9 
 
4.8 33.1 
Standard Deviation (°C) 1.1 0.2 
 
1.2 0.1 
Standard Error (%) 2.31 0.17  8.86 0.11 
 
 
